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Abstract
Clinical evidence shows that central (aortic) blood pressure (cBP) is a better marker
of cardiovascular risk than brachial pressure. However, cBP can only be accurately
measured invasively, through catheterisation. Although medical imaging techniques such
as magnetic resonance imaging and ultrasound provide good resolution aortic blood flow
and geometry, they do not currently provide cBP.
This thesis presents a novel approach to measure cBP non-invasively from medical
imaging data and a non-invasive peripheral pressure measurement, using zero and one-
dimensional computational models of aortic haemodynamics. The studies reported used
both in silico (simulated) and in vivo (clinical) data for algorithm development, testing,
and validation. Firstly, three in silico datasets were created using computational mod-
els whose inputs were cardiovascular properties from the clinical literature for healthy
humans. Secondly, existing and new methods to measure cardiovascular properties from
clinical data were investigated. These properties have clinical value for assessing cardio-
vascular function and are also used as inputs to computational models to measure cBP
non-invasively. Thirdly, the performance of three computational models of aortic haemo-
dynamics for non-invasive cBP measurement was assessed. Three in vivo datasets were
used to determine the preferred cBP algorithm: one containing invasive cBP measure-
ments for aortic coarctation patients; and two containing non-invasive cBP measurements
for hypertensive patients and normotensive volunteers, respectively. Finally, a ‘cohort-
specific’ in silico dataset was created to study the individual effect of cardiovascular
properties on the aortic pressure gradients – measured using magnetic resonance imag-
ing – in dilated cardiomyopathy patients. Hence, the main contributions of this thesis
were the development and testing of a range of tools to measure cardiovascular proper-
ties and cBP from non-invasive clinical measurements; and the study of the individual
cardiovascular determinants of the aortic pressure gradients.
In the clinic, the preferred cBP algorithm could be used to augment, at no additional cost,
the clinical data obtained from ultrasound and magnetic resonance imaging by providing
an accurate, patient-specific, non-invasive measurement of cardiovascular parameters and
cBP waves. Furthermore, the assessment of haemodynamic metrics (e.g. aortic pressure
gradients, blood pressure or flow waves) using ‘cohort-specific’ in silico datasets could be
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de disfrutar la vida desde pequeñito. Gran parte de lo que soy os lo debo a vosotros.
A mis queridos Koaleños, Ale, Edu, Félix, Guille, Jaime, Jorge, Moy, Nolo, Nuño, Olga,
Pepe y Terry, por ser una fuente inagotable de felicidad y diversión (y salseo) desde siem-
pre. A Javi, por todas las aventuras que hemos vivido juntos. Gracias por una larga lista
de recuerdos inolvidables y por los que nos quedan. A Manchón, por entenderme mejor
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Cardiovascular disease – any medical condition affecting the cardiovascular system –
is the most common cause of death worldwide (31% in 2016), with heart attack and
stroke accounting for 85% of these deaths [7]. Although there is no specific cause for
cardiovascular disease, there are a number of “risk factors” that increase the probability
of having it, such as family history, cholesterol, diabetes, obesity, an unhealthy lifestyle,
or high blood pressure (hypertension).
Blood pressure is a wave which fluctuates with every heartbeat, in the same way that
waves in the sea form peaks and troughs. Clinicians can monitor an individual’s cardio-
vascular health using blood pressure to detect hypertension or to assess arterial abnormal-
ities. Since the invention of the sphygmomanometer (commonly known as brachial cuff)
at the end of the XIX century, clinicians have been able to measure maximum (systolic)
and minimum (diastolic) blood pressure values non-invasively in the arm. Additionally,
recent technology allows the blood pressure wave to be measured non-invasively in pe-
ripheral (far from the heart) arteries, such as the carotid or radial arteries. However,
blood pressure levels in the heart or in the aorta, which are very useful to assess cardio-
vascular health, are normally measured via cardiac catheterisation, a highly invasive and
expensive procedure which carries a risk for the patient. Although there are non-invasive
methods to measure aortic blood pressure, they tend to use a combination of peripheral
measurements and empirical data. Therefore, a method which measures aortic blood
pressure non-invasively using patient-specific measurements – some of them obtained at
the aorta – is highly desirable.
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At a fundamental level, the flow of blood pumped by the heart into the arteries can
be described similarly to how water flows through a flexible tube, or to how air passes
around a Formula One car. These physical phenomena can be studied mathematically
using the equations of fluid dynamics. However, solving these equations with pen and
paper becomes increasingly difficult as the complexity of the phenomena increases, so a
computational model can be used to solve them instead. A computational model is a
mathematical representation of a physical phenomenon: it starts from a series of justified
assumptions, follows a set of mathematical rules, and can be used to simulate said phe-
nomenon on a computer. In the same way that there are simple phenomena (e.g. purely
elastic collisions) and more complex ones (e.g. n-body problem), there are computational
models with different levels of complexity. Zero-dimensional (0-D) models can be used to
study the global behaviour of a fluid over time, but are unable to provide information on
the direction of flow. One-dimensional (1-D) models can be used to study fluids which
move mostly in one direction (e.g. blood mainly flows parallel to the wall of the arter-
ies, rather than perpendicular to them). Three-dimensional (3-D) models can represent
fluid dynamics in all directions and in all kinds of problems. As complexity increases,
so does the computational cost, which indicates the amount of computational resources
(e.g. random access memory or RAM) required to simulate a given phenomenon. There-
fore, the choice of a computational model is normally conditioned by the nature of the
phenomenon under study and the availability of computational resources.
Non-invasive measurements remove any risks for the patient compared to cardiac catheter-
isation, and can be obtained much more quickly using computational models. In this
thesis, 0-D and 1-D models have been used to obtain reliable aortic blood pressure mea-
surements from magnetic resonance and ultrasound scans. 0-D models were used because
of their relatively low computational cost and because of their ability to measure blood
pressure from aortic flow – obtained via magnetic resonance imaging or ultrasound – and
a peripheral blood pressure measurement only. When the anatomy of the aorta from
magnetic resonance imaging was available, 1-D models were used as they allow the study
of the propagation of the blood pressure waves throughout the arteries while keeping the
computational cost low enough for a clinical setup. Regardless of the choice of model,
patient-specific models are created by extracting a series of cardiovascular parameters,
such as the heart rate or the stiffness of the aorta, from a given patient’s clinical mea-
surements. Therefore, a part of this thesis is dedicated to finding optimal methods to
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extract these parameters from clinical measurements with the ultimate aim of obtaining
reliable blood pressure measurements.
The aortic pressure gradient, calculated as the difference in blood pressure before and
after a narrowing of the aorta or between either side of the aortic valve, is used to detect
and monitor certain cardiovascular diseases. The magnitude of the pressure gradient
allows clinicians to plan drug therapy and to decide whether a surgical intervention is
necessary. There are both invasive and non-invasive methods to obtain aortic pressure
gradient measurements. Using non-invasive measurements of the aortic pressure gradient,
a part of this thesis investigates the differences in cardiovascular properties between
dilated cardiomyopathy patiens and healthy subjects.
1.2 Thesis objectives
This thesis studies how computational models of arterial blood flow can be used to assess
cardiovascular health. The overall aim of this thesis is:
To develop and assess the performance of algorithms to estimate aortic
blood pressure from non-invasive clinical measurements using
computational models.
The following objectives were identified to achieve the overall aim:
• To create datasets of thousands of healthy virtual subjects with known
cardiovascular parameters and physiological haemodynamic waves. Three
datasets of virtual subjects were created using computational models of arterial
blood flow of different complexities. The cardiovascular parameters required by the
models were extracted from the clinical literature for healthy adults. Each dataset
contained thousands of virtual subjects, whose unique cardiovascular parameters
and haemodynamic waves (i.e. flow, pressure, area) were known exactly at one or
more locations.
• To identify optimal methods to estimate cardiovascular parameters. An
exhaustive literature review of current methods to estimate cardiovascular param-
eters was performed. Additionally, novel methods were developed. Using the
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datasets of virtual subjects, both current and novel methods were assessed for
the first time against a common reference.
• To develop and assess novel aortic (central) blood pressure estimation
algorithms. Three novel central blood pressure estimation algorithms were devel-
oped combining optimal cardiovascular parameter estimation methods and three
computational models of arterial blood flow. They were assess assessed on three
clinical datasets and one dataset of virtual subjects. Each dataset contained refer-
ence central blood pressure and flow waves.
• To study the influence of individual cardiovascular parameters on the
aortic pressure gradient of dilated cardiomyopathy (DCM) patients. A
dataset of virtual subjects was created using the clinical characteristics of a group
of DCM patients and healthy controls. Since individual cardiovascular parameters
were varied between subjects, whilst all others were held constant, the virtual
dataset allowed the influence of cardiovascular parameters on the aortic pressure
gradient to be investigated.
1.3 Organisation of the Thesis
This thesis is structured as follows: Chapters 2 and 3 provide the background and moti-
vation of the thesis; Chapters 4 to 7 address each of the four objectives in turn: Chapter 4
describes the datasets and the methodology for creating in silico pulse waves; Chapters 5
to 7 report experiments concerning cardiovascular parameter estimation methods, aortic
blood pressure estimation algorithms, and the influence of cardiovascular parameters on
the aortic pressure gradient, respectively; and Chapter 8 contains the achievements of
the thesis and directions for future research. An individual description of each chapter
is presented next.
Chapter 2 presents the clinical background, including a brief description of the cardio-
vascular circulation, the clinical motivation of blood pressure measurements, and an
overview of methods for the invasive and non-invasive measurement of blood pressure.
In Chapter 3 the use of 0-D and 1-D computational models of the arterial circulation
is justified, their main assumptions are presented, and their mathematical formulations
are described. In Chapter 4 the different datasets used in this work are presented: the
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process of creating datasets of virtual subjects is detailed and the data acquisition and
post-processing of the clinical datasets is explained. In Chapter 5 a comprehensive review
of current cardiovascular parameter estimation methods is presented, novel methods are
developed using three datasets of virtual subjects, and the performance of every method
is assessed using the 1-D dataset of virtual subjects. Chapter 6 reports the perfor-
mance of three central blood pressure estimation algorithms. Their ability to reproduce
the central blood pressure wave is assessed using: a clinical dataset containing invasive
catheter measurements from patients suffering from coarctation of the aorta; two clinical
datasets containing non-invasive reference data for normotensive and hypertensive sub-
jects, respectively; and a dataset of virtual subjects. Chapter 7 presents a study on the
influence of individual cardiovascular parameters on the aortic pressure gradient of di-
lated cardiomyopathy patients and describes the creation of a dataset of virtual subjects
tailored to the clinical characteristics of a group of patients and healthy controls. Finally,
Chapter 8 summarises the achievements of this thesis, presents its main limitations, and
identifies directions for future work.
2 Clinical Background
In this chapter the clinical background to this thesis is presented. Firstly, the anatomy
and physiology of the cardiovascular system, focusing on the heart, the systemic arteries,
and the blood, is described. Secondly, the clinical motivation of blood pressure mea-
surements to assess cardiovascular health, focusing on non-invasive methods to estimate
brachial and central blood pressure, is outlined. Finally, a novel method for central blood
pressure estimation, which partly motivated the main aim of this thesis, is presented.
2.1 The cardiovascular circulation
Diffusion is the fundamental transport process at cellular level. However, the rate at
which diffusion occurs is inversely proportional to the distance due to the random nature
of this transport process. Therefore, for distances greater than ∼ 0.1 mm, a faster
transport system is required [8]. The main functions of the cardiovascular (CV) system
are to provide the rapid transfer of oxygen, nutrients and metabolites to the body and to
quickly get rid of metabolic waste products like carbon dioxide, urea and creatinine. The
CV system is also part of a control system since it distributes and secretes hormones;
plays a vital role in temperature regulation; and is crucial in the defence of the body by
the immune system [8]. From an engineering point of view, the cardiovascular system
is composed of a fluid (the blood) circulating under the action of a pump (the heart)
within a closed network of flexible tubes of varying diameter and thickness (the blood
vessels). Hence, the cardiovascular circulation can be analysed according to the physical
laws of fluid mechanics, accounting for the fluid-structure interaction between the blood
(fluid) and the heart and blood vessels (structure). The anatomy and the role of these
6
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Figure 2.1: Anterior view of the heart [9]. This view shows the four chambers (two atria
and two ventricles), the major arteries and veins, and the heart valves. The ascending
aorta, where central blood pressure is measured, is connected to the left ventricle via
the aortic valve.
components within the cardiovascular circulation, together with the propagation of the
pulse wave, are described in detail next.
2.1.1 The heart
The heart is an organ divided into four chambers, two on the right side and two on the
left side (see Figure 2.1). Each side contains a blood collection chamber (i.e. an atrium)
and a pump (i.e. a ventricle). The right ventricle receives deoxygenated blood from the
right atrium and pumps it to the lungs as part of the pulmonary circulation (shown in
Figure 2.3). Simultaneously, the left ventricle receives oxygenated blood from the left
atrium and pumps it through the aortic valve into the aorta and to the rest of the body
as part of the systemic circulation. The blood follows a closed circuit due to the action
of one-way valves located in the heart and the veins [8]. The current study focuses on
the systemic circulation, particularly on blood flow dynamics involving the left ventricle,
the systemic arteries, the arterioles, and the capillaries.
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2.1.2 The blood vessels
Blood vessels can distend because their tunica media, a middle layer with important
structural and contractile properties, contains two proteins: elastin and collagen (∼ 100
times stiffer than elastin) [8]. Arteries branch in a predominantly tree-like structure,
called the arterial tree, although there are a number of loops which provide some redun-
dancy (e.g. the circle of Willis in the cerebral circulation and the palmar arch in the
hand). Elastic arteries, whose diameters range between 1-4 cm, have highly distensible
walls because of their high elastin content. In muscular arteries, with diameters between
1-0.1 cm, the tunica media becomes thicker with respect to the diameter, the elastin
and collagen content decreases and the smooth muscle content increases. The arterioles,
small vessels with diameters < 0.1 cm, branch into even smaller vessels, the capillaries.
The flow of blood through these vessels is known as microcirculation, and the exchange
of fluids between capillaries and organs or tissues, as perfusion. The capillaries then
merge into venules which also merge to form small veins. Veins are thin-walled vessels
with valves to prevent backflow. As seen in Figure 2.3, arteries carry blood at a high
pressure away from the heart and veins carry blood at a lower pressure towards the heart.
Therefore, although arteries and veins present a similar layered structure, arterial walls
are thicker due to the much higher blood pressures which they are subjected to (see
Figure 2.2).
2.1.3 The blood
Blood is a complex suspension of blood cells in a fluid plasma. Plasma is an aqueous
solution containing proteins, mineral ions, hormones, and glucose, and behaves like a
Newtonian fluid for in vivo conditions. Blood presents high cellular volume concentra-
tions (between 40-45%), with red blood cells (RBCs) being the most common type of cell.
RBCs transport oxygen from the lungs to the body’s tissues and organs, and carry ∼ 25%
of the carbon dioxide waste to the lungs [9]. In blood vessels where the internal diameter
is large (i.e. > 0.5mm) compared to the size of the RBCs, blood can be assumed to be a
homogeneous, incompressible and Newtonian fluid [10, 11]. However, at slow shear rates,
blood has a non-Newtonian behaviour due to the aggregation of RBCs [11].
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Figure 2.2: The structure of blood vessel walls: arteries (left) and veins (right)
(adapted from [9]). Arterial walls are thicker and their lumen (i.e. the conduct through
which blood flows) is smaller. In arteries, the combination of thicker walls and high
pressures results in rounded lumens. Due to their thinner walls and lower pressures,
venous walls present flatter lumens. Additionally, veins oppose reduced resistance to
blood flow due to their larger lumens.
Figure 2.3: Diagram of the cardiovascular system (adapted from [9]). The systemic
arteries carry oxygenated blood (shown in red) from the left ventricle to the capillaries.
The systemic veins return deoxygenated blood (shown in blue) from the capillaries to
the right atrium. The pulmonary arteries carry this blood from the right ventricle to
the lungs for oxygenation. Finally, the pulmonary veins return this newly oxygenated
blood to the left side of the heart, closing the loop.
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Figure 2.4: Pulse wave propagation in the larger systemic arteries (adapted from [12]).
The shape of blood pressure and velocity waves changes as the pulse wave propagates
from central (ascending aorta) to peripheral (e.g. right common iliac artery) locations.
2.1.4 Pulse wave propagation
During systole, the contraction of the left ventricle ejects blood into the aorta through
the aortic valve distending the ascending aorta. This distension propagates as a wave, the
so-called pulse wave, through the arterial network producing changes in blood flow and
pressure with time. The pulse wave reflects multiple times at the aortic valve, arterial
bifurcations, and due to arterial wall tapering. This physical phenomenon is known as
pulse wave propagation and produces a variety of pressure and flow waves throughout the
systemic arteries (see Figure 2.4). At the end of systole, the (healthy) aortic valve closes
and the flow of blood from the heart stops. During diastole, as blood leaves the larger
arteries through the periphery and enters the microcirculation, pressure everywhere in
large arteries tends to decrease exponentially [8, 12]. The shape of the pressure wave
is determined by the physical properties of the cardiovascular system such as arterial
stiffness, arterial resistance, and cardiac ejection patterns. Since these physical properties
can be affected by CV disease, this wave carries valuable information for their diagnosis
and treatment and plays an important role in conditions such as hypertension.
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2.2 Clinical motivation of blood pressure measurements
According to the World Health Organisation, approximately 17.9 million people died from
cardiovascular (CV) disease in 2016, representing 31% of all global deaths – 85% of those
deaths were due to heart attack and stroke [7]. Although cancer was the largest (29%)
cause of death in the United Kingdom in 2014, CV disease followed closely as the second
largest (27%) [13]. According to the Office for National Statistics (2015), ischaemic heart
disease was the second (12%) leading cause of death in England and Wales [14]. While
ischaemic heart disease was the leading (14%) cause of death for males, dementia and
Alzheimer disease were the leading (15%) cause of death for females. Furthermore, CV
disease also has an important global economic impact. In the USA, the annual cost of
CV disease in 2016 was $555 billion; these costs were estimated to exceed $1.1 trillion
by 2035 [15]. In England, healthcare costs relating to CV disease are estimated at $7.4
billion per year [16].
High blood pressure (BP), also known as hypertension, is the main risk factor for mor-
tality worldwide. In the year 2010, over 20% (1.4 billion) of the world’s adult population
had hypertension [17]. It is estimated that by 2025 the global burden of hypertension
will exceed 1.6 billion [17, 18]. Hypertension is a high risk factor for CV diseases such
as ischemic heart disease, stroke, congestive heart failure, cardiomyopathy, atrial fibrilla-
tion, aortic aneurysm, and peripheral vascular disease; and other diseases such as chronic
kidney disease, vision loss, and dementia [19–23].
2.2.1 Non-invasive peripheral blood pressure
Recent (2017) clinical guidelines recommend the diagnosis of hypertension for levels of
systolic/diastolic BP (SBP/DBP ) ≥ 130/80 mmHg, measured at the brachial artery at
heart level with a validated sphygmomanometer (i.e. a pressure cuff) [24]. Brachial BP
must be recorded in both arms, with subsequent measurements taken in the arm with
the highest BP values. A reliable average BP measurement consists of the average of
≥ two measurements obtained on ≥ two occasions. A typical brachial pressure wave is
shown in Figure 2.5.
Chapter 2. Clinical Background 12


















Figure 2.5: Brachial blood pressure wave. The blue line respresents the value of blood
pressure as a function of time for a cardiac period. From top to bottom, the horizontal
red lines indicate the values of systolic (SBP ), mean (MBP ), and diastolic (DBP )
blood pressure measured at the brachial artery.
Figure 2.6: Diagram of early sphygmographs. Top: Vierordt’s original design (adapted
from [26]). Bottom: Marey’s improved design (adapted from [27]).
2.2.1.1 The sphygmograph and the sphygmomanometer
The first attempt to create a sphygmograph – the predecessor of the sphygmomanometer
– to measure peripheral blood pressure non-invasively came from Vierordt (1818-1884) in
1855 [25] (see Figure 2.6, top). This device measured the pressure which was required to
collapse the radial artery. In 1880, Marey (1830-1904) substantially improved the design
of Vierordt’s sphygmograph, but the device was still too cumbersome for routine clinical
use (see Figure 2.6, bottom).
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Figure 2.7: Diagram of early sphygmomanometers. Left: von Basch’s original design
(adapted from [29]). Right: Riva-Roci’s improved design, used nowadays (adapted
from [30]).
The sphygmomanometer, which was a simpler and more accurate device compared to
the sphygmograph, was invented by von Basch (1837-1905) in 1881 (see Figure 2.7, left).
However, the modern sphygmomanometer was developed by Riva-Rocci (1863-1937) and
reported in 1896. This device consisted of an inflatable cuff – connected to a mercury
manometer – surrounding the arm’s circumference at a radial or brachial location (see
Figure 2.7, right). First, the cuff is inflated using a hand pump until the pulse disappears.
Then, as the cuff slowly deflates the pulse reappears – detected by palpation – coinciding
with brachial SBP . Nevertheless, brachial DBP cannot be determined by palpation
alone since the pulse can be felt continuously from the moment it reappears [28].
2.2.1.2 The auscultatory method
Riva-Roci’s method became the gold standard for the simple, accurate, non-invasive
measurement of brachial SBP . However, it was Korotkoff (1874-1920) who in 1905
proposed the auscultatory method to measure DBP using a sphygmomanometer and a
stethoscope. Firstly, the cuff is inflated to stop the flow of blood through the brachial
artery. Secondly, the cuff is slowly deflated resulting in a series of sounds – known as
Korotkoff’s sounds – captured by the stethoscope. Finally, brachial SBP and DBP
correspond to the measured cuff pressure values when the first distinct sound appears
and when the last (fifth) sound disappears, respectively.
When measuring brachial blood pressure with the auscultatory method, mercury, aneroid,
and electronic pressure gauge sphygmomanometers can be used. However, these methods
generally present problems with calibration; they depend on the operator’s skills; and
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rapid inflation or deflation can affect the BP readings, especially in patients with slow
heart rates (< 60 bpm). For these reasons, the auscultatory method is being replaced by
oscillometric devices [31].
2.2.1.3 Oscillometric methods
Oscillometric methods identify SBP , mean BP (MBP ), and DBP from the amplitude
of the oscillometric wave (OMW) recorded in the arm as the pressure cuff deflates. The
amplitude of the OMW increases between SBP and MBP and decreases below MBP ,
allowing the direct measurement of MBP [32]. SBP and DBP are then estimated from
the OWM using device-specific maximum amplitude (MA) algorithms [33]. However,
most oscillometric methods do not provide a direct measurement of SBP and DBP ,
since they use population-based ratios between SBP/DBP and MBP (SBPR/DBPR)
to calculate SBP and DBP for a given subject (see Figure 2.8) [34].
Oscillometric devices intended for out-of-office (home) measurements have been adapted
for office use, but present less durability and reliability than more costly, professional os-
cillometric devices traditionally used in hospitals [31]. More recently, automatic devices
with the ability to calculate average BP values from multiple pressure measurements have
been developed, allowing automated office BP (AOBP) measurements [31]. An advantage
of this device over the auscultatory method is the reduced need for staff presence during
BP measurements. In fact, since the presence of an operator can affect the BP measure-
ments (e.g. due to the white coat syndrome or to the patient talking), this unattended
AOBP measurement is preferred for clinical use [31].
2.2.2 Central blood pressure
Brachial blood pressure (bBP) measurements have been used over the last century for
routine clinical assessment. However, as described in the previous section, these measure-
ments suffer from a number of errors due to the patient (e.g. recent food consumption,
movement, talking); the device (e.g. miscalibration, non-validated device); or the proce-
dure (e.g. inapropriate cuff size, not levelled with the heart).
Central blood pressure (cBP) is the blood pressure in the ascending aorta and close to
the aortic root (see Figure 2.1). Recent clinical studies have shown that cBP is a better
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for the a posteriori distribution of the SBPR and DBPR, which are used to estimate the SBP and DBP for
each individual subject. The methodology also assumes that the ratios are random variables unlike the
existing approaches in the literature where they are considered to be deterministic. This paper chooses
the value of the likelihood function that maximizes the a posteriori probability. An equally likely a prior
is used that creates a likelihood function using the blood pressure values obtained through the MAA
algorithm for each prior. It then chooses the likelihood value that maximizes the a posteriori probability
obtained using Bayes’ model. As a result, the mean difference (MD) and the standard deviation (SD) [15]
of the SBP and DBP estimate obtained with the SBPR and DBPR using the Bayesian model were
compared with the MD and SD of the estimates obtained using the conventional MAA method.
2.1. Conventional MAA Concepts
Based on the oscillometric BP envelope, the MAA is widely used to estimate the SBP and DBP, which
utilizes SBPR and DBPR to find the points which correspond to SBP and DBP. The amplitude of the
maximum point is multiplied by the fixed SBPR and DBPR obtained experimentally [2,3,5].
bsai,j = mi,j ⇥ brs (1)
bdai,j = mi,j ⇥ brd (2)
where bsai,j and bdai,j are the oscillometric amplitudes corresponding to the SBP and DBP, respectively, mi,j
is the maximum oscillometric amplitude (MA), brs and brd are the fixed SBPR and DBPR, and i = 1, ..., N
and j = 1, . . . , M ; N and M denote the number of subjects and the number of measurements per subject.
Thus, the oscillometric amplitudes corresponding to the SBP and DBP are mapped back to the deflation
curve obtaining the SBP and DBP values in mmHG as shown in Figure 1.
Figure 1. The concept of maximum amplitude algorithm (MAA). (a) cuff pressure (CP);
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and j = 1, . . . , M ; N and M d ote th number of subjects and the number of m asurements per subject.
Thus, the oscillometric amplitudes c rre ponding to th SBP and DBP are mapped back to h deflation
curve obta ing the SBP and DBP values in mmHG as sh wn i Figur 1.
Figure 1. The concept of maximum amplitude algorithm (MAA). (a) cuff pressure (CP);




































SBPR=systolic point’s amplitude / MA
DBPR=diastolic point’s amplitude /MA
Figure 2.8: Blood pressure measurement via oscillometric methods. (a) Cuff pressure
as it deflates, showing the values of SBP , MBP , and DBP . (b) Oscillometric wave
(OMW). (c) Envelope of the OMW: MBP coincides with the time of maximum am-
plitude (MA); SBP and DBP are calculated as a function of the MA from empirical
ratios. Adapted from [33].
cardiovascular risk indicator than bBP [35–39]. In fact, major organs are exposed to
cBP rather than bBP [38, 40]. Regardless of gender or disease, cBPs in subjects with
similar brachial SBP may differ by up to 33 mmHg, resulting in “a significant overlap of
central SBP scores between brachial SBP risk groups” [41]. Furthermore, bBP can be
misleading in healthy young adults due to central-brachial pulse pressure (PP , calculated
as SBP minus DBP ) amplification of up to 30 mmHg [42]. PP amplification between
central and peripheral arteries is illustrated in Figure 2.9.
2.2.2.1 Invasive gold-standard for central blood pressure measurements
The gold standard of cBP measurement is ascending aorta BP via cardiac catheterisation,
which carries risks to patients (e.g. blood clot formation, embolization, infection) even
when performed in specialised centres; is costly; and is not suitable for routine clinical
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Ascending aorta Carotid artery Brachial artery Radial artery
Figure 2.9: Blood pressure amplification from central to peripheral arteries (adapted
from [37]). Arterial locations from left to right: ascending aorta, carotid artery, brachial
artery, and radial artery. While DBP and MBP remain relatively constant within the
larger systemic arteries, SBP increases towards the periphery resulting in an amplifica-
tion of PP .
Figure 2.10: Central blood pressure measurement via cardiac catheterisation. A
catheter is commonly inserted into either the femoral or brachial artery, and threaded
up to the aorta where central blood pressure is measured. Adapted from [44].
practice [37, 43] (see Figure 2.10). Consequently, there is great value in developing
methods for estimating cBP non-invasively which are less risky and more suitable for
frequent use.
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Table 2.1: Summary of methods, commercial devices, pulse wave measurement meth-
ods, and measurement sites for non-invasive central blood pressure estimation. Abbre-
viations: AT: applanation tonometry; Osc.: oscillometry.
cBP method Device Pulse wave measurement Measurement site
Generalised
Transfer Function
SphygmoCor AT Radial, Carotid
GAON 21A AT Radial
Mobil-O-Graph Osc. (at DBP) Brachial
Centron cBP301 Osc. (at 65 mmHg) Brachial
Vicorder Osc. (at 70 mmHg) Brachial
PulseCor R7.0 Osc. (30 mmHg above SBP) Brachial
Surrogate PulsePen AT Superficial arteries
Complior Analyse AT Carotid
Wave analysis Omron HEM-9000AI AT Radial
Arteriograph Osc. (35 mmHg above SBP) Brachial
Moving average filter BPro (A-Pulse) AT Radial
Auscultatory Novacor Diasys Osc., electrocardiogram Brachial
2.2.2.2 Central blood pressure from peripheral blood pressure
A consensus on a specific technique for the non-invasive measurement of cBP does not
currently exist. In 2016, Papaioannou et al. [45] performed a systematic review and
meta-analysis of recent invasive validation studies (2003-2014) assessing commercial de-
vices for the non-invasive measurement of central SBP . Table 2.1 shows a summary
of different methods, commercial devices, pulse wave measurement methods, and the
corresponding measurement sites.
All these methods estimate cBP from non-invasive measurements recorded either via
oscillometric methods or applanation tonometry. Applanation tonometry consists of a
pressure sensor which partially flattens (applanates) a superficial artery, such as the
carotid or radial arteries, and records a pressure wave which must be calibrated from an
invasive or non-invasive BP measurement. This method was popularised by the develop-
ment of the high-fidelity Millar micromanometer [46]. However, applanation tonometry
must be calibrated from brachial BP; and it requires an experienced operator, since the
applanation pressure depends on the thickness of the tissues (e.g. skin, muscle, arterial
wall), and the position and angulation of the tip of the probe.
As seen in Table 2.1, most tonometry-based cBP estimation methods use radial tonom-
etry measurements. Although carotid tonometry is recommended for the measurement
of carotid-femoral pulse wave velocity (PWVc−f) [47], it is not currently advisable for
routine clinical measurement of cBP waves required in hypertension [43, 45, 46]. Carotid
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tonometry suffers from artifacts from patient movement and respiration, and can be un-
comfortable for the patient. Furthermore, although this method does not cause clinically
significant baroreceptor activation when performed by an experienced operator [48], in-
adequate applanation pressure does increase the possibility of baroreceptor activation
in the carotid artery [46]. Baroreceptors are neurons which are excited when the vessel
wall is stretched. This mechanism allows them to sense blood pressure changes and to
transmit this information to the brain to ensure that adecuate blood pressure levels are
maintained. Therefore, the activation of carotid baroreceptors during carotid tonometry
could affect blood pressure levels, thus making the measurement unreliable.
The different methods for the non-invasive estimation of cBP presented in Table 2.1 are
described next.
• Generalised transfer function: techniques based on the use of a generalised
transfer function (GTF), which estimate cBP from peripheral BP waves, have been
widely validated [49–51]. The SphygmoCor R© system (AtCor Medical, Sydney,
New South Wales, Australia) is the most commonly used of such devices [38, 52].
However, since GTFs are designed using data from clinical populations, they do
not account for inter-subject or intra-subject variability [53] and rely entirely on
peripheral BP, ignoring both patient-specific and central characteristics of the car-
diovascular system. GTFs have been developed to estimate cBP from carotid,
brachial and radial BP [54, 55].
• Surrogate measurements: the PulsePen R© (DiaTecne S.R.L. Milan, Italia) [56]
and Complior Analyse R© (Alam Medical, Saint-Quentin-Fallavier, France) [57, 58]
devices assume that the carotid BP wave calibrated by a brachial cuff BP measure-
ment is a surrogate of the cBP wave [45].
• Wave analysis methods: the HEM-9000AI R© device (Omron Healthcare, Kyoto,
Japan) [59] uses a radial BP wave obtained via tonometry to estimate cBP using a
regression equation applied to the second systolic peak [60]; the Arteriograph R© de-
vice (TensioMed, Budapest, Hungary) estimates cBP from the analysis of the waves
arriving at the occluded brachial artery (35 mmHg over SBP ) [61].
• Moving average filter: the BPro R© [62] device with the A-Pulse R© software
(HealthSTATS, New Century, Singapore) measures radial pressure waves at the
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wrist using radial applanation tonometry and computes cBP using a mathemati-
cal low-pass filter known as the n-point moving average filter [63]. A more recent
study showed that this method also works for brachial pressure waves measured via
oscillometry [64].
• Auscultatory methods: The Diasys R© devices (Novacor, Rueil-Malmaison, France)
measure brachial BP via an auscultatory method and the QKD interval via an elec-
trocardiogram [65]. The QKD interval is the time between the QRS complex on
the electrocardiogram and the detection of the last Korotkoff sound [66]. Central
SBP is estimated via the regression equation SBP = 105 + 1.29 ·MBP − 0.39 ·
HR− 0.30 ·H − 0.11 ·QKD, where SBP and MBP are given in mmHg, MBP is
calculated from brachial BP as 0.6 ·DBP + 0.4 · SBP , HR is given in bpm, H is
height given in cm, and QKD is given in ms.
2.2.2.3 Central blood pressure from aortic flow
As described in the previous section, methods which estimate cBP from a non-invasive pe-
ripheral pressure wave based on a generalised transfer function have been widely adopted.
Additional cBP estimation methods based on surrogate measurements, wave analysis,
mathematical filters, auscultation, and electrocardiograms have also been validated and
resulted in a range of commercial devices. However, most of these methods provide
limited subject-specificity, given that they depend on clinical population studies and
empirical coefficients. Furthermore, they focus on peripheral information such as the
radial, brachial, or carotid pressure waves, and disregard the influence of more central
information such as the aortic flow velocity.
In a proof-of-concept study, Vennin et al. showed that the cBP wave can be accurately
estimated combining the aortic flow velocity wave, U , and a peripheral pressure wave [67].
From these waves, ascending aorta pulse wave velocity (PWV ), DBP , MBP , and the
time constant (τ) of the exponential decay in diastole are extracted. Using in silico and
in vivo data, they developed an algorithm to estimate cBP which combines the water-
hammer equation, a second order polynomial, and an exponential fit. This algorithm is
divided in four parts (I-IV) if U presents reverse flow, or in three parts (I, II, and IV) if
it does not, and estimates cBP:
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I in early systole (between the start of the cycle and the time of peak aortic flow
velocity, tpeak) using the water-hammer equation Pwh = DBP + UρPWV , where ρ
is the blood density;
II in mid-systole (between tpeak and the start of diastole, td) using a second order
polynomial (i) which must result in MBP and (ii) whose start and end values must
equal the pressure values estimated from I and III/IV at tpeak and td, respectively;
III between the time where flow velocity first becomes negative and td using Pwh;
IV during the diastolic decay (between td and the end of the cycle), using a linear spline
interpolation and a least-squares fitting.
However, the original study used simultaneous, invasive measurements of pressure and
flow to estimate PWV , DBP , MBP , and τ .
The aim of this thesis, the non-invasive estimation of the cBP wave from aortic flow and
peripheral pressure using computational models of the cardiovascular system, was partly
motivated by the findings of this study.
2.3 Final remarks
This chapter has described the cardiovascular circulation, focusing on the heart, the
blood vessels, and the blood, and has presented the physical phenomenon of pulse wave
propagation, which is fundamental to the one-dimensional mathematical formulation pre-
sented in Chapter 3. The worldwide impact of cardiovascular disease, and the relevance
of hypertension as a cardiovascular risk factor has been highlighted. A review on the
different techniques and devices to measure brachial and central blood pressure has been
performed. Additionally, a proof-of-concept study which estimates central blood pressure
non-invasively from aortic flow and peripheral pressure has been described. Overall, this
chapter motivates the development of safe, non-invasive, and non-expensive methods to
accurately estimate central blood pressure. This thesis explores the use of computational
methods (Chapter 3) to create in silico datasets (Chapter 4), to estimate cardiovascular
parameters (Chapter 5) and central blood pressure (Chapter 6) from clinical data ob-
tained non-invasively, and to improve the understanding of haemodynamics in disease
(Chapter 7).
3 Mathematical Background
This chapter presents the mathematical background of the thesis. Firstly, a justification
of the use of zero-dimensional (0-D) and one-dimensional (1-D) computational models
of cardiovascular mechanics is provided. These models are used in this thesis to create
datasets of virtual subjects to test, develop, and assess cardiovascular parameter esti-
mation methods, and to estimate central blood pressure non-invasively from aortic flow.
Secondly, the two-element and three-element Windkessel (0-D) models are derived, and
some of their clinical applications are described. Finally, the 1-D mathematical formula-
tion is described, including some examples of clinically relevant applications of different
1-D models.
3.1 Justification for the use of 0-D and 1-D models
Three-dimensional (3-D) computational models of fluid mechanics can be used to study
complex physical phenomena (e.g. wall shear stress, turbulence, circulation patterns)
in complicated arterial geometries, such as those seen in severe aortic coarctation, brain
aneurysms, and transposition of the great arteries [68–70]. However, due to their high
computational cost, 3-D simulations of pulse wave propagation in the systemic circulation
are not feasible in the current clinical setup. Furthermore, the amount of clinical data
required to create a personalised computational model is proportional to its complexity.
Instead, 0-D or 1-D simulations of the arterial circulation provide an acceptable trade-off
between computational cost, required clinical data, and accuracy (Figure 3.1).
Also known as lumped parameter models, 0-D models can capture the global charac-
teristics of the arterial circulation during the cardiac cycle. They have a relatively low
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Figure 3.1: Computational cost vs model complexity for 0-D, 1-D, and 3-D models.
*Adapted from [71].
computational cost compared to other models, with a runtime of a few seconds on a PC.
Westerhof et al. showed that the 0-D three-element Windkessel model is able to describe
the pressure-flow relation for the systemic arterial system [72]. However, 0-D models are
space-independent and cannot be used to study pulse wave propagation or local changes
in the properties of the arterial system.
1-D models have a higher computational cost than 0-D models, with runtimes ranging
from a few seconds to a few minutes on a PC. However, they allow the study of pulse wave
propagation phenomena through the arterial system in the axial direction and during the
cardiac cycle. Several in vivo [73–75], in vitro [76–78], and in silico [3, 75, 79–82] studies
have shown that 1-D modelling can accurately reproduce the clinically relevant features
of the pressure, flow and area waveforms. Additionally, ‘reduced’ 1-D models containing
a small number of arteries have been shown to yield similar results to more ‘complete’
1-D models containing a large number of arteries at a fraction of the computational
cost [4, 83]. The clinical data required to create these ‘reduced’ 1-D models can be
readily obtained in the clinic.
Since this thesis focuses on the application of personalised computational models in a
clinical setup, where measurements must be available within a short time, 0-D and 1-D
models were chosen over 3-D models. As part of this study, the performance of 0-D and
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1-D models at estimating central blood pressure (cBP) in different clinical scenarios will
be compared.
3.2 0-D Windkessel models
3.2.1 The two-element Windkessel model
Also known as Frank’s Windkessel model in honour to Otto Frank, this model idealises
the arterial system as a time-varying reservoir of compliance CT [84]. Blood flows into
the reservoir from the heart, Qin(t), at a pressure P (t), encounters a resistance to flow,
RT, and flows out into the vascular beds at a pressure Pout (Figure 3.2). The governing
ordinary differential equation (ODE) is
dP
dt





which can be solved for P (t) using the integrating factor method,










RTCT dt′, t ≥ t0, (3.2)



















Two-element Windkessel modelInput: flow, Qin Output: pressure, P
















Figure 3.2: Two-element Windkessel model (middle). Left: inflow wave correspond-
ing to the baseline virtual subject from the datasets of virtual subjects described in
Section 4.1.1.1. Right: corresponding pressure wave simulated using the two-element
Windkessel model.
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3.2.2 The three-element Windkessel model
This model results from adding a resistor, Z0, in series to the two-element Windkessel
model where RT = Z0 + R (Figure 3.3). Z0 is commonly known as the characteristic












which can be solved analytically for P (t) using the integrating factor method,
P (t) = Pout + (P0 − Pout − Z0Q0)e
− t−t0









RCT dt′, t ≥ t0
(3.4)




































Three-element Windkessel modelInput: flow, Qin Output: pressure, P
Figure 3.3: Three-element Windkessel model (middle). Left: inflow wave correspond-
ing to the baseline virtual subject from the datasets of virtual subjects described in
Section 4.1.1.1. Right: corresponding pressure wave simulated using the three-element
Windkessel model.
3.2.3 Clinical applications of 0-D models
0-D models are commonly used as boundary conditions for 1-D and 3-D models [75]. They
have also been used independently to estimate relevant haemodynamic quantities, such
as arterial compliance [72], aortic impedance [85], or cardiac output [86]. Additionally,
the parameters derived when performing the reservoir-wave analysis – which uses the
two-element Windkessel model – have been shown to have clinical significance for the
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assessment of left ventricular diastolic function, hypertension, as a therapeutic target,
and as an independent predictor of cardiovascular events [87, 88].
3.3 1-D mathematical formulation
3.3.1 Model assumptions
The arterial network of 1-D models is decomposed into arterial segments connected to
each other at nodes. Each segment is modelled as a thin-walled, deformable, imperme-
able, axisymmetric tube with uniform properties around the circumference whose cur-
vature is small everywhere and can thus be described by the axial (x) coordinate alone.
These segments can be divided into non-overlapping spatial elements. Pulse waves prop-
agate in the x-direction with time t, modifying the luminal cross-sectional area, A(x, t),
and the cross-sectional averages of blood velocity, U(x, t), flow, Q(x, t), and pressure,
P (x, t). A plug flow velocity profile is assumed for the larger arteries [8]. Blood is as-
sumed to be a homogeneous, incompressible and Newtonian fluid, which is reasonable
for in vivo ranges [12]. Therefore, blood viscosity, µ, and density, ρ, are assumed to be
constant. Finally, blood flow is assumed to be laminar (i.e. Reynolds number ≤ 2000),
which is reasonable provided that the changes in arterial geometry are smooth.
3.3.2 Governing equations
























where ρ represents blood density and α is a velocity profile shape factor that affects the
frictional term f = f(α,U). An explicit algebraic expression relating P and A, known
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as the tube law, is used to close the system of equations:









where β(x) is related to wall mechanical properties and P0 and A0(x) are the reference
pressure and area values, which are normally taken as the pressure and area at the end
of diastole, respectively. If pulse wave velocity (PWV ) is assumed to be constant for
the whole 1-D model, β(x) only depends on vessel cross-sectional area values A(x) and
A0(x), as seen in Equation (3.7).
3.3.3 Characteristic analysis
The 1-D governing equations (Equation (3.5)) and the tube law (Equation (3.6)), writ-
ten in non-conservative form, form a system of non-linear hyperbolic partial differential
equations which can be analysed using Riemann’s method of characteristics [90]. The













and PWV0 is equal to PWV when A is equal to the reference area A0, which is normally
taken as the area at diastolic blood pressure.
In the clinical setup, PWV can be estimated from two pressure or flow waveforms sepa-
rated by a certain distance using the foot-to-foot method [91]. The characteristic analysis
shows that Wf propagates changes in pressure, flow, and cross-sectional area in the posi-
tive x-direction of each arterial segment (i.e. from the aortic root towards the peripheral
arteries); and Wb propagates these changes in the negative x-direction (i.e. backwards
from the periphery towards the aortic root).
The independent contributions of forward and backward waves in the arterial system
can be studied using wave separation analysis (WSA) [92] or wave intensity analysis
(WIA) [93], and can provide a better understanding of arterial haemodynamics in any of
the segments of the 1-D model.
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3.3.4 Numerical scheme
In this work, the non-linear system of 1-D equations (Equation (3.5) and Equation (3.6))
was solved using a discontinuous Galerkin finite element scheme, with a high-order 1-D
spectral/hp element spatial discretisation, as described in [90]. An explicit second-order
Adams-Bashforth time-integration scheme, with zero pressures and velocities as initial
conditions in each arterial segment, was used.
In this work, the relevant numerical parameters were: time step, polynomial and quadra-
ture order. In the discontinuous Galerkin scheme, each arterial segment is discretised into
e non-overlapping spatial elements, Ωe. The characteristic information moving away from
both sides of the boundary between two spatial elements must not affect the solution,
which imposes the following restriction on the time step, ∆t:
∆t ≤ ∆x2 max(|U ± PWV |) , (3.8)
where ∆x is the distance between quadrature points, as explained in [94]. Similarly to
Alastruey et al. [90], arterial segments were discretised into 2 cm long spatial elements
with polynomial and quadrature orders of 3. Segments or elements shorter than 1.1 cm
were given polynomial and quadrature orders of 2.
3.3.5 Boundary conditions
Boundary conditions (BCs) are prescribed at the inlet and outlet of every segment. The
BCs used in this work, classified as inflow, junction and terminal, are now described:
• An inflow BC condition based on a cardiac flow profile, Qin(t), is imposed at the
inlet of the ascending aorta (e.g. Figure 3.2, left).
• Junction BCs are prescribed at arterial segment connections and bifurcations.
• Terminal BCs are represented as three-element Windkessel models coupled to the
outlet of terminal arterial segments (Figure 3.3, middle). As suggested by Alastruey
et al. [90], these 0-D models represent the resistance to flow (RT = Z0 + R) and
the compliance (CT ) of downstream arteries while minimising reflections when Z0
is equal to the terminal characteristic impedance.
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3.3.6 Clinical applications of 1-D models
1-D models of the cardiovascular system allow the study of (i) blood pressure and flow
waves in the circulation and (ii) global interactions between the heart and the arteries
under normal and pathological conditions [81].
1-D models of the systemic circulation can be used to create datasets of virtual subjects
for algorithm testing and development. Willemet et al. created 3,325 virtual healthy
adult subjects using a 1-D model of the 55 larger arteries of the systemic circulation to
assess theoretically the accuracy of foot-to-foot pulse wave velocities as an estimate of
aortic stiffness [82]. Charlton et al. created 4,374 virtual healthy adult subjects using
a 1-D model with 116 arterial segments making up the larger arteries of the thorax,
limbs and head to assess theoretically: (i) the determinants of changes in pulse pressure
amplification with age, (ii) photoplethysmogram-derived pulse wave indices of aortic
stiffness, and (iii) the performance of two algorithms for cardiac output monitoring [3].
‘Reduced’ 1-D models allow the study of pulse wave propagation in controlled conditions.
Abdullateef et al. studied the effect of arterial bifurcations on arterial reflections after
imposing a Gaussian-shaped pulse at the aortic root [5]. Fossan et al. studied the
instantaneous wave-free ratio and the fractional flow reserve in a patient-specific coronary
network obtaining similar prediction accuracy to that of clinical measurements [4].
In this thesis, 0-D and 1-D models were used to (i) create datasets of virtual subjects to
test existing methods for cardiovascular parameter estimation and to develop new ones,
and (ii) to develop three algorithms for the non-invasive estimation of cBP from aortic
flow. Additionally, a “cohort-specific” dataset of virtual subjects was created using a 1-D
model of the 55 larger arteries to study the influence of cardiovascular properties on the
aortic pressure gradient in dilated cardiomyopathy patients.
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3.4 Final remarks
This chapter has described the mathematical formulation of 0-D and 1-D models and has
presented some of their applications. These models will be used in Chapter 4 to generate
three datasets of virtual subjects; in Chapter 5 to test and develop methods for cardiovas-
cular parameter estimation; in Chapter 6 to assess algorithms for cBP estimation and to
validate them by comparison against datasets of aortic coarctation patients, hypertensive
patients, and normotensive volunteers; and in Chapter 7 to investigate ventricular-arterial
interactions in a dataset of dilated cardiomyopathy patients and healthy volunteers.
4 Datasets
This chapter describes all clinical and computer-generated datasets used in this thesis to
assess the aortic pressure wave. The cardiovascular (CV) parameter estimation methods
in Chapter 5 and central blood pressure (cBP) algorithms in Chapter 6 were initially
developed and tested using three datasets of virtual subjects (Section 4.1). For each
dataset, CV parameters and central blood flow and pressure waves were known exactly for
thousands of virtual subjects. The cBP algorithms were then assessed using three clinical
datasets (Section 4.2). A “cohort-specific” dataset of virtual subjects (Section 4.1.2.2)
was created for the aortic pressure gradient study in Chapter 7. The characteristics of
each dataset are shown in Table 4.1.
4.1 Datasets of virtual subjects
Datasets containing pressure and flow waves measured in virtual subjects were created by
simulating arterial haemodynamics using 0-D and 1-D computational models respectively.
Each virtual subject was created from a unique set of CV parameter values which were
extracted from the clinical literature or from the clinical datasets described below. To
create a virtual subject, the computational model was parametrised using a set of CV
parameters, and an aortic flow wave was simulated as a function of heart rate (HR),
stroke volume (SV ), and left ventricular ejection time (LV ET ). The cBP wave was
simulated by imposing the flow wave as an inflow boundary condition at the aortic root.
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New 0-D datasets, whose reference CV parameter values were known precisely, were
used to test existing CV parameter estimation methods and to develop new ones (Sec-
tion 4.1.1). An existing 1-D dataset was used to further test and refine these methods
and the cBP estimation algorithms, as this dataset was based on a more complex and
physiological model of the arterial circulation of healthy adults (Section 4.1.2.1) [3]. Fi-
nally, a different existing 1-D dataset was adapted to study the aortic pressure gradient
in dilated cardiomyopathy patients (Section 4.1.2.2) [82].
4.1.1 0-D model datasets of virtual subjects
The 0-D datasets of virtual subjects had the advantage that every CV parameter was
imposed when creating the dataset and, hence, reference values were known exactly for
each virtual subject. This was not the case for the 1-D model dataset, where some of
these reference values needed to be extracted from the simulated pressure and flow waves.
Additionally, the computational cost of simulating 0-D virtual subjects is low compared
to that of 1-D virtual subjects: thousands of 0-D virtual subjects’ cBP waves can be
simulated within seconds on a PC, whereas it takes days to simulate the same number
of 1-D virtual subjects’ cBP waves. Since CV parameter reference values were known
exactly for each subject, and given their low computational cost, these datasets were used
as the initial step to testing existing CV parameter estimation methods and to developing
new ones.
4.1.1.1 Creating 0-D model datasets
Two 0-D datasets were created by using two-element [84] and three-element [95] Wind-
kessel models (Figure 4.1). Each virtual subject’s cBP wave was simulated using an
aortic flow wave calculated by the AorticFlowWave script in [96] (based on prescribed
values of HR, SV , and LV ET , as shown in Figure 4.2) in combination with prescribed
values of total arterial resistance (RT) and compliance (CT), characteristic impedance
(Z0), and outflow vascular pressure (Pout). Two steps were required to obtain CV pa-
rameter values: (i) mean (µ) and standard deviation (σ) values of each cardiovascular
parameter in healthy adults were identified from the clinical literature; and (ii) five values
for each parameter were calculated as µ, µ ± 0.5 σ, and µ ± σ (Table 4.2). A different
virtual subject was created for each combination of CV parameters, with a total of 3,125
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and 15,625 virtual subjects for the two-element and three-element Windkessel datasets,
respectively.































































Figure 4.1: Generating 0-D model datasets of virtual subjects. (a), top: a range
of values for each CV parameter was obtained from the clinical literature for healthy
individuals (see Table 4.2). (a), bottom: the thick line illustrates the flow wave cor-
responding to the baseline values of SV and HR, and the shaded region represents the
range of flow waves corresponding to all SV and HR variations. (b) The two-element
and three-element Windkessel models were used to generate cBP waves. (c) cBP waves
generated by each model: black lines illustrate the cBP wave corresponding to the base-
line set of parameter variations, and shaded regions represent the range of cBP waves
within each dataset.
The five observed ‘steps’ in the virtual cBP waves correspond to the five variations in HR.
For the 0-D datasets, when all other CV parameters are fixed, as HR increases, cardiac
period (T ) decreases and Q = 1/T
∫ T
0 Q(t)dt increases. According to Equation (5.2) with
P = MBP − Pout and Q = Q, since RT and Pout are fixed, as Q increases MBP must
increase, too. Finally, since CT is fixed, as MBP increases so does DBP .
4.1.1.2 Cardiovascular parameter variations for healthy adults
Mean and standard deviation values for each CV parameter were extracted from the
clinical literature to create two datasets of cBP waves representative of a sample of
healthy adults (Table 4.2). SV and HR values were extracted from 17 healthy subjects
in supine position [97]. Left ventricular ejection time (LV ET ) values were calculated
from SV and HR using the regression equation [97]:
LV ET = 242 + 1.1SV − 0.9HR, (4.1)
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Figure 4.2: Aortic flow waves for the 0-D model datasets of virtual subjects. Left: flow
waves as a function of heart rate (HR); right: flow waves as a function of stroke volume
(SV ). Mean (µ) and standard deviation (σ) values for both cardiac parameters were
identified from the clinical literature. The baseline case corresponds to the mean values
of HR and SV and is represented as a black line. The negative and positive variations
are represented as blue and red dashed lines, respectively. In both cases, LV ET was
calculated as a function of HR and SV using Equation (4.1) and is indicated with an
arrow.
with SV in mL and HR in bpm. Pout values were extracted from capillary blood pressure
measurements in the human lip from 13 healthy subjects seated upright [98]. RT and CT
values were extracted from 12 healthy subjects in supine position [99]. Since they were
originally normalised by body surface area (Abody), µ and σ values for each parameter
were multiplied by the mean body surface area to correct for this. Besides, RT values





where P and Q were the measured pressure and flow waves, respectively. Thus, to account
for non-zero Pout values in the calculation of RT, the following correction was required:




where Q (mL/s) was calculated from the cardiac index (CI, mL/(min m2)) as CI/Abody ∗
60. Z0 values were calculated from pulse wave velocity (PWV ), aortic cross-sectional
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Aortic arch PWV and AAo values were extracted from 162 healthy subjects using cine
phase contrast MRI [100].
Table 4.2: CV parameter variations for the 0-D datasets. These variations were used to
create the two-element and three-element Windkessel (0-D) datasets. Each CV parameter
value is based on observations in healthy humans from the clinical literature.
Variations
Negative Baseline Positive
CV parameter [units] µ− σ µ− 0.5 σ µ µ+ 0.5 σ µ+ σ References
SV [mL] 71.2 79.8 88.4 97.0 105.7 [97]
HR [bpm] 52.9 60.8 68.8 76.7 84.7 [97]
Pout [mmHg] 27.8 30.5 33.2 35.9 38.6 [98]
RT [mmHg·s/mL] 0.470 0.495 0.520 0.545 0.570 [99]
CT [mL/mmHg] 2.20 2.23 2.27 2.30 2.34 [101]
Z0 [mmHg·s/mL] 0.0256 0.0358 0.0485 0.0644 0.0847 [100, 102]
Abbreviations: µ and σ: mean and standard deviation values, respectively, for each CV
parameter from the clinical literature; SV : stroke volume; HR: heart rate; Pout: outflow
vascular pressure; RT: total arterial resistance; CT: total arterial compliance; and Z0:
aortic characteristic impedance.
4.1.2 1-D model datasets of virtual subjects
The cBP waves from the 0-D datasets contain some useful clinical features, such as SBP,
DBP, the incisura, and the diastolic decay (see Figure 4.1, c). However, since 0-D models
cannot simulate pulse wave propagation, these cBP waves do not contain space-dependent
features observed in the clinical literature, such as the early systolic inflection point. 1-D
models can simulate pulse wave propagation phenomena and thus reproduce a cBP wave
whose shape is more detailed and similar to that of physiological cBP waves.
The creation of a 1-D model dataset containing > 4000 virtual healthy adult subjects is
described in Section 4.1.2.1 [3]. Each virtual subject contained simulated blood pressure,
flow, and area waves at multiple arterial locations and free of measurement errors. For
this reason, this dataset was used in this work to test, develop, and assess a number of
methods for CV parameter estimation in Chapter 5, and to assess the performance of
three cBP estimation algorithms in Chapter 6. In Section 4.1.2.2, the characteristics of
the cohort of healthy controls and DCM patients used in Chapter 7 to create a “cohort-
specific” 1-D model datset are presented. The creation of both 1-D datasets, including
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imposed CV parameters and flow waves, the topology of both 1-D models, and simulated
BP waves, is shown in Figure 4.3.
4.1.2.1 Creating a 1-D model dataset
As described in Chapter 4, Charlton et al. used a 1-D model of the 116 arterial seg-
ments making up the larger arteries of the thorax, limbs and head to create a dataset of
4,374 healthy adult subjects containing pressure, flow velocity, cross-sectional area, and
photoplethysmographic (PPG) waves at common measurement locations [3]. The CV
parameters of 25-75 years old healthy subjects were identified through a comprehensive
literature review. In a similar way to 0-D model datasets (Table 4.2), five values for
each CV parameter were calculated as µ, µ ± 0.5 σ, and µ ± σ, and a different 1-D vir-
tual subject was created for each combination of CV parameters. This 1-D dataset was
verified via qualitative comparison between simulated waves and derived indices with cor-
responding clinical data. A more detailed description of the creation of the 1-D dataset
is available in [3].
This thesis contributed to the development of the 1-D dataset by identifying a relationship
between HR, SV and LV ET . As described in Section 4.1.1.2, a regression equation
(Equation (4.1)) relating HR and SV to LV ET for healthy subjects was found in the
clinical literature [97]. This relationship was implemented in the AorticFlowWave script
in [96] to determine the value of LV ET for each simulated aortic flow wave in the 1-D
dataset.
4.1.2.2 Creating a “cohort-specific” 1-D model dataset
A “cohort-specific” 1-D model dataset of virtual subjects was created using a 1-D model
of the 55 larger systemic arteries [82]. Unlike the previous datasets of virtual subjects, the
input CV parameters were extracted from the characteristics of a clinical cohort contain-
ing dilated cardiomyopathy (DCM) patients and controls (healthy volunteers). This 1-D
dataset provided new insights into arterial-ventricular interactions in DCM as part of the
study by Marlevi & Mariscal-Harana1 et al. [2]. This thesis’ main contributions towards
the manuscript, together with extended sections on the creation, analysis, and discussion
1Equal contributions
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of the “cohort-specific” dataset are presented in Chapter 7. The original manuscript and
supplementary material are reproduced in Appendices A.3 and A.4, respectively.
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Figure 4.3: Creating 1-D model datasets of virtual subjects. (a), top and bottom;
inflow waves for the 1-D model dataset and the “cohort-specific” 1-D model dataset, re-
spectively. The thick line illustrates the flow wave corresponding to the baseline values
of SV and HR, and the shaded region represents the range of flow waves correspond-
ing to all SV and HR variations. (a), middle; a range of CV parameter values was
obtained either from the clinical literature for healthy individuals (see [3]) or from the
characteristics of the DCM cohort (see Table 4.1). (b) two 1-D models containing 116
(top) and 55 (bottom) arterial segments were used to generate BP waves. (c) Central
blood pressure (top) and pressure gradient (bottom) waves: the thick line illustrates the
waves corresponding to the baseline set of parameter variations, and the shaded regions
represent the range of waves within each dataset.
Similarly to the 0-D datasets, the 1-D datasets present a series of ‘steps’ in the virtual
cBP waves which correspond to a discrete distribution of HR variations.
4.1.3 Physiological cBP filters from clinical datasets
To ensure that the simulated cBP waves in the previous datasets of virtual subjects
were within physiological ranges, filters based on BP values from the ‘Hypertensive’ and
‘Normotensive’ datasets (Table 4.1) were applied. Maximum values of central systolic
BP (cSBP) and central pulse pressure (cPP) were obtained from the ‘Hypertensive’
dataset. Minimum values of central diastolic BP (cDBP) and cPP were obtained from
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the ‘Normotensive’ dataset. Consequently, subjects with cSBP > 220 mmHg, cDBP < 44
mmHg, and cPP < 18 mmHg or > 109 mmHg were excluded. No subjects were excluded
from the two-element Windkessel dataset; 43 subjects were excluded from the three-
element Windkessel dataset; and 310 subjects were excluded from the 1-D model dataset.
These filters were not applied to the “cohort-specific” 1-D dataset, since studying CV
parameters and BP values in both healthy controls and in DCM patients was of interest.
4.2 Clinical datasets
Three clinical datasets were used for the validation of the cBP estimation algorithms. The
‘Aortic Coarctation’ dataset contained invasive cBP measurements from aortic coarcta-
tion patients obtained via cardiac catheterisation. The ‘Normotensive’ and ‘Hypertensive’
datasets contained non-invasive cBP estimates from the widely used SphygmoCor R© (At-
Cor, West Ryde, Australia) device. cBP and aortic flow waves for each dataset are shown
in Figure 4.4.
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Figure 4.4: Blood pressure (top) and flow (bottom) waves for the clinical datasets.
cBP waves were obtained invasively for the Aortic Coarctation dataset (left), and non-
invasively for the Normotensive and Hypertensive datasets (middle and right, respec-
tively). Aortic flow waves were obtained via 2-D phase contrast MRI for the Aortic
Coarctation dataset, and via continuous wave Doppler ultrasound for the Normoten-
sive and Hypertensive datasets. Black lines illustrate a random patient’s cBP or aortic
flow wave. Shaded regions represent the range of cBP or aortic flow waves within each
dataset.
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4.2.1 Aortic Coarctation
The ‘Aortic Coarctation’ dataset contains data acquired from 10 patients with aortic
coarctation. Inclusion criteria comprised native (5) or repaired (5) aortic coarctation.
According to the coarctation index (CI), calculated as the ratio of the coarctation min-
imum diameter to the descending aorta maximum diameter, four of these patients pre-
sented risk of recurrent coarctation (CI < 0.7 [103, 104]). These coarctations may present
local differences in aortic wall properties due to the aortic narrowing or to the surgical
procedure. However, these differences were not deemed significant enough for modelling
purposes to motivate exclusion. Exclusion criteria were the presence of stented aortic
coarctation or aortic dissection. These two clinical scenarios were expected to introduce
more significant differences in aortic wall properties: stents create discontinuities in wall
properties and dissections present complex geometries (i.e. two parallel vessels with dif-
ferent flows and wall properties) which the 1-D model used in this work does not currently
account for.
The ‘Aortic Coarctation’ dataset has been used in several studies to assess methods for
the estimation of the pressure gradient, artery wall stiffness, and pulse wave velocity.
Brown et al. used the data from one patient to compare the accuracy and computational
cost of three 3-D computational fluid methodologies to estimate blood pressure and flow
waves [105]. Barber et al. used the data from six patients to estimate aortic distensibility
and pulse wave velocity [106]. Bertoglio et al. used the data from another patient to
estimate artery wall stiffness combining a data assimilation method and a 3-D compu-
tational model [107]. Sotelo et al. used data from seven patients to assess the accuracy
of non-invasive aortic pressure gradient estimates using 3-D computational models [108].
Urbina et al. used data from 10 healthy volunteers and from two patients to design
MRI-compatible aortic phantoms simulating normal and aortic coarctation conditions,
and to compare their haemodynamics to those of volunteers and patients [109]. Finally,
Shi et al. used data from 14 patients to validate a non-invasive aortic pressure gradient
estimation method with a lower computational cost than previous methods [110].
4.2.1.1 Data acquisition
The clinical data acquisition was performed in a hybrid magnetic resonance/X-ray suite
guidance system. MRI data was obtained from a 1.5-T cylindrical bore MR scanner
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(Philips Intera, Philips, Best, The Netherlands). MRI data acquisition consisted of a
breath-hold 3-D contrast-enhanced angiography of the upper-thoracic aorta (used to
obtain aortic geometry measurements); and time-resolved, free-breathing 2-D phase con-
trast MRI flow velocity through-plane scans at the ascending aorta and at the descending
aorta (used to obtain flow waves at both locations).
Invasive BP data were obtained using X-ray cardiac catheterisation (Philips BV Pulsera).
Measurements were obtained simultaneously at the aortic root and at the abdominal
aorta, right after flow acquisition, using multi-purpose catheters (angiographic catheter
4F with carbon dioxide-filled balloon). A breath-hold was performed to register the
catheter pressures with a 1 kHz sampling rate over 20-50 heart cycles. A detailed de-
scription of the data acquisition process can be found in [110].
4.2.1.2 Data post-processing
The geometry of the aorta and supra-aortic arteries was segmented from the angiography
data using an in-house prototype software being developed by Philips Healthcare (a
detailed description can be found in [6]). User input was required to select the aortic
inlet and outlet, and the outlet of each supra-aortic artery. Automatic centreline tracking
was performed using a vesselness filter [111] to detect each artery, followed by a bi-
directional fast marching algorithm to find the minimal path [112]. The centreline was
then centred and smoothed using an active contour – an energy minimizing, deformable
spline – and resampled at equidistant locations. Arterial lumen contours were calculated
at each location based on the maximum intensity gradient [113]. Aortic and supra-
aortic centrelines were merged, and intersecting contours were removed to avoid arterial
volume duplication. In some cases, manual adjustment was required to correct for data
inaccuracies, such as the variation of lumen voxel intensity or poor intensity gradients at
the arterial wall. The segmentation process is shown for an Aortic Coarctation patient
in Figure 4.5.
Through-plane blood velocity and luminal area were extracted from 2-D phase contrast
MRI data for each time frame at the user-defined locations in the ascending and de-
scending aorta using the in-house software, too. Velocity and area were extracted by
propagating the segmentation of the arterial lumen throughout the cardiac cycle. Time-
resolved volumetric blood flow waves were then calculated at each arterial location via
Chapter 4. Datasets 41
Figure 4.5: Segmentation of the upper-thoracic aorta using an in-house software.
Top, left: two seed points are placed on different 2-D phase contrast images to indicate
the location of the start and end points of the aortic centreline; top, right: multiplanar
reconstruction is used to indicate the location of the end point of the supra-aortic centre-
lines; bottom, left: the aortic centreline is generated; bottom, middle: the supra-aortic
centrelines are connected to the aortic centreline; bottom, right: the segmentation is
complete.
integration of the velocity over the area for each time frame. The flow waves were filtered
as follows:
• the wave was upsampled via spline interpolation to ensure a cycle length ≥ 100
datapoints;
• a Savitzky-Golay polynomial smoothing filter (polynomial order = 4, window length
= 21 points) was applied to eliminate signal noise (i.e. high frequencies);
• and the resulting wave was analysed to identify the start of systole and shifted
accordingly if required.
The post-processing of the flow data from a patient is shown in Figure 4.6, top.
Raw pressure data obtained via cardiac catheterisation was sampled at 1 kHz over 20-50
cardiac cycles. The ensemble average pressure wave was calculated for each patient and
aortic location following these steps:
• a Savitzky-Golay polynomial smoothing filter (polynomial order = 2, window length
= 83 points) was applied to the raw data to eliminate signal noise;
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• periodic waves were identified using a feet detection algorithm [91];
• waves whose cardiac period was 25% shorter or longer than the median period were
removed;
• remaining waves were truncated to the shortest period;
• and the ensemble average of these waves was calculated.
The post-processing of the pressure data from a patient is shown in Figure 4.6, bottom.
Since pressure and flow waves were measured at different times and using different tech-
niques, the period of the post-processed waves does not coincide. Thus, the cardiac
period was extracted from the corresponding aortic root flow wave for each patient. A
visual check was performed for each flow and pressure wave, but no manual correction
was required.

















































Figure 4.6: Post-processing flow (top) and pressure (bottom) data for the Aortic
Coarctation dataset for a random patient. Top, left: upsampling using a spline interpo-
lation to ensure a minimum cycle length of 100 datapoints; top, right: smoothing via the
Savitzky-Golay filter and shifting the start of systole; bottom, left: smoothing multiple
cycles via the Savitzky-Golay filter; bottom, right: ensemble averaging of similar cycles.
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4.2.2 Normotensive and Hypertensive
The ‘Normotensive’ and ‘Hypertensive’ datasets were obtained from [114]: (i) 13 nor-
motensive healthy volunteers at baseline and after the administration of different doses of
four drugs with different inotropic and vasoactive properties (dobutamine, norepinephrine,
phentolamine, and nitroglycerin); and (ii) 158 subjects assessed for hypertension (those
found to be normotensive are included, too). Inotropic drugs increase or decrease the force
of cardiac contractions; vasoactive drugs increase (vasodilation) or decrease (vasoconstric-
tion) the arterial lumen diameter. The ‘Normotensive’ and ‘Hypertensive’ datasets have
been used in several studies to identify the main cardiovascular determinants of increased
central pulse pressure in hypertension. Fok et al. showed that increased central pulse
pressure during inotropic and vasopressor stimulation, and in essential hypertension is
mainly due to the forward component of the pressure wave [114]. Li et al. showed that
the backward component of the pressure wave has little effect on the increased central
pulse pressure during inotropic and vasomotor stimulation, and in essential hyperten-
sion [115]. Finally, Vennin et al. found that arterial stiffness and ventricular ejection
(flow and volume) are the most important determinants of increased central pulse pres-
sure in hypertension [116].
Although half of the subjects in the ‘Hypertensive’ dataset were on treatment, subjects
found to be normotensive were not necessarily on treatment, as this information was not
available. In fact, this dataset is made up of “those [subjects] evaluated for hypertension”.
From the modelling perspective, given that the estimates from the 0-D algorithms are
independent of health or disease, and given that clinical data acquisition was similar for
those subjects from the ‘Hypertensive’ and ‘Normotensive’ datasets, it would have been
possible to group subjects in other ways. Depending on the clinical question, different
groupings are possible: hypertensives vs normotensives, young vs old, males vs females, or
a single group containing all subjects. In this case, the decision of grouping patients into
the ‘Normotensive’ and ‘Hypertensive’ datasets was taken for consistency with previous
studies using the same datasets.
4.2.2.1 Data acquisition
Aortic root velocity time integral (VTI) was acquired using continuous wave Doppler
obtained in the apical 5-chamber view using the Vivid-7 R© ultrasound platform (General
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Electric Healthcare, Pollards Wood, United Kingdom). The cross-sectional area of the
aortic valve was obtained in the parasternal long-axis view.
Carotid and radial pressure waves were acquired non-invasively by applanation tonometry
using the SphygmoCor device, which uses a transfer function to calculate cBP from the
carotid pressure waves. The ensemble average of approximately 10 cardiac cycles for
each carotid pressure wave was used as input to the SphygmoCor device to obtain cBP.
A detailed description of the data acquisition process can be found in [114].
4.2.2.2 Data post-processing
VTI data was acquired during at least three cardiac cycles for all subjects. The original
data files contained three columns: time, raw VTI waves, and filtered VTI waves. Filtered
VTI waves were generated from raw VTI waves by setting any VTI values under a certain
threshold to 0 in order to eliminate noise during diastole. The filtered VTI waves were
further post-processed as follows:
• the start of each cardiac cycle was detected;
• the ensemble average was calculated for ≥ three cycles;
• the diastolic portion of the ensemble was set to zero;
• the resulting VTI wave was analysed to identify the start of systole, shifted accord-
ingly if required, and multiplied by the cross-sectional area of the aortic valve to
obtain aortic flow.
The post-processing of the flow data from a volunteer is shown in Figure 4.7.
Carotid pressure data obtained via the SphygmoCor device was acquired at 128 Hz over
approximately 10 cardiac cycles. For each subject, the ensemble average carotid pressure
wave was calculated automatically and used as input to the SphygmoCor transfer function
to obtain an estimate of cBP, as shown in Figure 4.8. The pressure waves did not require
further modifications.
Since pressure and flow waves were measured at different times and using different tech-
niques, the period of the post-processed waves does not coincide. Thus, the cardiac
period was extracted from the corresponding aortic root flow wave for each patient. A
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Figure 4.7: Post-processing flow data for the Normotensive and Hypertensive datasets.
Left: the start of each cycle is identified to calculate an ensemble average VTI wave;
right: the value of the VTI wave during diastole is set to zero and the resulting wave is
shifted so that the first datapoint coincides with the start of systole.




























Figure 4.8: Estimation of central blood pressure (dashed blue line) from carotid blood
pressure (black line) using the SphygmoCor device. Left: pressure data for a random
patient from the Normotensive dataset; right: pressure data for a random patient from
the Hypertensive dataset.
4.3 Justification for the choice of clinical scenarios
The choice of clinical scenarios presented in this chapter (i.e. aortic coarctation, hyper-
tension, dilated cardiomyopathy, and disease-free) was partly driven by data availability.
However, from the modelling and clinial perspectives, this choice can be justified by
several reasons which will be discussed in turn.
Firstly, the ‘Aortic Coarctation’ dataset allowed both the 0-D and 1-D algorithms to
be tested since it contained MRI data of aortic geometry and flow (required to run
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the 1-D algorithm). This dataset included invasive measurements of cBP, which were
necessary to validate all algorithms in vivo, and it allowed algorithm testing in patients
with tortuous aortic geometries. The heart of aortic coarctation patients must pump
harder as a consequence of an increased afterload, so a regular assessment of cBP would
be beneficial.
Secondly, the ‘Normotensive’ and ‘Hypertensive’ datasets allowed the 0-D algorithms to
be tested since they contained ultrasound aortic flow data. Since these datasets contained
cBP data from a large number of volunteers and patients, a wide range of non-invasive
cBP wave morphologies (representative of both health and disease) was available. Sim-
ilarly to aortic coarctation patients, hypertensives would benefit from a central rather
than brachial assessment of blood pressure.
Finally, the ‘Dilated Cardiomyopathy’ dataset allowed the use of the 1-D algorithm since
it contained sufficient MRI data of aortic geometry and flow. Instead of cBP measure-
ments, this dataset contained non-invasive measurements of the aortic pressure gradient
between the aortic root and the diaphragm. This dataset allowed the study of how the
aortic pressure gradient can help to differentiate between healthy and unhealthy subjects
with normal aortic geometries. Furthermore, patients suffering from DCM or other car-
diac diseases would also benefit from a non-invasive assessment of cBP, which is related
to relevant cardiac metrics such as left-ventricular pressure, afterload, and myocardial
stress.
4.4 Final remarks
This has described the datasets of virtual and clinical subjects which will be used in
the following chapters. The 0-D and 1-D datasets will be used in Chapter 5 to test and
develop methods for cardiovascular parameter estimation. The 1-D dataset will also be
used in Chapter 6 to assess algorithms for cBP estimation in silico. The “cohort-specific”
1-D dataset will be used in Chapter 7 to investigate ventricular-arterial haemodynamics
in a dataset of dilated cardiomyopathy patients. Finally, the three clinical datasets will
be used in Chapter 6 to assess and validate algorithms for cBP estimation in vivo.
5 Cardiovascular Parameter Estimation
In this chapter, (i) a comprehensive literature review of current cardiovascular parameter
estimation methods is presented; (ii) the development of new methods is described; (iii)
and the performance of every method is assessed using three datasets of virtual subjects
(described in Chapter 4) to identify optimal methods to estimate each cardiovascular
parameter.
5.1 Introduction
Cardiovascular (CV) parameters can be used to assess CV function from non-invasive
data available in the clinic. The clinical relevance of the CV parameters used in this
work is described next.
Left ventricular ejection time (LV ET ) is the period during which blood is ejected from the
left ventricle across the aortic valve and into the aorta, and coincides with the duration
of systole. LV ET is influenced by CV parameters such as heart rate, stroke volume,
preload or afterload, and by inotropic drugs, and is a valuable metric of left ventricular
performance both in health and disease [117].
The asymptotic pressure (Pout) is sometimes defined as the asymptotic value of the blood
pressure wave if the heart stopped beating [118], or as the pressure at which flow to the
microcirculation ceases [75]. Regardless of its definition, the physiological meaning and
range of values of Pout are still not fully understood [119]. According to some studies,
Pout is related to capillary and venous pressure [120], though others argue this pressure
is larger than the venous pressure due to the waterfall effect [121–123].
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Arterial resistance (RT) is the resistance to flow which the heart needs to overcome to
transport blood through the systemic arteries into the capillaries. In his book entitled
Haemastaticks (1733), the Reverend Stephen Hales (1677-1761) was the first to show
experimentally that most of this resistance is offered by the smallest blood vessels (ar-
terioles and capillaries) [124]. In 1846, Poiseuille (1799-1869) was the first to obtain
accurate experimental results which indicated that there is a relationship between the
pressure gradient (∆P ), flow (Q), tube length (L), and the fourth power of the tube’s
internal radius (r). This was later derived from first principles independently by Wiede-





where µ is the dynamic viscosity of the fluid. It can be shown from first principles that







However, the right-hand side of Equation (5.2) requires the dimensions of every vessel
down to the capillaries, which is unfeasible. Instead, RT can be approximated using the
middle term of Equation (5.2), with ∆P = MBP − Pout and Q = Q, where MBP and
Q represent the mean pressure and flow, respectively, measured at the aortic root. Due
to this relationship between arterial resistance and radius, small vessels exposed to high
blood pressure can constrict to increase RT to deliver steady flow to the capillary beds
in the terminal organs [125, 126].
Arterial compliance (CT) is the property of arteries which allows them to store blood by
distending during systole and to release it during diastole to maintain diastolic flow [127].
Additionally, compliance is the inverse of arterial stiffness [124], which is also related to
pulse wave velocity. Therefore, changes in CT can have important effects on the pulse
wave, left ventricular dynamics, cardiac output, and the ratio of systolic to diastolic flow
into the capillary beds [128].
Pulse wave velocity (PWV ) is the velocity of travel of pulse waves originating from
the left ventricle. It is regarded as the ‘gold standard’ for the assessment of arterial
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compliance, which is directly related to arterial stiffness, and has recently been proposed
as a marker of cardiovascular risk [124].
Input impedance (Z) is defined as the ratio between P and Q measured simultaneously
at the same arterial site [124], which is calculated for a given harmonic as




where |Z| = |P |/|Q| and θ are the modulus and the phase, respectively. Characteristic
impedance (Z0) is a measurement of input impedance assuming that P and Q are not
affected by wave reflections. However, since there are no physiological conditions where
this is the case, this measurement will always be influenced by wave reflections arriving






where ρ is the blood density and A is the arterial cross-sectional area. Thus, aortic PWV
and aortic Z0 are directly related to aortic stiffness, and are independent predictors of
CV risk [102, 116, 130, 131].
The main objective of this study was to identify optimal methods to estimate CV pa-
rameters using three datasets of virtual subjects whose reference CV parameter values
could be obtained free of measurement errors (see Chapter 4). These optimal methods
were then used as inputs to computational models of the circulation to estimate cBP
(see Chapter 6). The rationale behind this study was that using the most accurate CV
parameter estimation methods should lead to the most accurate cBP estimates.
5.2 Methods
The following CV parameters were required as inputs to at least one of the cBP estimation
algorithms: left ventricular ejection time (LV ET ), outflow vascular pressure (Pout), total
arterial resistance (RT) and compliance (CT), aortic pulse wave velocity (PWV ), and
aortic characteristic impedance (Z0).
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A comprehensive literature review of CV parameter estimation methods was performed.
Although the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) [132, 133] approach is considered the model of best practice, this literature
review belongs to this thesis’ earliest work and did not follow strict search criteria. Arti-
cles were primarily found using Google Scholar, KCL’s Library Search, and Google (UK),
but articles from other sources were also included (often identified from the references
of articles, and through discussions with colleagues). The main search terms included
different combinations of the terms “cardiovascular”, “parameters/properties” and “es-
timation/measurement” with the names of the cardiovascular parameters under study
(e.g. “left ventricular ejection time”, “outflow vascular pressure”). The methods listed
in Table 5.1 were implemented and assessed in this study. To be included, they had to
satisfy at least one of the following inclusion criteria: they were reported as the optimal
method [72, 134–138]; their performance was similar to that of the optimal method [72,
134, 138–140]; they were the only reported method [84, 85, 91, 99, 129, 130, 141–154]; or
their performance had not been sufficiently assessed due to their novelty [91, 147, 148].
Furthermore, each time a gap was identified upon implementing and assessing the pre-
vious methods, new, improved methods were developed. All CV parameter estimation
methods used in this study are described next. Novel methods are marked with an
asterisk in the title.
5.2.1 LV - Left ventricular ejection time, LVET
LV1 - dP/dt analysis, 1*
A peripheral pressure wave, P , is analysed from the time of peak pressure to 80% of the
duration of the cardiac cycle, T (Figure 5.1). The points at which dP/dt is equal to zero
are identified. If such intersection points exist, LV ET corresponds to the last of these
points. Otherwise, a tangent to P at the point of maximum negative dP/dt is projected.
LV ET corresponds to the first point where the value of the tangent is ≤ DBP .
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Figure 5.1: Novel method to estimate LV ET from a peripheral pressure wave, P . P
(left) and dP/dt (right) with time. Values from peak pressure to 0.8T are highlighted
in dashed lines. LV ET corresponds to the time of the last intersection point between
dP/dt and the x-axis (red triangle).
LV2 - dP/dt analysis, 2
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LV ET is calculated using the empirical relationship described in [149]: 0.37
√
T , where
T is the duration of the cardiac cycle in seconds.
LV4 - Q analysis*
Q is analysed from the global minimum after peak flow to 50% of T (Figure 5.2). If
all Q values are smaller than 1% of maximum Q, LV ET corresponds to the time of
the global minimum. Otherwise, starting from the time of the global minimum, all sign
changes (from negative to positive), all maxima, and all zero values are found. LV ET
corresponds to either the first sign change, the first local maximum, or the first zero value
(whichever one occurs first). If all else fails, method LV3 is used.
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Figure 5.2: Novel method to estimate LV ET from the aortic flow wave, Q. LV ET
corresponds to the time of the first sign change (green circle), which occurs earlier than
the local maximum (red triangle).
5.2.2 OP - Outflow pressure
OP1 - Diastolic decay fit, 1
The concept of a diastolic decay fit was first described in [84]. P is analysed between
LV ET and the end of diastole (Pd). The multidimensional unconstrained nonlinear
minimisation (Nelder-Mead) MATLAB R© function fminsearch is used to find the best
fit between Pd and an exponential decay curve of the form: Pexp = Pout + (Pexp(t0) −
Pout)e−(t−t0)/τ , where t0 = LV ET . To avoid non-physiological values of Pout, the follow-
ing filters are applied: if τ < 0 or Pout < 0, Pout is set to 0; and if Pout ≥ 0.75DBP , Pout
is set to 0.5DBP .
OP2 - Diastolic decay fit, 2
Similarly to OP1, but using t0 = 23LV ET +
1
3T instead, as described in [99].
OP3 - 50% of DBP*
Pout is estimated as 50% of DBP .
OP4 - 70% of DBP
As suggested by Parragh et al. Pout is estimated as 70% of DBP [119].
Chapter 5. Cardiovascular Parameter Estimation 53
5.2.3 AR - Arterial resistance
AR1 - Peripheral pressure waveform
RT is calculated using Equation (5.12) and MBP is calculated as the mean of P .
AR2 - Peripheral DBP and SBP values
Similarly to AR1, but using MBP = DBP + 0.4PP instead, as described in [137].
5.2.4 AC - Arterial compliance
AC1 - 2-point diastolic decay
The concept of a diastolic decay fit was first described in [84]. Using only the first and
last points of the diastolic part of P , CT is calculated as:
T − LV ET
ln(P (LV ET )−PoutDBP−Pout )RT
. (5.6)
AC2 - Diastolic decay fit, 1
Given that τ = (RT−Z0)CT (for the three-element Windkessel model), OP1 can be used





If τ is negative then Pout is set to 0 and τ is recalculated.
AC3 - Diastolic decay fit, 2
Similarly to AC2, but using t0 = 23LV ET +
1
3T instead, as described in [99].
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AC4 - Area method




RT(P (t1)− P (t2))
, (5.8)
where t1 and t2 are equal to 23LV ET +
1
3T and 90% of T , respectively.
AC5 - Two-area method
This method is described in [151]. CT is calculated by solving two simultaneous equations






(P − Pout)dt = CT(P (t1)− P (t2)), (5.9)
from the start of the cycle to LV ET , and from LV ET to T .
AC6 - Diastolic blood pressure method*
CT is calculated by minimising the relative error, DBPerr = (DBPest−DBPref)/DBPref ,
between the estimated (DBPest) and reference (DBPref) values of DBP , as seen in Fig-
ure 5.3. For each iteration, j, DBPest is calculated as the minimum of the estimated
pressure, Pest, using the three-element Windkessel model (Equation (3.4)). The ini-
tial conditions are CT,0 = SV/PP and P0 = DBPref . While DBPerr > 1%, CT,j =
CT,j−1/(1 +DBPerr)2. CT corresponds to the value of CT,j when DBPerr < 1%.
AC7 - Pulse pressure method
This method is described in [135]. Similarly to AC6, but minimising the relative PP
error, PPerr, instead.
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Figure 5.3: Novel iterative method to estimate CT from the aortic flow and peripheral
pressure (pBP) waves. CT estimates are calculated by minimising the relative error
between the estimated and reference values of DBP . The latter is obtained from the
pBP wave (black line). The pressure waves corresponding to the initial and optimal
estimates of CT are shown in red and blue lines, respectively. The black dashed line
indicates the value of DBP extracted from the cBP wave.
AC8 - Stroke volume over pulse pressure
This method is described in [140]. CT corresponds to SV/PP .
AC9 - Three-element Windkessel optimisation*
This method is described in A.1. The initial value of CT is calculated using AC8.
5.2.5 PV - Pulse wave velocity
The foot-to-foot (PV1 and PV2) and least-squares (PV3 and PV4) methods used here
are described in [91]. Both methods require the measurement of two pulse waves at both
ends of a given arterial path of length L. The foot-to-foot method focuses on detecting
the ‘feet’ (i.e. minimum value) of both pulse waves to calculate the transit time (TT )
between them. For each pulse wave, the ‘foot’ is detected as the intersection between a
horizontal projection of the minimum value and a projection of the maximum slope of
the systolic upstroke.
The least-squares method calculates the sum of the squared differences between the
systolic upstroke of both waveforms multiple times, by fixing one wave and shifting the
other one by one datapoint at a time. The temporal shift which minimises the squared
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differences is used to estimate TT . For both methods, PWV is then calculated as
PWV = L/TT .
PV1 - Foot-to-foot: aortic flow
The inputs are two non-invasive flow waveforms at the ascending and descending aorta.
PV2 - Foot-to-foot: carotid-femoral pressures
The inputs are two non-invasive pressure waveforms at the carotid and femoral arteries.
PV3 - Least-squares: aortic flow
The inputs are two non-invasive flow waveforms at the ascending and descending aorta.
PV4 - Least-squares: carotid-femoral pressures
The inputs are two non-invasive pressure waveforms at the carotid and femoral arteries.
PV5 - Sum of squares
This method has been adapted from the original one described in [153]. PWV is calcu-







where ρ is the blood density, A is the cross-sectional area at the aortic root, dP and dQ
are differences in P and Q, respectively, between two adjacent time points, and the sums
extend over a cardiac cycle. P and Q do not need to be aligned in time.
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5.2.6 Z - Aortic characteristic impedance
Methods Z1 and Z2 are sensitive to temporal mis-alignments between P and Q, so the
following restrictions were applied to account for waves which were not recorded simul-
taneously and/or at the same site: (i) P is shifted so that its value at the start of the
cycle coincides with DBP , and (ii) Q is shifted so that its value at the start of the cycle
is as close as possible to the intersection between the x-axis and the tangent of Q at the
time of maximum dQ/dt in early systole.
Z1 - Frequency methods
Frequency domain methods to estimate characteristic impedance (Z0) are based on the
Fourier analysis of P and Q extracted simultaneously at the ascending aorta. Z0 is usually
estimated as the average impedance modulus over a range of frequencies where fluctu-
ations – due to wave reflections – above and below the characteristic impedance value
are expected to cancel each other out. The following harmonic ranges, extracted from
the literature, have been assessed in this study: 2-12th [130], 6-10th [145], 1-8th [143], 1-
9th [134], 2-10th [144], 3-10th [146], 4-10th [141], 6-8th [142], and 4-8th harmonics [138].
These methods, in their original form, require P and Q measured simultaneously at the
ascending aorta. However, for the proposed algorithms, a peripheral P measurement is
used instead.
Z2 - P-Q loop methods
P-Q loop methods analyse the relationship between aortic P and Q during early systole,





where Q(0) is the value of Q at the start of the cycle (normally zero). In this study, four
P-Q loop methods were assessed where Z0 was estimated as:
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I the mean value of Equation (5.11) between the start of the cycle and the time of
maximum Q;
II the slope of the linear least squares fit to the ratio between P and Q between the
start of the cycle and the time of maximum flow;
III the value of Equation (5.11) at the time of maximum dQ/dt in early systole; and
IV the mean value of Equation (5.11) between the start of the cycle and the time of
maximum dQ/dt in early systole.
The best performing P-Q loop method, IV, was used to calculate the errors in Table 5.1.
These methods, in their original form, require P and Q measured simultaneously at the
ascending aorta. However, for the proposed algorithms, a peripheral P measurement is
used instead.
Z3 - 5% of RT
As suggested by Murgo et al. Z0 is estimated as 5% of RT [154].
Z4 - Approximated aortic characteristics*
During early systole, wave reflections reaching the aortic root are assumed to be absent,
and characteristic impedance can be estimated as Z0 = ∆P/∆Q, where ∆P and ∆Q are
the changes in blood pressure and flow rate, respectively [146]. Peak flow, Qpeak, and the
first systolic shoulder/peak, P1, occur at a similar time, so ∆Q = Qpeak and ∆P = P1,
and therefore Z0 ' P1/Qpeak, as seen in Figure 5.4. Assuming that DBP and MBP
remain constant within the large arteries, P1 is approximated as MBP−DBP extracted
from a peripheral P measurement. Hence, Z0 ' (MBP −DBP )/Qpeak.
Z5 - Aortic characteristics
This method is described in [129]. Assuming that the aortic radius is much larger than
the aortic wall thickness, Z0 corresponds to ρPWV/A, where ρ is the blood density,
PWV is the aortic pulse wave velocity, and A is the aortic-root cross-sectional area.
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Figure 5.4: Novel method to estimate aortic characteristic impedance from the aortic
flow and peripheral pressure waves. Pressure (top) and flow (bottom) waves at central
(left) and peripheral (right) arterial locations for a subject from the 1-D dataset. The
time of Qpeak and P1 is indicated by the vertical, red, dashed line. The value of P1 is
approximated as MBP −DBP calculated from the peripheral pressure wave.
Z6 - Three-element Windkessel optimisation*
This method is described in Appendix A.1. The initial values of CT and Z0 are calculated
using the AC8 and Z3 methods, respectively.
5.2.7 Performance assessment of cardiovascular parameter estimation
methods
The performance of the CV parameter estimation methods was assessed using the mean
percentage error (MPE) and standard deviation (SD) between estimated and reference
CV parameter values for the three datasets of virtual subjects (described in Chapter 4).
Additionally, Bland-Altman plots [155] were created to show the bias (MPE) and limits of
agreement (± 1.96 SD from the bias) between the estimated and reference CV parameter
values. For the 0-D datasets, reference values were obtained from the prescribed values
used to create each virtual subject (Table 4.2). For the 1-D dataset, reference values for
LV ET and Pout were obtained from the prescribed values. RT was calculated from the
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where MBP is the mean blood pressure and Qin is the mean blood flow. CT and Z0 were
extracted from aortic root pressure and flow waveforms using the optimised three-element









where r is the aortic root radius at MBP , and k1, k2, and k3 are empirical constants [81].
Two common clinical scenarios were considered when assessing CV parameter estimation:
‘Scenario 1’, where the carotid pressure waveform was available; and ‘Scenario 2’, where
only brachial DBP and SBP values were available (Figure 6.1a). The three-element
Windkessel and 1-D datasets of virtual subjects were used to determine, for each scenario
and CV parameter, the optimal (i.e. smallest MPE and SD) CV parameter estimation
methods to be used by the cBP algorithms described in Chapter 6. The two-element
Windkessel dataset contained a smaller range of cBP values and wave shapes than the
three-element Windkessel dataset. For this reason, and given that their mathematical
formulations are very similar, the two-element Windkessel dataset was only used for a
preliminary analysis, and was excluded from the final assessment. MPE and SD values
for the three datasets are presented in Table 5.1.
5.3 Results
The last three columns of Table 5.1 show mean percentage errors (MPE) and standard
deviation (SD) for all CV parameter estimation methods assessed using the three datasets
of virtual subjects. Table 5.2 shows the methods that led to the smallest MPE for each
scenario and dataset. For the 1-D dataset, MPE were reduced by at least 40% when using
the carotid pressure waveform (Scenario 1) instead of brachial DBP and SBP values
(Scenario 2). By using these optimal methods, all parameters from the 1-D dataset but
Z0 were estimated with MPE < 6% and < 10% for Scenario 1 and 2, respectively. Much
larger errors were obtained for Z0, especially in Scenario 2 (82%). All parameters from
the three-element Windkessel dataset were estimated with MPE < 2% in both scenarios.
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For the two-element Windkessel dataset, all parameters but CT were estimated with
MPE < 0.2% and < 10% for Scenario 1 and 2, respectively. Although MPE for CT for
Scenario 1 were < 0.1%, they were much larger for Scenario 2 (36%).
Figures 5.5 and 5.6 show Bland-Altman plots for all CV parameters estimated using the
optimal methods obtained from the two-element and three-element Windkessel datasets,
respectively. Figure 5.7 shows Bland-Altman plots for all CV parameters estimated using
the optimal methods obtained from the 1-D dataset.
Firstly, for the two-element Windkessel dataset, all parameters were estimated without
any considerable bias in Scenario 1. In Scenario 2, only RT and CT showed a considerable
bias, with a 5% underestimation and a 36% overestimation, respectively. The bias as a
function of each CV parameter reference value remained approximately unchanged, with
the exception of Pout in Scenario 2, whose bias decreased with increasing reference values.
Secondly, for the three-element Windkessel dataset, all parameters were estimated with-
out any considerable bias in both scenarios. The bias as a function of the reference values
of each CV parameter remained approximately unchanged, with the exception of Pout
and Z0 in Scenario 2, whose bias decreased with increasing reference values.
Finally, for the 1-D dataset, LV ET , Pout, RT, CT, and PWV were estimated without
any considerable bias of their corresponding reference mean values (< 6% for Scenario 1
and < 10% for Scenario 2), whereas Z0 was overestimated with a much greater bias of its
corresponding reference mean value (16% for Scenario 1 and 82% for Scenario 2). The
bias as a function of the reference values of each CV parameter remained approximately
unchanged, with the exceptions of Pout (which had a unique reference value), LV ET in
Scenario 2 (whose bias increased with increasing reference values), and CT in Scenario
2 (whose bias decreased with increasing reference values). The same optimal methods
were identified for PWV in Scenario 1 and 2. These optimal methods were then used in
the cBP estimation algorithms.
For each subject in the 0-D and 1-D datasets, all CV parameters were calculated in less
than 1 second using a standard PC (less than 1 hour for the entire 0-D or 1-D datasets).
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Table 5.1: Assessed CV parameter estimation methods. They were trialled using the 0-D and
1-D datasets in two clinical scenarios (Figure 6.1a). Scenario 1: carotid BP waveform available.
Scenario 2: only brachial DBP and SBP values available. Errors are presented as the mean ±
standard deviation of the percentage error between estimated and reference CV parameter values.
†New methods. *Pressure at the carotid and femoral arteries required.
Param Sc Ref Abb Percentage error [%]
2-Wk dataset 3-Wk dataset 1-D dataset
LV ET
1 † LV1 108.7 ± 12.9 -1.2 ± 0.6 11.6 ± 8.7
1 [148] LV2 61.5 ± 22.7 -12.4 ± 0.1 3.0 ± 4.4
1,2 [149] LV3 26.2 ± 8.6 26.2 ± 8.6 16.9 ± 8.9
1,2 † LV4 0.1 ± 0.2 0.1 ± 0.2 9.7 ± 0.7
Pout
1 [72, 84] OP1 0.0 ± 0.0 0.0 ± 0.0 -5.1 ± 8.0
1 [84, 99] OP2 0.0 ± 0.0 0.0 ± 0.0 -10.5 ± 7.5
1,2 † OP3 9.2 ± 18.4 1.6 ± 16.9 9.1 ± 11.0
1,2 [119] OP4 52.9 ± 25.7 42.3 ± 23.6 52.7 ± 15.4
RT
1 [84] AR1 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.1
2 [84, 136, 137] AR2 -4.6 ± 0.3 0.7 ± 5.7 -4.9 ± 2.9
CT
1 [84] AC1 9.6 ± 0.8 -0.1 ± 0.0 -6.5 ± 4.9
1 [84] AC2 10.3 ± 0.8 0.0 ± 0.0 -6.6 ± 3.3
1 [84, 99] AC3 10.3 ± 0.8 0.0 ± 0.0 -10.2 ± 5.0
1 [72, 140, 150] AC4 0.0 ± 0.0 -10.0 ± 4.1 -11.4 ± 4.6
1 [72, 151] AC5 0.0 ± 0.0 -10.0 ± 4.1 -7.1 ± 7.1
1,2 † AC6 45.7 ± 10.7 -1.5 ± 4.1 -17.3 ± 7.5
1,2 [72, 135] AC7 - -0.1 ± 0.2 -27.6 ± 11.6
1,2 [140] AC8 35.6 ± 5.8 -13.8 ± 20.3 4.9 ± 18.4
1 † AC9 0.2 ± 0.3 0.0 ± 0.3 -0.8 ± 4.2
PWV
1,2 [91] PV1 - - 8.2 ± 6.0
1* [91] PV2 - - 27.8 ± 10.8
1,2 [91] PV3 - - -12.7 ± 8.3
1* [91] PV4 - - 43.0 ± 36.0
1 [153] PV5 - - 33.2 ± 17.2
Z0
1 [130, 134, 138, 142–146] Z1 - 2.5 ± 2.1 64.6 ± 44.3
1 [134, 139, 141] Z2 - 0.2 ± 1.4 13.4 ± 56.6
1,2 [85, 154] Z3 - -1.5 ± 40.8 133.8 ± 66.7
1,2 † Z4 - -38.7 ± 12.4 82.3 ± 32.6
1,2 [129] Z5 - - 90.4 ± 18.1
1 † Z6 - -0.1 ± 0.7 37.1 ± 20.0
Abbreviations: Param: cardiovascular parameters; Sc: clinical scenarios; Ref : references; Abb:
coded abbreviations used to refer to each method; LV ET : left-ventricular ejection time; Pout: out-
flow pressure; RT: arterial resistance; CT: arterial compliance; PWV : pulse wave velocity; Z0:
characteristic impedance; 2-Wk and 3-Wk: two-element and three-element Windkessel, respectively.
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L] RT + LoA: -0.021
Bias:  -0.024
- LoA: -0.027
















g] CT + LoA: 1.1
Bias:  0.8
- LoA: 0.5
Figure 5.5: Bland-Altman plots: optimal CV parameter estimation methods using
the two-element Windkessel dataset. Estimates were obtained from the aortic flow and
pressure waves using Scenario 1 (top) and 2 (bottom).
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L] RT + LoA: 0.062
Bias:  0.004
- LoA: -0.055


















g] CT + LoA: 0.005
Bias:  -0.003
- LoA: -0.011

















0 + LoA: 0.032
Bias:  -0.008
- LoA: -0.049
Figure 5.6: Bland-Altman plots: optimal CV parameter estimation methods using
the three-element Windkessel dataset. Estimates were obtained from the aortic flow
and pressure waves using Scenario 1 (top) and 2 (bottom).
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Scenario 1
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Bias:  -0.041
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L] Z0 + LoA: 0.043
Bias:  0.023
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PWV + LoA: 1.8
Bias:  0.7
- LoA: -0.4
Figure 5.7: Bland-Altman plots: optimal CV parameter estimation methods using
the 1-D dataset. Estimates were obtained from the aortic flow and pressure waves using
Scenario 1 (top) and 2 (bottom).
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Table 5.2: Optimal CV parameter estimation methods. Performance was assessed for both
clinical scenarios using the 0-D and 1-D virtual datasets.
Independent CV parameter estimation (mean percentage error [%])




OP1/2 (0.0) AR1 (0.0) AC4/5 (0.0)
N/A N/A




OP1/2 (0.0) AR1 (0.0) AC2/3 (0.0)
N/A
Z6 (-0.1)
2 OP3 (1.6) AR2 (0.7) AC7 (-0.1) Z3 (-1.5)
1-D
1 LV2 (3.0) OP1 (-5.1) AR1 (0.0) AC9 (-0.8)
PV1 (8.2)
Z2 (15.8)
2 LV4 (9.7) OP3 (9.1) AR2 (-4.9) AC8 (4.9) Z4 (82.3)
Abbreviations: Sc: scenario; LV ET : left-ventricular ejection time; Pout: outflow pressure;
RT: arterial resistance; CT: arterial compliance; PWV : pulse wave velocity; Z0: character-
istic impedance; 2-Wk and 3-Wk: two-element and three-element Windkessel, respectively.
5.4 Discussion
Obtaining reliable in vivo reference values for the CV parameters studied here is challeng-
ing. Therefore the accuracy of several CV parameter estimation methods was assessed
using three datasets of virtual subjects for which theoretical reference values were known
exactly, without measurement errors. This approach provided the optimal combination
of methods for the cBP algorithms and identified accurate methods for estimating CV
parameters that, by themselves, can be used to assess cardiovascular function from non-
invasive data available in the clinic. The optimal methods according to the results from
the assessment using the 1-D dataset of virtual subjects are discussed next.
5.4.1 LV ET estimation methods
Left ventricular ejection time (LV ET ) is a relevant metric of cardiac performance [117].
According to the results for Scenario 1 (MPE ± SD: 3 ± 4%), LV ET can be estimated
accurately from the peripheral pressure wave using an existing method for dicrotic notch
detection [148]. However, the incisura, which is a high frequency feature of the pressure
wave caused by aortic valve closure, provides a more accurate value of LV ET [10]. The
dicrotic notch is actually a feature of the pressure wave caused by the reflection of waves
produced by the resistance of peripheral vessels (see Figure 5.8). In fact, as seen in
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O’Rourke [156] and in Figure 5.8, as the pulse wave travels from the aortic root towards
the periphery, the dicrotic notch moves away from the pulse wave onset. This explains the
observed LV ET overestimation, since both dP/dt methods focus on the detection of the
dicrotic notch rather than the incisura. Future studies could look at ways of improving
this estimate by applying a variable correction factor (based on clinical data) to account
for the location of the peripheral pressure wave.
When a peripheral pressure measurement is not available (Scenario 2), analysis of the
aortic flow wave can also lead to reasonable estimates (10± 1%). Estimating LV ET as
a fixed proportion of the cardiac period led to larger errors in this assessment. This is
explained by the fact that LV ET depends both on T and SV , as it was prescribed using
Equation (4.1) [97] when creating the in silico flow waves.























Figure 5.8: Evolution of the pressure wave along the aorta at 5 cm intervals for a
subject from the 1-D dataset. As indicated by the dashed line, the dicrotic notch moves
away from the pressure wave onset as the pressure wave travels towards the periphery.
The delay between the dicrotic notch measured at the aortic root and at a 50 cm distance
along the aorta is in this case approximately 50 ms. All pressure waves are plotted
starting at the time of pressure wave onset for comparison. Only the onset of the aortic
root pressure wave coincides with the start of the cardiac cycle.
The poor performance (> 100% MPE) of the novel LV1 method on the two-element
Windkessel dataset is a consequence of the shape of the pressure waves created by the
two-element Windkessel model. These pressure waves lack a pair of local minimum/-
maximum points, and therefore the method proceeds to estimate LV ET as described
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in Section 5.2.1. This issue disappears in the more physiological three-element Wind-
kessel and 1-D datasets, where at least one pair of local minimum/maximum points is
present for each subject’s pressure waveform. Consequently, MPE are smaller for these
two datasets (1% and 15%, respectively).
5.4.2 Pout estimation methods
The asymptotic pressure Pout is currently not fully understood [119]. It was found that
estimation methods based on an exponential fit to the diastolic part of the pressure wave
outperformed those using a percentage of DBP (−5± 8% vs 9± 11%).
5.4.3 RT estimation methods
The arterial resistance (RT) estimated at the aortic root represents the resistance op-
posed by peripheral vessels to the flow of blood into the microcirculation. According to
the results of this study, accurate estimates could be obtained when using the whole pe-
ripheral pressure wave (Scenario 1) to estimate MBP (MPE and SD < 1%). Estimation
of RT using an empirical relation [136, 137] requiring peripheral DBP and SBP values
(Scenario 2) to estimate MBP underestimated reference RT values by 5% on average.
Although the second method assumes that MBP remains constant in the large arteries,
MBP at the brachial artery is on average 0.2% lower than that at the aortic root. This
difference contributes towards the underestimation of RT in Scenario 2.
5.4.4 CT estimation methods
Arterial compliance (CT) affects the pulse wave, left ventricular dynamics, and flow de-
livery to the capillaries [128]. The proposed optimised three-element Windkessel method
(Scenario 1), performed much better than existing methods (−1±4%). In Scenario 2, the
‘stroke volume over pulse pressure’ method had a lower MPE than the ‘diastolic blood
pressure’ and ‘pulse pressure’ methods (5% vs 18 and 28%, respectively), but a higher
SD (18% vs 8 and 12%, respectively). Similarly to [157], this study found MPE < 12%
for the ‘diastolic decay’, ‘area’ and ‘two-area’ methods. However, the MPE for the ‘pulse
pressure’ method were higher (−28%) than those reported in [157] (17%).
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5.4.5 PWV estimation methods
Aortic pulse wave velocity (PWV ) is a proxy for aortic stiffness and an independent
cardiovascular risk indicator [102, 131]. Methods for estimating PWV which used the
ascending and descending aorta flows were found to outperform those using the carotid
and femoral pressure waves (8% and 13% vs 28 and 43%). In both cases, the foot-to-foot
(f-f) method was preferred over the least-squares method. This superiority of methods
based on the aortic flow is explained by the fact that the reference value of PWV for
the 1-D dataset was calculated using Equation (5.13) at the aortic root. According to
this equation, PWV will be minimum at the aortic root, where the arterial radius, r,
is largest, and will increase towards the periphery as r decreases. The average r along
the carotid-femoral arterial path is smaller than that along the ascending-descending
aorta path, which results in a larger overestimation of PWV for the former path. Sim-
ilarly, Obeid et al. [158] also generated aortic pressure waveforms using a 1-D model
containing 143 arterial segments and found that aortic PWV is better captured by the
f-f method when using waveform pairs located closer to the aorta. Although the carotid-
femoral pulse wave velocity (PWVc−f) is considered as the ‘gold-standard’ method for
the measurement of arterial stiffness [159], the current expert consensus does not specify
a preferred measurement site along the femoral artery [159–161]. In any case, it has
been suggested that the shorter the distance between two recording sites, the greater
the relative error in the measurement of arterial length and transit time, and hence the
greater the PWVc−f estimation error [159].
5.4.6 Z0 estimation methods
Similarly to aortic PWV , aortic characteristic impedance (Z0) is directly related to aortic
stiffness [116, 130]. Existing methods involving P and Q waves normally require these
waves to be measured simultaneously at the same location, but in this study, P was
taken from the periphery (Scenario 1) and combined with the aortic flow wave, which
resulted in the large MPE seen in Table 5.1. The PQ-loop method was the exception
since it led to reasonable MPE, though with a large SD (13±57%). The PQ-loop method
assumes a linear proportionality between aortic P and Q in early systole which, according
to current results, is largely maintained between peripheral P and aortic Q, most likely
because P and Q morphology in early systole is mainly determined by the propagation
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of the forward wave travelling from the heart to the periphery, with the backward wave
having little influence [93]. This observation led to the derivation of the novel method
Z4 which provided the smallest MPE for Scenario 2 (82%). The proposed optimised
three-element Windkessel method led to a higher MPE than the PQ-loop method (37%
vs 13%), but to a considerably lower SD (20% vs 57%).
Comparative studies for the estimation of LV ET , Pout or RT could not be found in the
literature.
5.5 Final remarks
Using the datasets of virtual subjects, methods from the literature were tested and some
new methods were designed to address the limitations of the existing ones. Since theoret-
ical reference values were know exactly, without any measurement error, it was expected
that this testing approach should provide lower bounds for mean percentage errors. As
seen when comparing the results for the 0-D and 1-D datasets, the performance of CV
parameter estimation methods depends on the dataset. However, since the reference
values of most CV parameters cannot be obtained in the clinic, CV parameter estima-
tion methods can only be assessed using virtual datasets. The optimal combination of
methods was chosen based on the results from the 1-D dataset since it displayed more
physiological features than the 0-D datasets.
In Scenario 1, when a peripheral pressure wave (P ) was available, optimal CV parameter
estimation methods used: the derivative of P to estimate LV ET ; an exponential fit
applied to the diastolic portion of P to estimate Pout; P and the ascending aorta flow
(Q) to estimate RT; an optimisation based on the three-element Windkessel model using
P and Q to estimate CT ; and a PQ-loop method applied to the early systolic portion
of P and Q to estimate Z0. In Scenario 2, when only peripheral DBP and SBP were
available, the optimal methods used instead: and analysis of Q to estimate LV ET ; half
of DBP to estimate Pout; DBP , SBP , and Q to estimate RT; SV and PP to estimate
CT ; and DBP , SBP , and Q to estimate Z0. The foot-to-foot method applied to the
ascending and descending aorta flows was used to estimate PWV in both scenarios.
These optimal methods will be used in Chapter 6 to assess cBP estimation algorithms in
both scenarios.
6 Central Blood Pressure Estimation
In this chapter, (i) the clinical motivation of and current gold standards for central
(aortic) blood pressure (cBP) measurements are presented; (ii) a novel patient specific,
non-invasive approach for the measurement of cBP using aortic flow, peripheral pressure,
and computational models is proposed; (iii) the calculation of the model parameters
from clinical data is described; (iv) the approach is assessed using a combination of in
silico and in vivo data.
6.1 Introduction
As seen in Chapter 2, recent clinical evidence suggets that cBP is a better marker of
cardiovascular risk than brachial blood pressure (bBP), which highlights the importance
of obtaining accurate, non-invasive cBP measurements.
A potential approach is to use a computational model of the circulation to estimate cBP
from non-invasive measurements of aortic flow and peripheral BP [162]. Aortic flow can
be measured using magnetic resonance imaging (MRI) or ultrasound. Peripheral systolic
and diastolic BP can be easily measured using a brachial cuff, whilst a peripheral pres-
sure waveform can be measured using applanation tonometry. MRI can also measure
vascular geometry which can be used to further refine the model. Consequently, compu-
tational models could be personalised to estimate cBP in cardiac MRI and ultrasound
settings. Although previous studies have used reduced-order models to estimate cBP non-
invasively, they did not validate their cBP estimates against invasive cBP measurements
or compare the performance of several algorithms [75, 162–165].
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The aim of this study was to develop and assess three novel algorithms of increasing
complexity for estimating cBP from aortic flow, using non-invasive, patient-specific data
and physical phenomena occurring in the upper-thoracic aorta (Figure 6.1). Each al-
gorithm used a different blood flow model: the two-element [84] and three-element [95]
zero-dimensional (0-D) Windkessel models, and a one-dimensional (1-D) model of the
upper-thoracic aorta [75]. The first step in each algorithm was to estimate cardiovascular
(CV) parameters from non-invasive haemodynamic data measured in the upper-thoracic
aorta coupled with a peripheral blood pressure measurement, using the optimal methods
described in Chapter 5. The second step was to use these parameters as inputs to one
of the three blood flow models to estimate a patient-specific cBP waveform. Finally, the
performance of the cBP algorithms against reference clinical data, including invasive cBP
measurements, was assessed.
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Figure 6.1: Methodology for the study of cBP estimation algorithms. (1) cBP estima-
tion algorithms consisted of three steps. (a) Clinical data acquisition and pre-processing:
blood flow measured at the ascending and descending (1-D algorithm only) aorta; pe-
ripheral pressure measurement; and aortic anatomy (1-D algorithm only). (b) Cardio-
vascular (CV) parameters estimated from clinical data. (c) These parameters, along
with the non-invasive clinical data, were used as inputs to one of three cBP models.
(2) Algorithm performance was assessed by comparing cBP estimates provided by each
model to reference values.
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6.2 Methods
The three algorithms used to estimate cBP each consisted of two stages (see Figure 6.1).
Firstly, CV parameters were estimated using the optimal CV parameter estimation meth-
ods described in Chapter 5. Secondly, a cBP waveform was simulated using a computa-
tional model of arterial blood flow. Two 0-D models were considered: the two-element
and three-element Windkessel models; and a 1-D model of the upper-thoracic aorta,
referred to as the ‘1-D aortic’ model hereafter [75]. The mathematical formulation of
and the inputs to the two-element and three-element Windkessel models are described in
Chapter 4 (Sections 3.2.1 and 3.2.2, respectively). The 1-D mathematical formulation is
described in Chapter 4 (Section 3.3). The inputs to the ‘1-D aortic’ model are presented
in Section 6.2.1.
6.2.1 1-D aortic model
This model uses the 1-D equations of blood flow in the network of compliant vessels
shown in Figure 6.1c (bottom) to compute cBP [75]. The inputs to the model are:
(i) the geometry (i.e. lengths and cross-sectional areas) of the upper-thoracic aorta,
including the supra-aortic arteries; (ii) flow waves at the ascending and descending aorta
and, when available, each supra-aortic artery; and (iii) a peripheral BP measurement.
This model was used to estimate cBP in the two datasets described in Chapter 4 which
contained the required geometry, flow, and pressure data: the 1-D model dataset and the
‘Aortic Coarctation’ dataset.
For the 1-D model dataset, the arterial geometry (i.e. arterial length, and cross-sectional
area at diastolic BP) and haemodynamic data were extracted at the following arterial
locations (Figure 6.2):
• (1) Ascending aorta (geometry, flow wave at the aortic root)
• (2) Aortic arch (geometry)
• (3) Descending aorta (geometry, flow wave at the outlet)
• (4) Brachiocephalic artery (geometry)
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• (5) Left common carotid artery (geometry, pressure wave at 50% length; Scenario
1 only)
• (6) Left subclavian artery (geometry)








Figure 6.2: Arterial locations in the 1-D dataset. Arterial geometry and flow and
pressure waves were extracted at these locations to create a corresponding ‘reduced’ 1-D
model for each virtual subject in the 1-D dataset.
For the ‘Aortic Coarctation’ dataset, the geometry of the upper-thoracic aorta was ex-
tracted from MRI data using an in-house prototype software being developed by Philips
Healthcare (a detailed description can be found in [6]), as shown in Figure 4.5.
For both datasets, volumetric blood flow waves were obtained at the ascending (Qin,
acquired as close to the aortic root as possible) and descending thoracic (Qout) aorta. Qin
and Qout were used to calculate the pulse wave velocity, PWV , as described in Table 5.1.
Qin was imposed as an inflow boundary condition at the aortic root. Outflow boundary
conditions were calculated as 3-element Windkessel models coupled to the outlet of each
terminal 1-D model segment. The parameters of each outflow model j are Zj0,Wk, C
j
T,Wk
and RjWk, were calculated using Qin, Qout, and the outflow distribution (OD) in the
supra-aortic arteries, ODjflow = Q
j
out/Qin, under the assumption that DBP , MBP , and
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where CT,art is the total compliance of the 1-D model arterial segments calculated as the







with Ak the average area and Lk the length of the arterial segment k. When Qjout were
unavailable at each outflow j, the difference between the mean values of Qin and Qout was
distributed among the supra-aortic arteries proportionally to their outlet areas, Ajout, as





6.2.2 Assessing central blood pressure estimation algorithms
The performance of each cBP estimation algorithm was assessed by comparing estimated
cBP values to corresponding reference cBP values in the three clinical datasets, and in
the 1-D dataset of virtual subjects. The 0-D datasets of virtual subjects were excluded
since the 1-D dataset was based on a more complex and physiological model of the
arterial circulation and hence presented a broader range of pulse waves. Performance
was quantified using the mean absolute error and standard deviation for central diastolic
(cDBP ), mean (cMBP ), and systolic (cSBP ) blood pressure, and pulse pressure (cPP ).
Additionally, Bland-Altman plots [155] were used to show the bias and limits of agreement
between the estimated and reference BP values. Finally, the root mean square error
(RMSE) between estimated and reference cBP waves was computed.
6.3 Results
Table 6.1 shows the estimation errors for all three cBP estimation algorithms, with each
algorithm evaluated in four datasets for both clinical scenarios. In the 1-D dataset,
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RMSEs in Scenario 1 (mean ± SD: < 3.4 ± < 1.7 mmHg) were lower than those in
Scenario 2 (< 5.1 ± < 2.5 mmHg). In the clinical datasets, RMSEs were similar for both
scenarios and larger than those obtained in the 1-D dataset. The 1-D aortic algorithm
led to the smallest RMSEs in the 1-D dataset (2.0±1.0 mmHg) and ‘Aortic Coarctation’
(6.4 ± 2.8 mmHg) dataset. The 3-element Windkessel algorithm led to the smallest
RMSEs in the ‘Normotensive’ (5.9 ± 2.4 mmHg) and ‘Hypertensive’ (5.7 ± 2.4 mmHg)
datasets, where the 1-D aortic algorithm could not be applied.
Overall, estimation errors for cDBP , cMBP , cSBP and cPP were smaller in the 1-D
dataset compared to the clinical datasets, for all cBP algorithms and scenarios. Further-
more, cDBP and cMBP errors were smaller than cSBP and cPP errors in all datasets
and for all algorithms and scenarios. In each dataset and scenario, all three cBP algo-
rithms led to similar cMBP errors. However, cDBP , cSBP and cPP errors changed
considerably with the type of cBP algorithm used.
The 1-D and ‘Aortic Coarctation’ datasets contain the vascular geometry and PWV
information required to run the 1-D aortic algorithm. In both datasets and scenarios,
the 1-D aortic algorithm led to cSBP and cPP errors that were smaller or similar
compared to the 0-D models (< 2.2 ± < 6.3 mmHg vs < 5.3 ± < 7.2 mmHg for the 1-D
dataset; < 4.1 ± < 10.7 mmHg vs < 16.4 ± < 9.2 mmHg for the ‘Aortic Coarctation’
dataset). Both 0-D algorithms performed similarly in both datasets and led to smaller
cDBP errors than the 1-D aortic algorithm.
In the ‘Normotensive’ and ‘Hypertensive’ datasets, both 0-D models estimated cDBP ,
cMBP , cSBP , and cPP values with errors < 6.0 ± 4.9 mmHg, though the 3-element
Windkessel algorithm led to smaller RMSEs (< 5.9 ± 2.4 mmHg vs < 10.6 ± 4.1 mmHg).
All errors were considerably smaller in Scenario 2.
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Table 6.1: Performance of cBP estimation algorithms. They are denoted as 2-Wk
(2-element Windkessel), 3-Wk (3-element Windkessel) and 1-D aortic. Results are pre-
sented as mean (µ) and standard deviation (SD) errors between estimated and reference
values of cDBP, cMBP, cSBP, and cPP. The RMSEs between estimated and reference
cBP waves is shown in the last column. Each cBP algorithm was assessed in four datasets
and two clinical scenarios: Scenario 1 (peripheral BP waveform available) and Scenario
2 (only peripheral SBP and DBP available). Abbreviations: Sc: clinical scenario; cBP
algo: cBP algorithm.
Estimation error (µ ± SD) [mmHg]
Datasets Sc cBP algo cDBP cMBP cSBP cPP RMSE
1-D dataset
1
2-Wk 1.2 ± 0.7 0.1 ± 0.1 1.0 ± 0.8 -0.2 ± 1.3 3.4 ± 1.1
3-Wk 0.1 ± 1.0 0.1 ± 0.1 1.8 ± 1.9 1.7 ± 2.8 2.0 ± 1.7
1-D aortic 0.1 ± 1.1 0.2 ± 0.6 2.2 ± 1.8 2.1 ± 2.3 2.0 ± 1.0
2
2-Wk 0.8 ± 1.5 -3.0 ± 1.9 -4.5 ± 5.9 -5.3 ± 7.2 5.0 ± 2.5
3-Wk -2.6 ± 0.8 -2.9 ± 1.9 -0.2 ± 4.7 2.4 ± 5.2 5.1 ± 2.0




2-Wk 0.8 ± 3.1 -3.4 ± 2.8 -15.7 ± 7.2 -16.4 ± 8.5 10.1 ± 3.9
3-Wk 0.2 ± 2.8 -3.5 ± 2.8 -15.4 ± 7.4 -15.6 ± 8.6 8.0 ± 3.2
1-D aortic -3.4 ± 4.8 -2.5 ± 2.6 -0.0 ± 9.7 3.4 ± 10.7 6.4 ± 2.8
2
2-Wk -1.5 ± 2.4 -5.5 ± 2.8 -17.3 ± 7.9 -15.8 ± 9.2 10.9 ± 4.3
3-Wk -1.8 ± 2.5 -5.7 ± 2.9 -17.2 ± 7.9 -15.4 ± 9.1 8.4 ± 3.6
1-D aortic -6.1 ± 2.8 -5.3 ± 3.0 -2.1 ± 9.2 4.1 ± 10.6 7.8 ± 3.3
Normotensive
1
2-Wk 4.7 ± 1.9 0.3 ± 0.1 -8.6 ± 5.0 -13.3 ± 6.2 10.3 ± 3.0
3-Wk -4.4 ± 3.5 -0.9 ± 0.7 13.4 ± 13.4 17.9 ± 16.5 8.6 ± 5.5
2
2-Wk -0.1 ± 0.5 0.2 ± 2.2 -3.3 ± 3.5 -3.2 ± 3.4 11.0 ± 3.5
3-Wk 0.2 ± 0.5 -0.2 ± 2.1 -3.7 ± 4.0 -3.9 ± 4.1 5.9 ± 2.4
Hypertensive
1
2-Wk 5.0 ± 3.2 0.3 ± 0.1 -8.3 ± 6.3 -13.3 ± 9.0 10.6 ± 4.1
3-Wk -2.9 ± 3.6 -0.9 ± 1.0 8.0 ± 10.6 11.0 ± 13.4 7.1 ± 4.2
2
2-Wk -0.3 ± 0.8 -1.1 ± 2.0 -5.5 ± 4.0 -5.2 ± 4.1 11.1 ± 4.2
3-Wk 0.0 ± 0.6 -1.5 ± 2.0 -6.0 ± 4.7 -6.0 ± 4.9 5.7 ± 2.4
Bland-Altman plots of cDBP (Figures 6.3 and 6.4), cMBP (Figures 6.5 and 6.6), cSBP
(Figures 6.7 and 6.8), and cPP (Figures 6.9 and 6.10) show increases in the absolute bias
for cMBP , cSBP , and cPP with increasing reference BP values in the 1-D dataset in
Scenario 2. Furthermore, in the ‘Normotensive’ and ‘Hypertensive’ datasets, the absolute
bias for cPP increased with increasing reference BP values when using the 2-element
Windkessel algorithm in Scenario 1, and cSBP followed the same trend when using both
0-D algorithms in Scenario 2. Remaining estimates were less affected by varying reference
BP values.
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cBP algorithms: cDBP (Scenario 1)
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Figure 6.3: Bland-Altman plots for cDBP estimation for Scenario 1. The 2-element
Windkessel (4), 3-element Windkessel (×) and 1-D aortic (©) algorithms were assessed
in the 1-D (top), ‘Aortic Coarctation’ (second row), ‘Normotensive’ (third row), and
‘Hypertensive’ (bottom) datasets. y-axes are estimated minus reference cDBP values.
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cBP algorithms: cDBP (Scenario 2)
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Figure 6.4: Bland-Altman plots for cDBP estimation for Scenario 2. The 2-element
Windkessel (4), 3-element Windkessel (×) and 1-D aortic (©) algorithms were assessed
in the 1-D (top), ‘Aortic Coarctation’ (second row), ‘Normotensive’ (third row), and
‘Hypertensive’ (bottom) datasets. y-axes are estimated minus reference cDBP values.
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cBP algorithms: cMBP (Scenario 1)
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Figure 6.5: Bland-Altman plots for cMBP estimation for Scenario 1. The 2-element
Windkessel (4), 3-element Windkessel (×) and 1-D aortic (©) algorithms were assessed
in the 1-D (top), ‘Aortic Coarctation’ (second row), ‘Normotensive’ (third row), and
‘Hypertensive’ (bottom) datasets. y-axes are estimated minus reference cDBP values.
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cBP algorithms: cMBP (Scenario 2)
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Figure 6.6: Bland-Altman plots for cMBP estimation for Scenario 2. The 2-element
Windkessel (4), 3-element Windkessel (×) and 1-D aortic (©) algorithms were assessed
in the 1-D (top), ‘Aortic Coarctation’ (second row), ‘Normotensive’ (third row), and
‘Hypertensive’ (bottom) datasets. y-axes are estimated minus reference cDBP values.
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cBP algorithms: cSBP (Scenario 1)
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Figure 6.7: Bland-Altman plots for cSBP estimation for Scenario 1. The 2-element
Windkessel (4), 3-element Windkessel (×) and 1-D aortic (©) algorithms were assessed
in the 1-D (top), ‘Aortic Coarctation’ (second row), ‘Normotensive’ (third row), and
‘Hypertensive’ (bottom) datasets. y-axes are estimated minus reference cDBP values.
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cBP algorithms: cSBP (Scenario 2)
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Figure 6.8: Bland-Altman plots for cSBP estimation for Scenario 2. The 2-element
Windkessel (4), 3-element Windkessel (×) and 1-D aortic (©) algorithms were assessed
in the 1-D (top), ‘Aortic Coarctation’ (second row), ‘Normotensive’ (third row), and
‘Hypertensive’ (bottom) datasets. y-axes are estimated minus reference cDBP values.
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cBP algorithms: cPP (Scenario 1)
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Figure 6.9: Bland-Altman plots for cPP estimation for Scenario 1. The 2-element
Windkessel (4), 3-element Windkessel (×) and 1-D aortic (©) algorithms were assessed
in the 1-D (top), ‘Aortic Coarctation’ (second row), ‘Normotensive’ (third row), and
‘Hypertensive’ (bottom) datasets. y-axes are estimated minus reference cPP values.
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cBP algorithms: cPP (Scenario 2)
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Figure 6.10: Bland-Altman plots for cPP estimation for Scenario 2. The 2-element
Windkessel (4), 3-element Windkessel (×) and 1-D aortic (©) algorithms were assessed
in the 1-D (top), ‘Aortic Coarctation’ (second row), ‘Normotensive’ (third row), and
‘Hypertensive’ (bottom) datasets. y-axes are estimated minus reference cPP values.
Figures in Appendix A.2 show individual cBP waveform estimations by each cBP algo-
rithm for a set of randomly chosen subjects in the 1-D dataset and for all subjects in the
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‘Aortic Coarctation’, ‘Normotensive’ and ‘Hypertensive’ datasets, in both clinical scenar-
ios. The 0-D algorithms spent less than 1 second per patient to compute the cBP wave
using a standard PC, whereas the 1-D aortic algorithm took less than 1 minute (both
times account for the time required to calculate all patient-specific CV parameters).
6.4 Discussion
Algorithms for reconstructing the cBP waveform from non-invasive data have been devel-
oped. These algorithms are based on physical phenomena occurring in the upper-thoracic
aorta and are patient-specific – all physical parameters except for blood density and vis-
cosity can be calculated from non-invasive data obtained by tonometry and ultrasound or
magnetic resonance imaging. Results showed that the 1-D aortic algorithm outperformed
the 0-D algorithms at estimating cBP wave morphology (RMSE < 6.4 ± 2.8 mmHg for
the clinical data), as well as cSBP and cPP values (errors < 3.4 ± 10.7 mmHg), when
the aortic vascular geometry was available. When only the aortic flow and peripheral
pressure waves were available, both 0-D models estimated cDBP , cMBP , cSBP , and
cPP values with similar errors (<6.0 ± 4.9 mmHg), though the 3-element Windkessel
algorithm produced smaller RMSEs.
6.4.1 Proportional bias and outlier clusters
Proportional bias was observed in the 1-D model dataset for all cBP algorithms in Sce-
nario 2. Given that Bland-Altman error values and trends were similar across all three
algorithms, this proportional bias is most likely a consequence of a sub-optimal cardio-
vascular parameter estimation. Focusing on the results for the 1-D aortic algorithm,
Figure 5.7 shows two parameters which were estimated with proportional bias and rela-
tively poorly in Scenario 2 compared to Scenario 1: RT and CT. Firstly, consistent cMBP
underestimation in Figure 6.6 may be explained by a corresponding RT underestimation
in Figure 5.7. Secondly, negative proportional bias in cPP estimation may be explained
by a corresponding negative proportional bias in CT estimation. Due to the inverse rela-
tionship between CT and cPP , CT overestimates should result in cPP underestimates.
In Figure 5.7, CT overestimates correspond to small CT reference values, which in turn
correspond to large cPP reference values. Figure 6.10 shows that large cPP reference
values do correspond to cPP underestimates. Furthermore, Figure 6.11 confirms that
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cPP overestimates/underestimates correspond to CT underestimates/overestimates for
the 1-D aortic algorithm. Finally, given that cDBP errors are small compared to cSBP
ones, the latter may be better explained by cPP results, which present both a similar
negative proportional bias and error values.


























Figure 6.11: Inverse relationship between cPP and CT estimation errors in the 1-D
dataset using the 1-D algorithm in Scenario 2.
































































































































































Figure 6.12: cDBP (left), cMBP (middle) and cSBP (right) errors against PWV
errors in the 1-D model dataset for the 1-D algorithm in Scenario 1 (top) and Scenario
2 (bottom).
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Clusters of outliers were observed in the 1-D model dataset for the 1-D algorithm in both
scenarios. These clusters correspond to those observed for PWV estimates in Figure 5.7
for both scenarios, as confirmed by Figure 6.12.
6.4.2 Central blood pressure algorithms
When choosing the computational models for the cBP estimation algorithms, 0-D models
were chosen for their simplicity and low number of required CV parameters, and the
1-D aortic model was chosen because it captures pulse wave propagation phenomena,
though at the expense of a much larger number of parameter estimations. The rationale
behind the chosen arterial segments of the 1-D aortic model is twofold. Firstly, cardiac
MRI generally provides arterial geometry and flow of the thoracic aorta only. Secondly,
previous work showed that it is possible to reduce 1-D models containing a large number
of arterial segments to a 1-D model containing fewer segments, decreasing the topological
complexity of the arterial network and the number of parameters to be estimated, while
sufficiently capturing relevant blood pressure values such as cSBP and cPP [4, 83].
Although the CV parameter estimation methods for the cBP algorithms were chosen ac-
cording to the results from the 1-D dataset (Table 5.2, bottom), all possible combinations
of optimal methods according to the 0-D datasets were also trialled. However, since cBP
estimation errors were always similar or higher, and given that the 1-D dataset presents
more ‘physiological’ pressure waves than the 0-D dataset, these results are not presented
here.
In the 1-D aortic model, pulse wave velocity (PWV ) is used to prescribe wall properties
through an elastic tube law which relates pressure (P ) and area (A):









where β is related to the wall elasticity, P0 is the reference pressure (normally DBP ), and
A0 is the reference area when P = P0 [90]. Although PWV (and hence wall properties)
increases along the aorta [74], clinical PWV can only be obtained locally (e.g. using the
sum of squares method [153]) or as an average value over an arterial path (e.g. using the
foot-to-foot method [91]). This limitation means that wall properties were not accurately
prescribed in the 1-D aortic model. Furthermore, although nonlinear viscoelastic 1-D
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models are more representative of arterial wall properties, current clinical data only
allows the characterisation of an elastic model.
Bayesian optimization (a machine learning method) has been applied to a 1-D model
of the arterial circulation to calculate outflow boundary conditions [166]. The ability
to numerically generate datasets containing thousands of physiological virtual subjects
opens up the possibility of testing machine learning methods, such as long short-term
memory (LSTM) recurrent neural networks, to estimate cBP values from readily available
non-invasive data [167–169].
6.5 Final remarks
In this chapter, fast algorithms for reconstructing the cBP waveform from non-invasive
data have been developed. These algorithms use 0-D and 1-D computational models
based on physical phenomena occurring in the upper-thoracic aorta and are patient-
specific; i.e. all physical parameters except for blood density and viscosity can be calcu-
lated from non-invasive data obtained by tonometry or brachial cuffing, and ultrasound
or magnetic resonance imaging. 0-D models were chosen for their simplicity and low
number of CV parameters. The 1-D aortic model was chosen because it captures pulse
wave propagation phenomena, though at the expense of a much larger number of parame-
ter estimations. Only the upper-thoracic aorta was simulated using 1-D model segments,
since cardiac MRI can generally provide arterial geometry and flow in the thoracic aorta
only. Results showed that, when the aortic vascular geometry was available, the 1-D
aortic algorithm outperformed the 0-D algorithms at estimating cBP wave morphology
as well as cSBP and cPP values, leading to RMSE <2.0 ± 1.0 when all input data
and reference cBP waves are free of measurement errors and <6.4 ± 2.8 mmHg when
considering clinical data with invasive reference cBP waves. When only the aortic flow
and peripheral pressure waves were available, both 0-D models estimated cDBP , cMBP ,
cSBP , and cPP values with similar errors though the 3-element Windkessel algorithm
produced the smallest RMSEs.
7 Haemodynamics in Dilated Cardiomyopathy
Some of the contents of this chapter are part of a manuscript submitted, as a joint-first
author, to the American Journal of Phisiology – Heart and Circulatory Phisiology [2].
The aim of this study was to evaluate aortic structure and haemodynamics in dilated
cardiomyopathy (DCM) using 4-D flow magnetic resonance imaging (MRI) and a “cohort-
specific” 1-D model dataset – referred to as a “virtual cohort” in the manuscript and in
this chapter, for consistency. A novel methodology to create a virtual cohort representa-
tive of three clinical groups – two groups of DCM patients, and one group of controls – was
developed as an extension to the methodology described in Chapter 4. My main contribu-
tions towards the original manuscript, which included the creation of the ‘cohort-specific’
dataset and the analysis and discussion of the results, are presented and expanded on
in this chapter. Additionally, a summary of each original section (i.e. Introduction,
Methods, Results, Discussion and Conclusion), which I contributed towards through dis-
cussion and draft revisions, is provided for context. The manuscript and supplementary
material are provided in Appendices A.3 and A.4 for reference1.
7.1 Introduction
Although remodelling mechanisms and haemodynamics in the heart and arteries are
closely related, cardiomyopathy patients are commonly assessed using cardiac metrics.
However, aortic stiffness [170] and hypertension [171] have been related to dilated car-
diomyopathy (DCM), and prognosis after cardiac resynchronization [172] and ventricular
reverse remodelling [173] have been related to arterial behaviour. Medical imaging, and
1Note that, although this thesis follows British English spelling rules, the manuscript followed Amer-
ican English spelling rules.
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particularly cardiac magnetic resonance imaging (MRI), is increasingly used for the clin-
ical assessment of cardiovascular function. Recently, 4-D flow MRI has been shown to
provide valuable clinical information about diastolic ventricular flow in DCM [174], aortic
relative pressure [175–177], ventricular-vascular interaction in chronic heart failure [178],
and right-ventricular-pulmonary coupling [179]. The aim of this study was to investigate
ventricular-arterial interactions in DCM using aortic relative pressure (i.e. blood pres-
sure difference between two aortic locations) derived from 4-D flow MRI. Additionally, a
“virtual cohort” based on DCM patients and healthy volunteers was developed to study
isolated effects of such interactions.
7.2 Methods
Figure 7.1 shows an overview of data sources and analysed cardiovascular (CV) param-
eters.
Figure 7.1: Overview of assessed study metrics. Cardiovascular (CV) characteristics
were given by cardiac MRI, aortic haemodynamics were obtained from 4-D flow MRI, and
central blood pressure from sphygmomanometer measurements. The isolated influence
of listed CV parameters on aortic relative pressure is determined using a computational
virtual cohort. LV: left ventricular; RV: right ventricular; EDV: end-diastolic volume;
ESV: end-systolic volume; SV: stroke volume; EF: ejection fraction; CO: cardiac output;
CI: cardiac index, PWV: pulse wave velocity; TTP: time-to-peak relative pressure.
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7.2.1 Study population
The dataset included 14 patients treated for moderate DCM-related heart failure and 16
healthy controls. At the time of scanning, several DCM patients presented improved left
ventricular (LV) function. As a result, DCM patients were divided into two groups: sub-
jects with reduced LV function (DCMred, EF < 50%, n = 9) and subjects with preserved
LV function (DCMpres, EF ≥ 50%, n = 5). Prior to data collection, DCM patients had
their beta blocker treatment discontinued for 48 hours to examine their native CV func-
tion. All subjects participated under informed consent, with data collection approved by
the Regional Ethics Committee, South East London, UK (REC, 12/LO/1456). Subject
characteristics are shown in Table 7.2.
7.2.2 Imaging, data collection, and post-processing
Full-field tissue structure and blood flow was quantified using structural and 4-D flow MRI
(1.5 T, Philips ACHIEVA, Philips, Best, The Netherlands). Relevant cardiac indices were
calculated for all subjects from the short-axis images using cvi42 R© (Circle Cardiovascu-
lar Imaging Inc, Alberta, Canada). The thoracic aorta was segmented for all subjects
using an in-house algorithm implemented in MATLAB R© R2016a (MathWorks, Natick,
MA, USA). Aortic relative pressure was computed using a validated virtual work-energy
approach (shown in Figure 7.2) [177]. The mathematical details of this computation
are provided in Appendix A.4. Additionally, time-to-peak aortic relative pressure was
computed as the time from acquisition onset (triggered by the ECG R-wave) to maxi-
mum relative pressure. Aortic pulse wave velocity was estimated from the ascending and
descending aorta flow waves using a validated cross-correlation method [91]. Aortic stiff-
ness was subsequently calculated using the Moens-Korteweg equation (Equation (7.1)).
Finally, cBP was estimated using a validated transfer function device applied to the
brachial cuff pressure wave (Centron cBP301 R©, SunTech Medical Inc., Morrisville, NC,
USA).
7.2.3 Virtual cohort
Structural and functional CV characteristics can be studied by means of non-invasive
imaging. However, the intertwined nature of ventricular-vascular interaction makes it
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Figure 7.2: Overview of the virtual work-energy principle. This principle was used to
derive aortic relative pressure (∆P ) from 4-D flow MRI (left). Aortic segmentations (S,
upper mid-portion) are shown together with corresponding virtual work-energy fields
(lower mid-portion), used to isolate aortic relative pressure. Maximum relative pres-
sure, minimum relative pressure, and time-to-peak relative pressure (TTP ) are derived
(right). Each case is processed individually, with the colour coding of the segmentations
corresponding to the ones of the relative pressure traces.
difficult to isolate independent factors that impact CV function. Computational mod-
elling, however, allows for the study of the CV system while also enabling controlled
variation of isolated factors (e.g. stroke volume, aortic pulse wave velocity). To under-
stand aortic relative pressures, the methodology presented by Willemet et al. [82] was
used to create a novel virtual cohort, where blood pressure (BP), blood flow, and arterial
area waveforms were simulated using a validated one-dimensional (1-D) computational
model of arterial haemodynamics consisting of the 55 larger arteries of the human sys-
temic circulation [90]. Importantly, such models have been extensively validated and
verified to accurately represent 1D arterial hemodynamic behavior through the larger
arterial system [73, 74].
The methods used to create the virtual cohort were adapted to match the clinical char-
acteristics for arterial resistance (RT), stroke volume (SV ), cardiac period (T ), aortic
area (A), and aortic pulse wave velocity (PWV ). A virtual group was created for each
clinical group: virtual DCM patients with reduced and preserved LV function (DCMred
and DCMpres, respectively) and virtual controls. For each virtual group, a baseline vir-
tual subject was first created to match the mean of the clinical characteristics shown
in Table 7.1. For each parameter under study, two virtual subjects were then created
by varying said parameter whilst keeping the remaining parameters at baseline level.
Parameter variations corresponded to the ‘min’ and ‘max’ values shown in Table 7.1,
respectively. Thus, 11 (1 baseline +2 ∗ 5 variations) virtual subjects were created for
each virtual group, and the isolated influence on aortic relative pressure from RT, SV ,
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T , aortic A, and aortic PWV could be evaluated. Input CV parameter values for each
virtual group (all originating from the clinical acquisitions) are presented in Table 7.1.
Table 7.1: Cardiovascular (CV) parameter variations for each virtual group with all
data derived from in vivo imaging. For each group, the baseline virtual subject corre-
sponded to the mean CV parameter value. Each additional virtual subject within that
group corresponded to the variation of a single, isolated CV parameter (varied from
minimum to maximum, one at a time). 1 [mmHg s/mL]
Virtual DCMred Virtual DCMpres Virtual controls
CV parameters min mean max min mean max min mean max
Arterial resistance, 1 0.69 0.77 0.84 0.64 0.89 1.2 0.61 0.78 1.04
Stroke volume, [mL] 55 95.5 132 53 86 100 66.3 91.7 122.9
Cardiac period, [s] 0.75 0.91 1.13 0.59 0.8 1 0.7 0.88 1.03
Aortic area, [cm2] 1.86 2.96 3.87 1.21 1.96 2.72 1.72 2.49 3.66
Aortic PWV, [m/s] 6.1 11 19.4 5.2 7.7 10 4.5 7.5 13.9
Similarly, flow profiles were generated based on through-plane left ventricular outflow
tract (LV OT ) flows from the 4-D flow MRI of each group, respectively. For each virtual
subject, aortic relative pressure was calculated from the LV OT to the end of the thoracic
aorta, with relative pressure normalized by aortic length to match the derived clinical
data.
General cardiovascular parameter values, which were kept constant over all virtual sub-
jects, were taken from Willemet et al. [82] and modified when appropriate. The parame-
ters (and their corresponding values) were: blood density (1050 kg/m3), blood viscosity
(0.0025 Pa s), velocity profile coefficient (1.33, corresponding to Poiseuille flow), and
outflow pressure, Pout (0 Pa). 1-D simulations were run for a total of 20 s, with a 0.1
ms time step to ensure numerical convergence according to Equation (3.8). Remaining
numerical parameters were chosen as described in Section 3.3.4. Additionally, a visual
check of all simulated pressure waveforms at the aortic root and the end of the thoracic
aorta was employed to confirm convergence.
For each virtual group, left ventricular ejection time (LV ET ) and time-to-peak flow
(TTP ) were extracted from the corresponding clinical flow data. Firstly, flow waveforms
containing less than 100 datapoints were filtered using a 100-point spline interpolation
to ensure sufficient smoothness. Secondly, the filtered wave was modulated to enforce
zero flow during diastole by: (i) contructing a tangent to the point of maximum negative
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slope during the systolic downslope, (ii) finding the intercept between this tangent and
the x-axis, and (iii) making the flow equal to zero from this point until the end of the
cycle. Finally, LV ET was extracted as the first zero flow value during diastole using
the novel LV 4 method proposed in Section 5.2.1, and TTP was extracted as the time
of maximum flow. For each group, the average values of LV ET and TTP were used to
generate the virtual flow profiles.
RT values were calculated from mean pressure (MBP , in mmHg) and mean flow (Q, in
mL/s) values from each clinical group using Equation (5.2), with Pout equal to zero in
this study.
The clinical aortic lengths ranged from 21 to 38 cm. These values were extracted by col-
laborators from the centrelines obtained using the approach presented in [177]. However,
this data did not include all the aortic sections of interest (i.e. from the aortic root to
the end of the thoracic aorta), so all the aortic segment lengths for the virtual cohort
were taken from [82]. Therefore, relative pressure was calculated between the start and
end points of the arterial path along the following aortic segments (see indices in Fig-
ure 7.3): ascending aorta (1), aortic arch (2 and 14), and thoracic aorta (18 and 27).
The combined length of these virtual segments was 30.6 cm, a value which falls within
the extracted clinical values (21-38 cm). Virtual aortic segment areas (at DBP ) were
initially extracted from [82]. Then, the areas corresponding to the aortic segments noted
as 1, 2, 14, 18, 27, 28, 35, 37, 39, and 41 in Figure 7.3 were scaled according to the ratio
between clinical and virtual average aortic areas calculated as follows:
• a weight was given to each segment based on the ratio between segment length and
total aortic length (i.e. 30.6 cm);
• each weight was multiplied by its corresponding virtual segment average area (cal-
culated as the average of the inlet and outlet areas, which is correct for linearly-
tapered arterial segments);
• the virtual average aortic area was calculated as the sum of these weighted average
areas;
• the clinical average aortic area was calculated as the average area of the MRI aortic
geometry;
Chapter 7. Haemodynamics in Dilated Cardiomyopathy 96
• the “area scaling factor” was calculated as the ratio between clinical and virtual
average aortic areas.
Remaining virtual segment areas (i.e. those not corresponding to the aorta) were taken
from the original reference.





where ‘h’ is the arterial wall thickness and was set to 1.6 mm [180], and ensuring that
PWV in the virtual groups was equal to the PWV values extracted from each clinical
group. PWV was imposed in the 1-D model using the empirical tube law described in
Equation (5.13). The following iterative method was used to calculate the value of k3
which minimised the absolute difference between the desired (clinical) and the theoretical
average aortic PWV s [3]:
• an initial set of constants was provided: inlet and outlet segment radii, segment
lengths, desired average aortic PWV , blood density, and three empirical constants,
k1, k2, and k3;
• the theoretical average PWV for each segment was calculated using Equation (5.13),
with r calculated as the average of the inlet and outlet radii;
• the theoretical wave transit time (TT ) for each segment was calculated by dividing
the segment length by its theoretical average PWV ;
• the theoretical average aortic PWV was calculated by dividing the total aortic
length by the sum of all TT s;
• fminsearch.m, a MATLAB R© minimisation function, is used to find the value of
k3 – while keeping k1 and k2 constant – which minimises the absolute difference
between desired and theoretical average aortic PWV s.
Although the subdivision into two groups of DCM patients is not ideal from the modelling
perspective and given the small number of patients, it was imposed by the main clinical
analysis. Ideally, DCM patients should be grouped to work with a more representative
sample of the disease.
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Figure 7.3: Arterial network of the 1-D model used to create the virtual cohort. It
contains the 55 larger arteries of the human systemic circulation. Aortic relative pressure
was calculated between the aortic root (inlet of segment 1) and the thoracic aorta (outlet
of segment 27). The “area scaling factor” was applied to the segments along the aortic
path starting at segment 1 and ending at segment 41.
7.2.4 Statistical analysis
Statistical differences in subject characteristics, cardiac metrics, and aortic outputs were
evaluated to assess potential correlations between subject characteristics and output met-
rics. All evaluations were performed using MATLAB R© R2016a (MathWorks, Natick,
MA, USA).
7.3 Results
7.3.1 Clinical data and subject characteristics
Clinical data and subject characteristics are provided in Table 7.2. The DCMred group
showed significantly higher body mass index, LV volumes and systolic and mean BP; and
significantly lower EF, LV cardiac index (CI) and right ventricular CI than the controls.
In comparison, the DCMpres group only differed from the controls in EF (56.6% versus
63.9%).
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7.3.2 Aortic relative pressure in dilated cardiomyopathy patients
Aortic relative pressure characteristics are provided in Table 7.2, with Figure 7.4 showing
the flow-derived markers where significant differences were inferred.
Table 7.2: Data and subject characteristics for the reduced LV function (DCMred),
preserved LV function (DCMpres), and control groups, respectively. Intragroup p-
values are reported with significant differences indicated by * (p<0.05), ** (p<0.01),
or *** (p<0.001). Volumes are normalized by body surface area (BSA). 1[mL/m2],
2[mmHg/m], 3[ms].
p-value
DCMred DCMpres Controls DCMred DCMpres DCMred
(n = 8) (n = 5) (n = 16) Controls Controls DCMpres
Characteristics
Age [years] 50.9 ± 5.5 42.8 ± 15.5 42.4 ± 12.4 0.08 0.97 0.52
Height [cm] 169.8 ± 5.8 165.6 ± 10.4 173.0 ± 8.7 0.35 0.17 0.45
Weight [kg] 87.8 ± 15.7 73.8 ± 24.1 72.3 ± 14.9 0.02* 0.8 0.33
BSA [m2] 2.05 ± 0.22 1.83 ± 0.35 1.85 ± 0.23 0.05 0.97 0.28
Male / Female [n] 4 / 4 3 / 2 9 / 7 0.77 0.88 0.72
HR [beats/min] 66 ± 10.5 75.2 ± 15.8 68.3 ± 8.0 0.4 0.38 0.33
Cine SSFP MRI
LVEDV/BSA1 109.6 ± 38.9 86.7 ± 21.5 78.5 ± 9.4 0.03* 0.69 0.44
LVESV/BSA 1 69.2 ± 33.1 37.2 ± 11.9 28.8 ± 6.6 0.0003*** 0.18 0.04*
SV/BSA 1 46.1 ± 10.9 47.0 ± 6.2 49.6 ± 5.5 0.56 0.5 0.94
EF [%] 41.6 ± 5.7 56.6 ± 6.1 63.9 ± 5.9 0.0001*** 0.04* 0.002**
CO [L/min] 6.1 ± 1.1 6.3 ± 1.1 6.2 ± 1.0 0.67 0.97 0.83
CI [L/(min/m2)] 2.9 ± 0.4 3.5 ± 0.4 3.4 ± 0.5 0.03* 0.62 0.04*
RVEDV/BSA [mL] 86.0 ± 28.5 76.9 ± 13.1 84.7 ± 8.6 0.97 0.3 0.83
RVESV/BSA [mL] 44.3 ± 9.4 29.6 ± 7.7 36.0 ± 5.3 0.81 0.07 0.52
RVSV/BSA [mL] 44.3 ± 9.4 47.1 ± 6.1 49.5 ± 5.5 0.21 0.56 0.52
RVEF [%] 53.3 ± 8.2 61.8 ± 4.7 58.3 ± 4.1 0.26 0.2 0.12
RVCO [L/min] 5.9 ± 1.1 6.3 ± 1.1 6.2 ± 1.0 0.46 1 0.5
RVCI [L/(min/m2)] 2.9 ± 0.4 3.5 ± 0.4 3.4 ± 0.5 0.02* 0.69 0.02*
Aortic curvature [-] 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.1 0.93 0.97 0.52
Aortic length [cm] 27.8 ± 4.8 26.9 ± 3.1 25.5 ± 2.1 0.43 0.71 0.83
Aortic radius [cm] 0.8 ± 0.1 0.6 ± 0.1 0.7 ± 0.1 0.15 0.08 0.03*
cBP
SBP [mmHg] 125.3 ± 8.8 116 ± 10.2 116.9 ± 8.8 0.02* 0.99 0.17
DBP [mmHg] 75.5 ± 5.6 69.6 ± 7.3 71.4 ± 5.8 0.12 0.43 0.11
MBP [mmHg] 86.8 ± 4.9 79.6 ± 7.8 81.3 ± 6.3 0.03* 0.51 0.06
4-D flow MRI
Maximum ∆P/L 2 61.6 ± 10.0 79.4 ± 13.8 78.9 ± 18.0 0.02* 0.65 0.02*
Minimum ∆P/L 2 -41.3 ± 5.6 -58.3 ± 25.9 -39.4 ± 12.3 0.23 0.06 0.17
Time-to-peak ∆P 3 109 ± 22 108 ± 38 55 ± 22 0.0002*** 0.01* 0.91
PWV [m/s] 11.0 ± 4.6 7.5 ± 2.5 7.5 ± 2.6 0.03* 0.97 0.13
Aortic stiffness [kPa] 14.5 ± 12.0 5.5 ± 3.6 6.3 ± 5.1 0.03* 0.84 0.13
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Figure 7.4: A comparison of aortic parameters between dilated cardiomyopathy sub-
jects (with reduced and preserved LV function) and controls. (a) Maximum relative
pressure, (b) TTP, (c) PWV, and (d) aortic stiffness for DCMred, DCMpres, and the
control groups, respectively. p-values are reported throughout with significance indi-
cated by * (p<0.05) or ** (p<0.01).
7.3.3 Correlation of aortic relative pressure with clinical, structural,
and central blood pressure metrics
Complete correlation results are provided in Supplementary Table 2 (Appendix A.4).
For the DCMred and DCMpres groups, no correlations could be inferred between any
clinical parameter and the derived aortic metrics, including central blood pressures. For
the control group, similar behavior was observed, with only body surface area and body
mass index correlated to minimum relative pressure and aortic stiffness, respectively.
7.3.4 Influence of isolated cardiovascular parameters on aortic relative
pressure
The isolated influence of CV parameters on aortic relative pressure was analysed using
the virtual cohort. Aortic relative pressure for each virtual group, together with the
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corresponding clinical traces, are shown in Figure 7.5.
For the virtual cohort, aortic maximum relative pressure varied within a range of 23.9 –
56.5, 28.3 – 62.5, and 30.4 – 72.1 Pa/m for the reduced LV function (DCMred), preserved
LV function (DCMpres), and control groups, respectively. For reference, the clinical
cohort showed variations of 61.2 ± 10.0, 79.6 ± 14.2, and 78.9 ± 18.0 Pa/m within the
same three groups, respectively.
Aortic stiffness and aortic area were the two dominant CV parameters influencing max-
imum relative pressure. Specifically, variations in aortic stiffness accounted for 47% of
the possible variations in maximum relative pressure in the DCMred group, 63% in the
DCMpres group, and 100% in the control group. Similarly, variations in aortic area ac-
counted for 87, 91, and 73% of the possible variations in maximum relative pressure in
the same three groups, respectively. Cardiac parameters had an inferior influence, with
variations in SV accounting for 67, 46 and 46% of the possible variations in the DCMred,
DCMpres, and control groups, respectively. Aortic maximum relative pressure values as
a function of individual CV parameter variations are given in Table 7.3.
For minimum relative pressure, similar behaviour could be observed where aortic stiff-
ness and aortic area were the two major contributors to the observed variations, with
aortic stiffness equalling 70, 63, and 94% of the total variations, and aortic area equalling
95, 100, and 92% (again reported for the DCMred, DCMpres, and control groups, respec-
tively). Aortic minimum relative pressure values as a function of individual CV parameter
variations are given in Table 7.4.
Table 7.3: Virtual cohort analysis: aortic maximum relative pressure per unit length.
Variations in relative pressure are shown as a function of isolated variations of arterial
resistance, stroke volume, cardiac period, aortic area, and aortic stiffness, respectively.
Data provided for mean (baseline), minimum and maximum range, with all values re-
ported in mmHg/m. The bottom row shows the complete range of aortic maximum
relative pressure over all variations.
Virtual DCMred Virtual DCMpres Virtual controls
CV parameters min mean max min mean max min mean max
Arterial resistance 36.3 36.5 36.7 39.8 42.0 43.8 49.4 51.3 52.5
Stroke Volume 23.9 36.5 45.6 30.1 42.0 46.0 41.5 51.3 60.8
Cardiac period 35.9 36.5 37.2 42.7 42 .0 42.9 50.2 51.3 51.3
Aortic area 28.1 36.5 56.5 31.5 42.0 62.5 38.1 51.3 68.5
Aortic stiffness 26.5 36.5 41.9 28.3 42.0 49.7 30.4 51.3 72.1
All CV parameters 23.9 36.5 56.5 28.3 42.0 62.5 30.4 51.3 72.1
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Figure 7.5: Aortic relative pressure traces from clinical and virtual analysis. Aortic
relative pressure traces from the clinical (top row) and virtual cohort (remaining rows),
presented as a function of isolated variations of arterial resistance, stroke volume, cardiac
period, aortic area, and aortic stiffness, respectively. Relative pressure is shown for
DCMred (left), DCMpres (middle), and controls (right). For the clinical data, each
individual subject is given in black. For the virtual data, isolated variations around
baseline (black) are given as positive variations (red) and negative variations (blue),
respectively, superimposed on the data range (grey).
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Table 7.4: Virtual cohort analysis: aortic minimum relative pressure per unit length.
Variations in relative pressure are shown as a function of isolated variations of arterial
resistance, stroke volume, cardiac period, aortic area, and aortic stiffness, respectively.
Data provided for mean (baseline), minimum and maximum range, with all values re-
ported in mmHg/m. The bottom row shows the complete range of aortic maximum
relative pressure over all variations.
Virtual DCMred Virtual DCMpres Virtual controls
CV parameters min mean max min mean max min mean max
Arterial resistance -38.4 -38.5 -38.7 -45.2 -43.8 -41.9 -38.5 -37.5 -36.1
Stroke Volume -42.8 -38.5 -32.2 -45.0 -43.8 -37.2 -38.9 -37.5 -34.1
Cardiac period -43.0 -38.5 -37.1 -49.0 -43.8 -42.0 -39.8 -37.5 -36.4
Aortic area -57.8 -38.5 -30.2 -62.2 -43.8 -33.2 -51.1 -37.5 -26.5
Aortic stiffness -49.0 -38.5 -28.9 -50.7 -43.8 -31.4 -49.2 -37.5 -23.9
All CV parameters -57.8 -38.5 -28.9 -62.2 -43.8 -31.4 -51.1 -37.5 -23.9
7.4 Discussion
Aortic relative pressure in DCM has been assessed using 4-D flow MRI in this study, un-
covering a set of significant hemodynamic alterations. At inclusion, all patients reported
DCM-related heart failure, however, the imaging session was not performed until after
treatment had been initiated. During this period, patients had the chance to respond
to therapy, and the DCM group was consequently split in two: a responding DCMpres
group, and a non-responding DCMred group. Thus, indicated hemodynamic changes
could be examined in conjunction to patient treatment response.
7.4.1 Changes in aortic relative pressure – relation to cardiac and aortic
physiology
The DCMred group showed a significantly reduced maximum aortic relative pressure. The
corresponding differences in aortic relative pressure between the DCMred and DCMpres
groups indicate that differences in cardiac function are reflected on the vascular side.
In previous studies, DCM has been associated with a reduction in peak aortic outflow
acceleration [181]; deteriorating cardiovascular status in DCM has been correlated to a
decrease in LV OT outflow gradients [182]; and aortic relative pressure has been directly
correlated to LV remodelling [175]; highlighting how ventricular dilation affects vascular
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hemodynamics. Together with this study’s findings, this indicates how vascular response
could be used as a potential surrogate measure for intrinsic cardiac behaviour.
In contrast, no significant differences could be inferred for minimum aortic relative pres-
sure. Minimum aortic relative pressure, which is related to the deceleration of blood
during late systole, has been linked to aortic reservoir function [183] rather than cardiac
disease. However, with apparent differences in aortic stiffness suggesting reservoir differ-
ences between DCMred and DCMpres groups, this indicates an intertwined relationship
between cardiac status, aortic function, and relative pressure. In other diseases, aortic
relative pressure has been related to both cardiac and aortic physiology [184], supporting
the notion of coupled cardiac and vascular hemodynamic behaviour.
In comparison to the above, TTP is a metric directly coupled to the contractile pumping
efficiency of the left ventricle: the shorter the TTP the faster the ventricular contraction.
In this study, a significant delay in TTP was observed in DCM patients regardless of LV
function, with an almost doubling of the time required to reach peak driving acceleration,
indicating that an underlying electrocardiac pathophysiology seems to persist. In DCM,
ventricular conduction delay is commonly reported [185] and it has been shown to be
a powerful prognosis predictor [186]. Current findings on TTP seem to indicate the
presence a conductive abnormality masked by the pharmaceutically improved cardiac
output.
A significant increase in PWV and aortic stiffness was reported in the DCMred group.
Arterial stiffening in DCM patients has been described previously [170] and reduced
maximum relative pressure was recently reported in an elderly cohort [175], connecting
reduced aortic acceleration to increased arterial stiffness in a similar way to how findings
from this study connect reduced relative pressure with increased aortic stiffness. In
general, arterial stiffening is a commonly ascribed vascular response mechanism following
cardiovascular disease development where – in the case of impaired ventricular efficiency
– increased arterial stiffening may arise to help maintain a timely forward-flow of blood
into the peripheral circulation.
Lastly, the DCMred group showed significantly increased systolic blood pressure com-
pared to the control group. This increase in afterload is however not coupled to any
variations in SV , signalling that an increase in ejection force is required to maintain sys-
temic circulation. Besides, an increase in mean blood pressure indicates elevated systemic
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resistance in the same group. However, this is slightly opposed by unaltered diastolic
blood pressure. In general, the development of hypertension is common in DCM [187].
It highlights a persistent detrimental remodeling feedback loop, in which long-term con-
gestion leads to increased afterload due to sympathetic activation. The chronic overload
of the ventricle thus in turn leads to worsening contractile properties.
7.4.2 Correlation to aortic relative pressure – independent role of aortic
hemodynamics
The correlation analysis revealed a general lack of defined relationships between aortic
hemodynamics and standard metrics for the DCM patients. However, aortic metrics
derived in this study provided a clear differentiation for the DCMred group, separating
responding from non-responding DCM patients. Furthermore, the independent asso-
ciation between aortic relative pressure and LV remodelling [175] has been indicated,
highlighting relative pressure as a complementary and independent biomarker for refined
cardiac diagnosis.
7.4.3 The role of isolated cardiac and aortic parameters on relative
pressure – virtual cohort study
Out of the evaluated metrics in the virtual cohort analysis, aortic stiffness and area were
the main determinants of aortic relative pressure. While positive variations in stiffness
increased relative pressure magnitudes, positive variations in area decreased them (see
Figure 7.5, two last rows). The combination of these two phenomena could explain the
similar minimum relative pressures observed in DCM patients and controls (see Fig-
ure 7.5, first row). However, this does not explain the observed decrease in maximum
relative pressure with decreased LV function. This reduction could instead be attributed
to cardiac changes such as modified contractility [188] or a lack of contractile coordina-
tion [185], but could also be influenced by coupled reservoir behaviour. Nevertheless,
the combination of clinical and computational results indicate adapted reservoir function
and altered cardiac conductivity, both present in DCM.
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7.4.4 Aortic change in DCM – clinical implications of image-based find-
ings
A number of aortic hemodynamic changes have been inferred for DCM. Non-responding
DCMred patients showed depressed relative pressure, delayed TTP , increased aortic stiff-
ness and increased systolic blood pressure, whereas responding DCMpres patients showed
a comparable normalisation of aortic metrics. Considering the fact that all DCM pa-
tients followed the same treatment protocol, this separation is particularly noteworthy,
and could in fact indicate that cardiac treatment efficacy is coupled to vascular adaption
abilities.
Antihypertensive medications have been shown to reduce arterial stiffness [189], being
part of a general strategy to hinder continuous dilation through ventricular unloading.
Poor vascular adaption in non-responders could keep the ventricle in a state which re-
quires excessive work to maintain systemic perfusion due to increased BP and aortic
stiffness. Furthermore, with sustained hypertension correlated to aortic dilation [190],
and with aortic area decreasing relative pressure, these patients will experience decreased
acceleration of the ejected blood, potentially affecting long-term stable systemic circula-
tion. If additional medication could decrease stiffness or BP, a continuous unfavourable
depression of relative pressure could follow. Thus, through poor vascular adaption, the
general treatment potentially fails in unloading the heart, instead pushing it further down
a pathological remodelling spiral. Using arterial function as a measure of drug effective-
ness is not a new concept [191], but this study indicates that unloading the heart requires
a unified look at cardiac, aortic, and systemic function.
7.4.5 Clinical outlook – non-invasive imaging for the assessment of
ventricular-vascular function
4-D flow MRI permits detailed hemodynamic analysis and improves the assessment of
cardiovascular disease[175–177, 192]. This study has shown that aortic hemodynamics
are altered in cardiac disease, and that aortic relative pressure can be directly connected
to cardiac and vascular function, as well as potential treatment efficacy, highlighting
clinical impact of refined flow imaging. The proposed biomarkers can thus be added as
a complement to the traditional diagnostic procedure. Further studies are required to
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uncover the initiation and sequential order of the remodelling response, however, imaging
has the potential to play a key role in studying such behaviour in a non-invasive setting.
7.4.6 Limitations
A fairly small sample size was used, and the generalisation of these findings to a global
DCM population is potentially limited. However, since the statistical methods incorpo-
rated sample size effects, the observed behaviour might still be representative of aortic
change in DCM.
For the virtual cohort, the analysis was limited to a selection of conventional CV pa-
rameters (i.e. RT, SV , T , A and PWV ). Additional parameters (e.g. varying LV ET ,
LV OT outflow gradient) could be included in order to disentangle cardiac and aortic in-
fluence. The virtual cohort also showed slightly lower relative pressure compared to the
retrieved clinical data in all three subgroups. While some characteristics (e.g. SV , T )
were tailored to reflect DCM behaviour, other (e.g. aortic lengths) were retrieved from
published literature values on healthy subjects. Consequently, these underlying baseline
characteristics might not be entirely reflective of the assessed clinical cohort and might
cause the observed bias. Nonetheless, with virtual and clinical cohorts showing similar
trends with respect to aortic relative pressure (i.e. decreasing relative pressure with in-
creasing LV impairment), this may indicate that the influence of evaluated cardiovascular
parameters on the virtual cohort is reflective of similar behaviour on the clinical side.
7.5 Conclusion
In this study, 4-D flow MRI and computational modelling were used to study aortic
relative pressure in DCM. Significant aortic hemodynamic changes were observed, relat-
ing to specific physiological aspects of the disease: decreased maximum relative pressure
indicating affected ventricular ejection, prolonged time-to-peak relative pressure indicat-
ing remaining latent conduction delay, and increased aortic stiffness and systolic blood
pressure indicating pathological arterial remodelling. With the aortic response sepa-
rating responders from non-responders, vascular adaption could be a novel marker in
assessing treatment efficacy in DCM. Similarly, with the assessed hemodynamic metrics
uncorrelated to conventional diagnostic metrics, complementary diagnostic value could
Chapter 7. Haemodynamics in Dilated Cardiomyopathy 107
be achieved through aortic assessment. Overall, the study highlights the clinical value of
vascular adaption in DCM and shows how ventricular-vascular interactions can be effec-
tively studied using 4-D flow MRI and computational models of the systemic circulation.
8 Conclusions
This chapter contains a summary of the achievements of this thesis (Section 8.1) and
directions for future work (Section 8.2).
8.1 Summary of Achievements
This thesis has successfully achieved the aim and objectives outlined in Section 1.2.
The aim and main achievement of this thesis was the development and assessment of
algorithms to estimate central blood pressure (cBP) from clinical data obtained non-
invasively. This was achieved using 0-D and 1-D computational models of fluid dynam-
ics, which augment the clinical data obtained from ultrasound and magnetic resonance
imaging by providing an accurate, patient-specific, non-invasive estimate of cBP.
Chapters 4 to 7 present the research done to address the individual objectives. Addition-
ally, Chapter 7 presents a clinical cohort study where some of the methods developed in
the previous chapters were applied and extended. The individual achievements of this
thesis are summarised below for each chapter.
Chapter 4: Datasets
The main achievement of Chapter 4 was the creation of three in silico datasets, each
containing thousands of healthy virtual subjects with unique cardiovascular (CV) pa-
rameters and haemodynamic waves. The cardiovascular parameters were extracted from
the clinical literature for healthy adults. For all virtual patients in each dataset, the
haemodynamic waves (i.e. flow, pressure, and area) were simulated using a different
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computational model of arterial blood flow. These waves were available at the aortic
root for all three datasets, and at additional locations (e.g. carotid and brachial arter-
ies) for a dataset created using a 1-D model. The unique cardiovascular parameters and
haemodynamic waves from each virtual patient – free of experimental error due to their
in silico nature – were used as reference data for the development and assessment of algo-
rithms for the estimation of cardiovascular parameters (Chapter 5) and cBP (Chapter 6).
These datasets are also a valuable tool for developing and assessing future methods for
cardiovascular parameter or cBP estimation. This chapter also presented the creation of a
“cohort-specific” in silico dataset based on the characteristics of dilated cardiomyopathy
patients and healthy controls.
This chapter also described three in vivo datasets containing reference cardiovascular
data. Several post-processing operations were performed to make the in vivo datasets
ready to be used in the next chapters. Invasive aortic blood pressure waves – obtained
via cardiac catheterisation – and aortic geometry and blood flow measurements – ac-
quired from cardiac magnetic resonance scans – were available for a dataset of “Aortic
Coarctation” patients. The other two datasets corresponded to a “Normotensive” and
a “Hypertensive” dataset, respectively. Both datasets contained aortic flow measured
using ultrasound, non-invasive peripheral blood pressure waves from carotid applana-
tion tonometry, and non-invasive cBP waves calculated using the SphygmoCor R© device.
Similarly to the 1-D model in silico datasets, the in vivo datasets were used as reference
data for the assessment of algorithms for the estimation of cBP (Chapter 6).
Chapter 5: Cardiovascular Parameter Estimation
The main achievement of Chapter 5 was to identify optimal methods to estimate car-
diovascular parameters from non-invasive clinical data. To achieve this, a comprehen-
sive literature review was performed to find current methods to estimate cardiovascular
parameters was performed. Additionally, novel methods were developed for some cardi-
voascular parameters. Current and novel methods were assessed using the three datasets
of virtual subjects presented in this chapter as reference data. The six cardiovascular
parameters of interest were: left-ventricular ejection time, asymptotic pressure, arterial
resistance, arterial compliance, pulse wave velocity, and characteristic impedance (Z0).
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For each dataset, all parameters but Z0 were estimated with mean absolute errors smaller
< 10%. Z0 was the most challenging parameter, with 16% errors when using the carotid
blood pressure wave, and 82% errors when only using brachial diastolic and systolic blood
pressure values. For any virtual subject, estimating all six cardiovascular parameters
using the optimal methods took less than one second on a standard PC. These methods
were combined with three different computational models of arterial blood flow to develop
the algorithms to estimate cBP presented in (Chapter 6).
Chapter 6: Central Blood Pressure Estimation
The main achievement of Chapter 6 was the development of three novel cBP estimation
algorithms using optimal cardiovascular parameter estimation methods and three com-
putational models of arterial blood flow. These algorithms were then tested on three
clinical datasets and one dataset of virtual subjects. Each dataset contained reference
central blood pressure and flow waves.
Each algorithm used one of three computational models of arterial blood flow – the
two-element or three-element Windkessel models, or a 1-D model of the larger systemic
arteries – in combination with the optimal cardiovascular parameter estimation methods
identified in Chapter 5. These algorithms were developed using reference haemodynamic
waves from the 1-D model dataset of virtual subjects, and tested in vivo using three
clinical datasets.
In the “Aortic Coarctation” dataset – the only in vivo dataset containing aortic geome-
try and invasive aortic pressure measurements – the 1-D model algorithm led to smaller
systolic blood pressure and pulse pressure mean absolute errors (< 4.1 ± < 10.7 mmHg)
than the 0-D model algorithms (< 17.3 ± < 9.2 mmHg). In the “Normotensive” and
“Hypertensive” datasets, both 0-D model algorithms estimated blood pressure values
similarly with errors < 6.0 ± 4.9 mmHg, although according to the root mean square
error, the three-element Windkessel outperformed the two-element Windkessel (< 5.9 ±
2.4 mmHg vs < 10.6 ± 4.1 mmHg). Interestingly, errors for the 0-D models were consid-
erably smaller when using brachial DBP and MBP instead of the entire carotid pressure
wave. This study has shown that, in a clinical setup where the aortic geometry can be
acquired, a 1-D model of the upper-thoracic aorta can simulate aortic haemodynamics
more accurately than 0-D models. These findings will be useful to augment the clinical
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data from cardiac magnetic resonance and ultrasound scans, providing a patient-specific,
non-invasive estimate of cBP.
Chapter 7: Haemodynamics in Dilated Cardiomyopathy
The main achievement of Chapter 7 was the development and analysis of the first cohort-
specific dataset of virtual subjects. This chapter was part of an in vivo and in silico study
investigating the influence of individual cardiovascular parameters on the aortic pressure
gradient of dilated cardiomyopathy (DCM) patients. While previous datasets were cre-
ated using the characteristics of healthy subjects found in the clinical literature only,
this cohort-specific dataset contained virtual patients created from the characteristics of
DCM patients. Subjects from this dataset were divided into three groups: healthy con-
trols, DCM patients with moderate cardiac function, and DCM patients with reduced
cardiac function.
Significant differences in aortic hemodynamics, relating to specific aspects of the dis-
ease, were observed in DCM patients: decreased maximum relative pressure; prolonged
time-to-peak relative pressure; and increased aortic stiffness and systolic blood pressure.
These findings suggest that, in DCM patients, arterial remodelling could be a novel
marker in assessing treatment efficacy, and that these four hemodynamic metrics could
provide additional diagnostic value. Furthermore, the added value of a cohort-specific in
silico analysis for the study of the independent physical mechanisms behind a cardiovas-
cular disease has been shown.
“Disease-specific” datasets of virtual patients can be helpful in pre-clinical studies to
better understand the role played by haemodynamics in a given disease. However, the
virtual patients contained in these datasets represent a range of average population CV
parameters rather than those of a given patient. Instead, the results from computational
models parametrised using “patient-specific” clinical data, such as the ones studied in
this thesis, should be used to guide clinical decisions. These physics-based models rely
heavily on fluid mechanics rather than statistics, and hence provide clinical measurements
which are tailored to the cardiovascular properties and function of individual patients.
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8.2 Future Work
This thesis has identified a number of challenges which will need to be addressed so that
these novel algorithms for the non-invasive estimation of central blood pressure (cBP)
and cardiovascular parameters can be translated into the clinic. These challenges and
their potential solutions are listed below, together with a number of ideas for future
research, based on the experience gained throughout this work.
8.2.1 Central Blood Pressure Algorithms
The main clinical assessment for the current work was performed using the “Aortic Coarc-
tation” dataset, which contained invasive cBP data for 10 patients only. Although two
larger datasets – containing reference cBP values acquired using the current non-invasive
gold-standard device for non-invasive cBP estimation – were used as well, invasive refer-
ence cBP values are preferred. Therefore, larger clinical populations of patients with a
range of cardiovascular diseases containing invasive cBP, aortic geometry and flow, and
non-invasive peripheral pressures are required to fully assess the cBP algorithms. Cardio-
vascular diseases which do not significantly alter the aortic geometry would be preferred,
given that current 1-D models do not account for energy losses due to the appearance
of turbulent blood flow or recirculation (phenomena which occur, respectively, in aortic
coarctation or aortic aneurysm patients). In fact, the in silico or in vitro development
and assessment of 1-D models with the ability to account for tortuous aortic geometries
could increase the accuracy of current cBP estimation algorithms for such patients.
8.2.2 Cardiovascular Parameter Estimation
Optimal cardiovascular parameter estimation methods were identified using in silico ref-
erence data representative of healthy populations only. Ideally, an assessment of both
current and novel methods should be performed using in vivo reference data obtained
from healthy and unhealthy subjects, although this may not be feasible for some cardio-
vascular parameters. Among the parameters under study, arterial resistance, character-
istic impedance, and pulse wave velocity at the aortic root, and left ventricular ejection
time, can all be measured directly and accurately in vivo. In fact, in a recent study, Asai
et al. [193] compared a number of cardiovascular parameter estimation methods using
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swine data. However, asymptotic pressure (whose physiological meaning is not clear yet)
and arterial compliance (which mainly accounts for the compliance of the larger systemic
arteries) are parameters whose measurement in vivo are technically challenging. On the
one hand, asymptotic pressure should be measured simultaneously at multiple capillary
locations to better understand it and to extract reference values in humans. On the
other hand, reference arterial compliance should be measured from full body dynamic
arterial volume measurements. Methods for the reliable direct measurement of these car-
diovascular parameters in vivo must be developed to validate the proposed non-invasive
estimation methods.
As seen in Chapter 5, the estimation of aortic characteristic impedance from aortic flow
and peripheral pressure requires substantial further work. However, since this parameter
is determined only by local arterial properties, it may be difficult to improve estimates
using a peripheral pressure wave. Furthermore, the cBP estimation algorithm which uses
a three-element Windkessel model would significantly benefit from an accurate estimate
of aortic characteristic impedance.
8.2.3 Machine Learning, Wearables and the Digital Twin
The availability of larger numbers of in silico (e.g. virtual subjects presented in this the-
sis) and in vivo (e.g. UK Biobank) datasets motivates the development and assessment of
machine learning methods to estimate blood pressure and cardiovascular parameters not
only centrally but also at other arterial locations of clinical relevance. The potential util-
ity of such methods for estimating relevant cardiovascular metrics is increasing with the
widespread use of wearables, which could potentially facilitate continuous cardiovascular
monitoring.
Several examples of algorithms for monitoring physiological parameters have been pro-
posed in the literature. For instance, Charlton’s PhD thesis (2017) “developed and
assessed the performance of techniques for continuous respiratory rate monitoring using
electrocardiogram (ECG) and photoplethysmogram (PPG) signals for use in wearable
sensors to detect deteriorations” [194]. In 2018, Mathieu et al. demonstrated the feasi-
bility of assessing left ventricular ejection time using wrist PPG signals, such as those
acquired by smart watches [195]. More recently, Tanveer et al. proposed a “Long Short
Term Memory” Artificial Neural Network model for the continuous estimation of blood
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pressure using data from ECG and PPG wearable sensors [168]. Furthermore, Apple is
currently conducting a very large study on “the ability of the Apple Watch algorithm to
identify pulse irregularity and variability which may reflect previously unknown atrial fib-
rillation (AF)” [196]. Preliminary results show that this smart watch accurately detects
AF [197].
These methods and sources of continuous physiological data could be combined with
current algorithms based on computational models of fluid dynamics to create a digital
twin. A digital twin, in this context, is a digital replica of a human which updates
using data from multiple sources such as machine learning models, wearables, clinical
populations, biophysical models, or even other digital twins. Digital twins, using such
statistical and physical models, would ideally be able to benefit from vast amounts of
data and use it to predict negative health outcomes for its corresponding human and
advise accordingly. Finally, the efficacy of the digital twin would improve with time as
it “learns” from mistakes and from the vast amounts of data provided by the Internet of
things, which allows the any kind of smart device to connect to others and constantly
send and receive data.
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A Appendix
A.1 Calculating reference Z0 and CT at the aortic root
Reference Z0 and CT values for the 1-D dataset were calculated from aortic root pressure,
P , and flow, Qin, waves using an in-house algorithm written in MATLAB R© and based
on the 3-element Windkessel model (Figure A.1). Assuming that Pout is known and that
the total resistance RT = Z0 + R is given by Equation (5.12), a parameter estimation
problem can be solved for Z0 and CT . The estimated pressure at time tk can be written
as
P (tk) = f(Z ′0, C ′T, Qin(tk)) + ek, (A.1)
with ek the residual error between the estimated and reference pressures at each time
tk, k = 1, . . . ,K, and Z ′0 and C ′T the estimated parameters. The problem can be solved
through iterative minimisation of the cost function e>e, where e is the vector containing
the residual errors at each time tk. The iterative procedure starts from an initial estimate
(Z ′0,0, C ′T,0). The parameters at iteration i+1 are then calculated using the recursive
equation
(Z ′0,i+1, C ′T,i+1) = (Z ′0,i, C ′T,i)−Hiqi, (A.2)
where Hi and qi are the Hessian and the gradient, respectively, of the cost function eval-
uated at iteration i. This equation can be obtained by approaching the cost function by a
second-order Taylor expansion and minimising the approached function. The ‘mean cBP




with ek the residual error at time tk.
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Figure A.1: Extracting reference Z0 and CT values at the aortic root. (a) Reference
cBP waveform for a 1-D model virtual subject, and corresponding initial and optimal
estimates. (b) Contour plot (in mmHg) of the mean difference between the estimated
and reference cBP waves, with Z0 in the x-axis and CT in the y-axis. Each iteration is
shown in white squares; iterations 0 and 5 correspond to the initial and optimal cBP
estimates, respectively. (c) The values of Z0, CT, and the cBP mean difference are shown
for the initial estimate and for every iteration until numerical convergence is reached.
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A.2 Reference vs estimated cBP waves












































































































































































































































































































































































































































































































































































































































































Figure A.2: cBP waveform estimations for Scenario 1. cBP waves calculated using the
2-element Windkessel (dashed red lines), 3-element Windkessel (dashed blue lines), and
1-D aortic (dashed black lines) cBP algorithms. They are compared against reference













































































































































































































































































































































































































































































































































































































































































Figure A.3: cBP waveform estimations for Scenario 2. cBP waves calculated using the
2-element Windkessel (dashed red lines), 3-element Windkessel (dashed blue lines), and
1-D aortic (dashed black lines) cBP algorithms. They are compared against reference
cBP waves from the 1-D model dataset (thick black lines).
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120Figure A.4: cBP waveform estimations for Scenario 1. cBP waves calculated using the
2-element Windkessel (dashed red lines), 3-element Windkessel (dashed blue lines), and
1-D aortic (dashed black lines) cBP algorithms. They are compared against catheter
























































































120Figure A.5: cBP waveform estimations for Scenario 2. cBP waves calculated using the
2-element Windkessel (dashed red lines), 3-element Windkessel (dashed blue lines), and
1-D aortic (dashed black lines) cBP algorithms. They are compared against catheter
measurements from the ‘Aortic Coarctation’ dataset (thick black lines).
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Figure A.6: cBP waveform estimations for Scenario 1. cBP waves calculated using the
2-element Windkessel (dashed red lines), 3-element Windkessel (dashed blue lines), and
1-D aortic (dashed black lines) cBP algorithms. They are compared against reference




















































































































































































































































































































































































































































































































































































































































































































Figure A.7: cBP waveform estimations for Scenario 2. cBP waves calculated using the
2-element Windkessel (dashed red lines), 3-element Windkessel (dashed blue lines), and
1-D aortic (dashed black lines) cBP algorithms. They are compared against reference
cBP waves from the ‘Normotensive’ dataset (thick black lines).
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Figure A.8: cBP waveform estimations for Scenario 1. cBP waves calculated using the
2-element Windkessel (dashed red lines), 3-element Windkessel (dashed blue lines), and
1-D aortic (dashed black lines) cBP algorithms. They are compared against reference















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure A.9: cBP waveform estimations for Scenario 2. cBP waves calculated using the
2-element Windkessel (dashed red lines), 3-element Windkessel (dashed blue lines), and
1-D aortic (dashed black lines) cBP algorithms. They are compared against reference
cBP waves from the ‘Hypertensive’ dataset (thick black lines).
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Introduction 
The heart and the vasculature are inherently coupled, and remodeling mechanisms on one side 
is commonly attributed to previous pathological manifestation on the other. Arterial and 
ventricular stiffening have been observed in heart failure patients with preserved ejection 
fraction(5). Pulse wave velocity and augmentation index – arterial measures related to vascular 
stiffness – have both been correlated to left ventricular (LV) systolic dysfunction(39). 
Vascular hemodynamics have also been closely coupled to ventricular function, with aortic 
relative pressure – the change in blood pressure over aortic segments – being linked to 
hypertrophic outflow tract obstruction(20), LV remodeling(6), and aortopathies (e.g., 
coarctation, aneurysm, or dissection)(25). Despite this, arterial function is seldom studied in 
cardiomyopathy patients. Instead, cardiomyopathy is typically seen as a “heart-only” disease, 
with diagnosis and intervention guided primarily using measures of cardiac function. 
Despite clear anatomical and functional phenotypes, Dilated Cardiomyopathy (DCM) is 
commonly idiopathic with associated poor prognosis(12). Refined prognostic and diagnostic 
biomarkers are thus merited, and herein, ventricular-vascular interaction has been 
hypothesized as a key component in understanding disease progression. An increased aortic 
stiffness has been identified in DCM(4), and vascular hemodynamics have been linked to 
disease development, with pulmonary and systemic hypertension correlated to DCM 
mortality(1). Interestingly, the prognosis following cardiac resynchronization of heart failure 
patients (including DCMs)(42), as well as the ability to induce left ventricular reverse 
remodeling (experienced in up to 40% of all DCM patients(28)) have been related to arterial 
behavior, highlighting the importance of the vasculature.  
To date, the clinical assessment of cardiovascular function has been largely based on medical 
imaging. In addition to diagnosing DCM by means of LV size and function, myocardial tissue 
characterization by cardiac magnetic resonance imaging (MRI) (using T1 or T2 mapping) is 
being increasingly used in clinical assessment(18). To this, phase-contrast (PC-) MRI methods 
such as 2D or 4D flow MRI(15) now permit comprehensive evaluation of blood flow in the 
cardiovascular system. 4D flow MRI in particular has uncovered altered diastolic ventricular 
flow routes in DCM(16), quantified aortic relative pressure in association with ventricular 
remodeling(6), and has enabled accurate estimation of relative pressure in vivo(13, 27). MRI 
flow imaging has been suggested as a possible tool for assessing ventricular-vascular behavior 
 
in chronic heart failure(10), and right-ventricular-pulmonary coupling(26). Thus, 4D flow 
MRI can provide a more comprehensive evaluation of cardiac and vascular behavior, and may 
allow for refined understanding of ventricular-vascular interaction in DCM patients. 
The aim of this study was to examine aortic hemodynamic changes in a DCM cohort, utilizing 
4D flow MRI, to non-invasively assess vascular alterations in cardiac disease. Specifically, 
aortic relative pressure was derived from the 4D flow MRI data, utilizing the fact that changes 
in relative pressure are coupled to both cardiac function and reservoir status(6, 20, 25) to 
assess overall vascular response to myocardial dysfunction. Furthermore, given the challenges 
of studying isolated effects of arterial and ventricular perturbations in patients due to their 
physiologic interdependence, we developed a computational virtual cohort(40) (representing a 
model equivalent of the blood flow in the larger systemic arteries) to understand the impact of 
cardiovascular properties on aortic relative pressure. Using this combination of advanced 
blood flow imaging and computational cardiovascular simulations techniques, we aim to map 
aortic and cardiac hemodynamic function, and uncover possible signs of ventricular-vascular 
interplay in DCM.     
 
Methods 
Figure 1 shows an overview of all utilized data sources. Additionally, extracted quantities are 
specified, showing the spectrum of cardiac and aortic parameters analyzed. 
Study population 
Adult subjects were recruited at St Thomas’ Hospital, King’s College London, through the 
British Heart Foundation Integrated Mathematical Modelling and Imaging (BHF-IMMI) 
project, with data acquired during March 2013 – April 2014. The inclusion criteria for the 
patient cohort were age > 18 years, and diagnosed non-ischemic symptomatic (NYHA class 
III) DCM-related heart failure. The exclusion criteria were known airway disease, pregnancy, 
renal or hepatic impairment, previous history of angina or cardiac arrhythmias for which 
continuous administration of beta blockers was deemed necessary, as well as contraindications 
to MRI. In addition to patients, the BHF-IMMI project also recruited healthy control subjects 
without any known cardiovascular, pulmonary, renal, hepatic, diabetic, or other systemic 
diseases.   
In this retrospective study, 14 patients and 16 healthy controls were included. Patient treatment 
followed guideline medical management for heart failure, specifically including beta blocker 
administration. At the time of MRI, a subgroup of DCM patients presented with preserved LV 
function following medical therapy. Consequently, the DCM cohort was divided into two 
subgroups: subjects with reduced LV function (DCMred, LV ejection fraction (EF) < 50%, n = 
9) and subjects with preserved LV function (DCMpres, EF ≥ 50%, n = 5). Prior to data 
collection, the entire patient cohort had their beta blocker treatment discontinued for 48 hours 
to examine native cardiovascular function.  
All subjects provided informed consent, with data collection approved by the Regional Ethics 
Committee, South East London, UK (REC, 12/LO/1456). Subject demographics are shown in 
Table 1.  
Imaging, data collection, and post-processing  
a) Cardiac functional imaging 
 
MRI was performed at 1.5T (Philips ACHIEVA) using a 32-channel cardiac coil. Cardiac 
function and characteristics were assessed using cine steady-state free precession (SSFP) MRI 
of stacked short axis, and three long axis view planes. Left and right ventricular end-systolic 
and end-diastolic volumes, along with cardiac output metrics (EF, stroke volume (SV), cardiac 
output (CO), cardiac index (CI)) were obtained from all subjects (imaging and processing 
details are provided in Supplementary Material). 
b) Vascular flow imaging and aortic relative pressure estimation 
All subjects were imaged using 4D flow MRI (8-fold acquisition using the k-t PCA 
technique(32) in combination with a sparsifying transform(24), spatial resolution ~2.5 mm3, 
temporal resolution ~33 ms, prospective ECG gating, velocity encoding range ~120-190 
cm/s). The thoracic aorta was segmented using an in-house software. Aortic relative pressure 
was computed from the left ventricular outflow tract (LVOT) to the diaphragm level of the 
descending aorta using a validated virtual work-energy approach (see Marlevi et al(27) and 
Supplementary Material). From each relative pressure trace, maximum and minimum relative 
pressure were derived. Additionally, time-to-peak relative pressure (TTP) was computed, 
given as the time from acquisition onset (triggered at ECG R-wave) to maximum relative 
pressure. These three metrics were chosen to represent aortic hemodynamic behavior, with 
positive and negative relative pressure relating to the acceleration and deceleration of blood 
through the aorta, and with TTP relating to ventricular conduction(36) and myocardial 
contractility(35). An illustration of the derived metrics is given in Figure 2. 
Aortic pulse wave velocity (PWV) was derived using a validated cross-correlation 
method(19), assessing the flow transit time between prescribed inlet and outlet. Aortic 
stiffness was subsequently calculated using the Moens-Korteweg equation(29).   
c) Central blood pressure estimation 
Central blood pressure (CBP) estimates were derived from brachial sphygmomanometer 
cuffing acquired prior to imaging, using dedicated equipment (CENTRON cBP301, SunTech 
Medical Inc., Morrisville, NC, USA) where brachial pressures are converted into CBP by 
means of validated transfer functions(7). 
Virtual cohort 
 
Structural and functional cardiovascular characteristics can be studied by means of non-
invasive imaging. However, the intertwined nature of ventricular-vascular behavior makes it 
difficult to isolate independent factors that impact cardiovascular function. Computational 
modeling, however, allows for the study of the physiological effects of specific parameters on 
the cardiovascular system in an isolated fashion(9). To understand aortic relative pressures, a 
virtual cohort was thus created, solving 1D blood flow equations through a systemic 
circulatory model, all based on the models described in Willemet et al(40) and Alastruey et 
al(2). Importantly, such models have been extensively validated and verified to accurately 
represent 1D arterial hemodynamic behavior through the larger arterial system(31, 33). 
The virtual cohort was adjusted to match clinical characteristics (arterial peripheral resistance, 
SV, cardiac period, aortic area, aortic stiffness), with both DCMred and DCMpres having a 
corresponding virtual subgroup. By varying isolated parameters around a subgroup baseline, 
the independent influence of these defined clinical characteristics was assessed. Virtual 
relative pressures were derived from the LVOT to the descending aorta, with outputs 
normalized over aortic length. Technical details of the virtual cohort are provided in 
Supplementary Material. 
Statistical analysis 
Statistical differences in subject characteristics, cardiac metrics, and aortic outputs were 
evaluated using a Mann-Whitney U-test for continuous data, and a χ2 test for nominal data 
(significance inferred at p < 0.05). Outliers were evaluated by Tukey’s fences.  
The Pearson correlation coefficient was evaluated to assess potential correlations between 
subject characteristics and output metrics. Correlation was inferred for |R| > 0.5 and p < 0.002 
(determined from p < 0.05 together with a Bonferroni correction for m = 21 tested correlates, 
introduced to account for the multiple comparisons).   
All evaluations were performed using MATLAB R2016a (MathWorks, Natick, MA, USA).  
 
Results  
Based on the acquired image data, one DCM subject with reduced LV function was excluded 
following the identification of mild aortic stenosis (maximum aortic outflow velocity = 1.8 
m/s versus group mean = 0.8 ± 0.3 m/s, falling beyond the outer Tukey fence), and a 
significantly altered aortic geometry (aortic diameter = 1.0 cm versus a group mean = 1.6 ± 0.2 
cm, LVOT cross-sectional area = 1.5 cm2 versus a group mean = 5.9 ± 2.9 cm2). 
Clinical data and subject characteristics 
Complete characteristics and data output are provided in Table 1. The DCMred group showed 
significantly higher body mass index (BMI) and LV volumes, and significantly lower LV EF, 
LV cardiac index (CI), as well las right ventricular (RV) CI. Systolic and mean blood pressure 
were also elevated.  
Aortic relative pressure in dilated cardiomyopathy patients 
Aortic relative pressure characteristics are provided in Table 2, with Figure 3 showing 
comparisons of flow-derived markers. 
The DCMred group showed a significantly decreased maximum aortic relative pressure, with an 
average reduction of 22% (61.6 ± 10.0 mmHg/m vs. 78.9 ± 18.0 mmHg/m, p = 0.022). 
However, this difference was not reflected for the minimum relative pressure, where similar 
values were obtained as for the control group. 
A markedly prolonged TTP was seen in both DCMred and DCMpres groups. Strong statistical 
differences in group means were seen between the control group and both DCM groups (p ≤ 
0.01), with the DCM patients requiring twice as much time to reach maximum relative 
pressure (109 ± 22 and 108 ± 38 ms vs. 55 ± 22 ms).  
The DCMred group showed a higher aortic PWV compared to the control group, with an 
increase of 47% (11.0 ± 4.6 m/s vs. 7.5 ± 2.5 m/s, p = 0.034).  Increased PWV was not noted 
in the DCMpres. Similar results were observed for derived aortic stiffness, where the DCMred 
group had a significantly higher aortic stiffness, with an increase of 130% (14.5 ± 12.0 kPa vs 
6.3 ± 5.1 kPa, p = 0.035).  
 
Correlation of aortic relative pressure with clinical, structural, and central blood 
pressure metrics 
Complete correlation results are provided in Supplementary Table 2. In short, for the DCMred 
and DCMpres groups, no correlations could be inferred between any clinical parameter and the 
derived aortic metrics, including central blood pressures. For the control group, similar 
behavior was observed, with only BSA and BMI correlated to minimum relative pressure and 
aortic stiffness, respectively.   
Influence of isolated cardiovascular properties on aortic relative pressure 
The individual influence of cardiovascular properties on aortic relative pressure was analyzed 
using the virtual cohort. Aortic relative pressure for each virtual subgroup, together with 
corresponding clinical traces, is shown in Figure 4.  
For the virtual cohort, aortic maximum relative pressure varied between 23.9 – 56.5, 28.3 – 
62.5, and 30.4 – 72.1 Pa/m for the DCMred, DCMpres, and control groups, respectively. For 
reference, the clinical cohort varied between 42.4 – 72.8, 62.2 – 102.7, and 57.3 – 121.4 Pa/m 
within the same three groups, respectively. Individual variations as a function of isolated 
variables are given in Supplementary Table 3. 
For the virtual cohort, aortic stiffness and aortic area were the two dominant properties 
influencing aortic relative pressure. Specifically, variations in aortic stiffness alone recovered 
47% of the total variations observed in maximum relative pressure in the DCMred subgroup, 
63% of the total variations observed in the DCMpres group, and 100% of the total variations in 
the control group. Similarly, variations in aortic area alone recovered 87, 91, and 73% of the 
total observed variations in maximum relative pressure in the same three groups, respectively. 
In contrast, cardiac parameters (SV, cardiac period) had a comparatively smaller influence.  
For minimum relative pressure, similar behavior could be observed where aortic stiffness and 
aortic area were the two major contributors to the observed variations (aortic stiffness equaling 
70, 63, and 94% of the total variations, compared to aortic area equaling 95, 100, and 92%, 
again reported for the DCMred, DCMpres, and control groups, respectively).  
 
Discussion 
In this study we have used 4D flow MRI to evaluate aortic hemodynamic changes in patients 
with DCM. We identified clear evidence of vascular modifications in the patients with reduced 
LV function, with decreasing maximum aortic relative pressure, and increased aortic stiffness 
estimates evident from the flow-based analysis. We also inferred potential signs of ventricular 
conduction delay from the aortic analysis, with prolonged TTP evident in all patients, 
independent of LV function. Furthermore, our computational virtual cohort showed that these 
aortic hemodynamic metrics are predominantly governed by arterial behavior (aortic size and 
stiffness), indicating an active role of the vasculature in the development and manifestation of 
DCM. With previous observations linking both cardiac disease and interventional outcome 
success to arterial behavior(28, 42), our results highlight how highlight how vascular 
evaluation could complement the clinical assessment of DCM patients, and provide insights 
into the pathophysiological interactions between cardiac and arterial function.  
Changes in aortic relative pressure – relation to cardiac and aortic physiology 
The DCMred group showed a significantly reduced maximum aortic relative pressure, being on 
average 22% lower than the control group. Conversely, the DCMpres group did not differ 
significantly from the control, maintaining maximum aortic relative pressure. While the 
DCMred and DCMpres groups are defined on the basis of cardiac function, the observed 
differences in aortic relative pressure show how changes in cardiac function are reflected on 
the vascular side. In previous studies, DCM has been associated with a reduction in peak aortic 
outflow acceleration(22), and deteriorating cardiovascular status has been correlated to a 
decrease in LVOT outflow gradients(3), highlighting how ventricular dilation affects vascular 
hemodynamics. Given that aortic relative pressure has been correlated to LV remodeling(6), 
our findings suggest that vascular response could be important for better understanding disease 
progression in DCM.  
In contrast, no significant differences could be inferred for minimum aortic relative pressure, 
where both DCMred and DCMpres groups showed similar values to the control group. Minimum 
aortic relative pressure – an entity related to the deceleration of blood during late systole – has 
been less studied in conjunction to cardiac disease, and has instead been linked to aortic 
reservoir function(34). However, with apparent differences in aortic stiffness estimates 
 
inferred between DCMred and DCMpres groups, this instead indicates a possible intertwined 
relationship between cardiac status, aortic function, and relative pressure. In other disease (e.g. 
bicuspid aortic valve, or aortic dissection), aortic relative pressure has been related to both 
cardiac and aortic physiology(25), supporting the role of coupled cardiac and vascular 
hemodynamic behavior.     
In comparison to the above, TTP is an entity coupled to the contractility of the left ventricle: 
the shorter the TTP the faster the ventricular contraction. In our study, a significant delay in 
TTP was observed in both DCM groups relative to controls, with an almost doubling of the 
time required to reach peak relative pressure. Ventricular conduction delay is commonly 
reported for DCM(23), and although conduction abnormalities were not assessed in our study, 
prolonged QRS duration has been correlated to a reduction in maximum intraventricular 
relative pressure(41) – in-line with our findings on TTP. Especially noteworthy is the fact that 
the entire DCM group exhibited prolonged TTP, regardless of LV status. That is, even though 
ventricular function was decreased in some and preserved in others, an underlying 
electrophysiological pathology could be possibly indicated in both groups. In DCM, 
ventricular conduction delay has shown to be one of the most powerful predictors of 
prognosis(38), and our results seem to indicate a persistent conduction abnormality despite 
medical management and preserved LV ejection fraction. Idiopathic DCM is connected to the 
long-term development of heart failure(17), and latent subclinical contractile abnormalities 
could have detrimental long-term ramifications even in groups where short-term improvement 
in cardiac function is observed. 
A significant increase in PWV and aortic stiffness estimates were obtained in the DCMred 
group, with aortic stiffness estimates increasing by a factor of almost 2.3 compared to the 
control group. On the contrary, the DCMpres group did not differ significantly from the control 
group. Arterial stiffening in DCM patients has been described previously(4) and reduced 
maximum relative pressure was recently reported in an elderly cohort(6), in sorts similar to 
how our clinical findings connect reduced relative pressure with increased estimated aortic 
stiffness. In general, arterial stiffening is a commonly ascribed vascular response mechanism 
in cardiovascular disease where – in the case of impaired ventricular efficiency – increased 
arterial stiffening may contribute to maintaining necessary forward-flow of blood into the 
peripheral circulation.   
 
Lastly, the DCMred group showed significantly increased systolic blood pressure compared to 
the control group. This increase in afterload is however not coupled to any significant 
differences in SV, suggesting that increased ejection force is required to maintain systemic 
circulation in the DCMred group. Furthermore, the simultaneous increase in mean blood 
pressure indicates elevated systemic resistance in the DCMred group, however, this is slightly 
opposed by unaltered diastolic blood pressure. In general, the development of hypertension is 
common in DCM(12) and originates in part from increased neurohormonal activation(8). It 
highlights a persistent detrimental remodeling feedback loop, in which long-term congestion 
leads to increased afterload due to sympathetic activation,. The chronic overload of the 
ventricle thus in turn leads to worsening contractile properties.  
Correlation to aortic relative pressure – independent role of aortic 
hemodynamics  
The correlation analysis revealed a general lack of defined relationships between aortic 
hemodynamics and standard volumetric and functional metrics for the entire DCM cohort. 
This should be contrasted to the clear differences in the DCMred group seen with the derived 
aortic metrics. In other words, the assessment of aortic relative pressure may be a useful 
parameter for assessing function in DCM patients beyond standard EF assessment, and may 
have independent value given the lack of strong correlation with other conventional functional, 
volumetric, and hemodynamic parameters. Others have indicated the independent association 
between aortic relative pressure and LV remodeling(6), highlighting relative pressure as a 
complementary and independent biomarker for refined cardiac diagnosis.   
The role of cardiac and aortic function on relative pressure – isolated virtual 
cohort study 
Out of the evaluated metrics in the virtual cohort analysis, estimated aortic stiffness and mean 
cross-sectional area were the main counteracting determinants of aortic relative pressure: 
while positive changes in stiffness increase relative pressure magnitudes, positive changes in 
area decrease them. Such balancing reservoir behavior could explain the maintained minimum 
relative pressure; however would not completely clarify the corresponding net decrease in 
maximum relative pressure. This reduction could instead be attributed to cardiac changes such 
as modified contractility(21), lack of contractile coordination(23), or coupled reservoir 
 
behavior. Regardless, the combination of clinical and computational results indicates both 
modified reservoir and altered cardiac function, both mutually present in DCM.  
Aortic change in DCM – clinical implications of image-based findings 
In our study, a number of aortic hemodynamic changes have been inferred for DCM. In 
particular, the aortic response differed between DCMred and DCMpres. With the two groups 
following similar guideline therapeutic management, the separation could indicate how cardiac 
treatment efficacy may be, at least in part, coupled to vascular adaption abilities.  
Antihypertensive medications have been shown to reduce arterial stiffness(14), being part of a 
general strategy to hinder continuous dilation through ventricular unloading. In the DCMred 
group, however, modified vascular adaption could render an ineffective response, where – 
despite treatment – increased blood pressure and aortic stiffness require excessive myocardial 
work to maintain systemic perfusion. Furthermore, with hypertension correlated to aortic 
dilation(30), and with an increased aortic cross-sectional area decreasing relative pressure, the 
DCMred will experience decreased acceleration of the ejected blood being potentially impactful 
for long-term stability of the systemic circulation. If, at this stage, an additional medication 
could decrease aortic stiffness or blood pressure, an additional unfavorable depression of 
relative pressure could follow. This suggests that due to poor vascular adaption, the standard 
treatment may potentially fail to unload the heart, instead pushing it further down a 
pathological remodeling spiral. While using arterial function as a measure of drug 
effectiveness is not a new concept(11), our study indicates that unloading the heart requires a 
unified look at cardiac, aortic, and systemic function. 
Clinical outlook - non-invasive imaging for the assessment of ventricular-vascular 
function 
Advanced MRI blood flow imaging permits detailed hemodynamic analysis. As evident from 
our study, aortic hemodynamics are altered in cardiac disease, and aortic relative pressure may 
be directly connected to cardiac and vascular function, going beyond what can be inferred by 
conventional cardiac assessment (using e.g. EF, SV, or ventricular volumes). With physics-
based image processing allowing for relative pressure to be derived directly from acquired 
image data, the proposed biomarkers can thus be added as a complement to the traditional 
diagnostic information. Several examples exist of where volumetric flow imaging improves 
 
the assessment of cardiovascular disease: quantifying 4D intraventricular flow in relation to 
heart failure severity(37), providing accurate estimates of relative pressure(13, 27) or assessing 
aortic hemodynamics in conjunction to ventricular remodeling(6). Our study underlines this 
clinical impact of advanced flow imaging, with arterial alterations indicating active vascular 
response to manifested cardiac disease. Further studies are required to uncover the initiation 
and sequential order of the remodeling response, however, imaging has the potential to play a 
key role in studying such behavior in a non-invasive setting.  
Limitations 
A fairly small sample size was used, and the generalization of these findings to a global DCM 
population requires further investigation. Instead, our results can be seen as an example of 
how advanced flow imaging together with biophysical modelling can provide novel insights 
into pathophysiological developments, specifically addressing the concept of aortic 
hemodynamic response in cardiac disease.  
For the virtual cohort, the analysis was limited to a selection of key cardiovascular properties, 
chosen based on their conventional use in cardiovascular practice. The virtual cohort showed 
slightly lower relative pressure compared to the retrieved clinical data in all three subgroups. 
As is common in 1D cardiovascular simulations, systemic baseline characteristics (peripheral 
resistance, systemic variations in PWV, segment diameters etc.) were retrieved from published 
literature values on healthy subjects, with only conventionally assessable metrics (SV, heart 
rate) tailored to reflect certain pathologies. Consequently, these underlying baseline 
characteristics might not be entirely reflective of the assessed clinical cohort and might cause 
the observed bias. However, with virtual and clinical cohorts showing similar trends with 
respect to aortic relative pressure (decreasing relative pressure with increasing LV 
impairment), there are reasons to believe that the isolated influence of evaluated 




In this study a combination of non-invasive MRI blood flow imaging and computational 
modeling were used to study aortic relative pressure in DCM. Significant aortic hemodynamic 
changes were observed, relating to specific physiological aspects of the disease: decreased 
maximum relative pressure indicating impaired ventricular ejection (DCMred group); 
prolonged TTP indicating conduction delay (both DCM groups regardless of LV status); and 
increased aortic stiffness and systolic blood pressure indicating compensatory arterial 
remodeling (DCMred group). Given that the aortic response was different between the patients 
with preserved and reduced LV function, vascular adaption could be a novel complementary 
marker for assessing disease severity and treatment efficacy in DCM. Further, with the 4D 
flow derived hemodynamic parameters not correlated to conventional cardiac metrics (e.g., 
EF, SV or ventricular volumes), the aortic assessment could provide additional diagnostic and 
prognostic value. Overall, this study highlights the important role of vascular adaption in the 
pathogenesis and progress of DCM, and also demonstrates how ventricular-vascular 
abnormalities can be effectively studied using 4D flow imaging and advanced biophysical 
image processing.  
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FIGURE 1: Overview of assessed study metrics. Overview of the assessed metrics of the 
study, with cardiovascular (CV) characteristics given by cardiac MRI, aortic hemodynamics 
from 4D flow MRI, and central blood pressure from sphygmomanometer measures. The 
isolated influence of listed cardiovascular properties on aortic relative pressure is determined 
using a computational virtual cohort. LV = Left ventricle. RV = Right ventricle. EDV = End-
diastolic volume. ESV = End-systolic volume. SV = Stroke volume. EF = Ejection fraction. 




FIGURE 2: Overview of the virtual work-energy principle. Overview of the virtual work-
energy principle to derive aortic relative pressure from 4D flow MRI (left). Aortic 
segmentations (S, upper mid-portion) are shown together with corresponding virtual fields 
(lower mid-portion), used to isolate aortic relative pressure. Maximum relative pressure, 
minimum relative pressure, and time-to-peak relative pressure (TTP) are derived (right). Each 
case is processed individually, with the color coding of the segmentations corresponding to the 
ones of the relative pressure traces. 
 
 
FIGURE 3: Key results from aortic relative pressure analysis. (a) Maximum relative pressure, 
(b) TTP, (c) PWV, and (d) aortic stiffness for DCMred, DCMpres, and the control groups, 




FIGURE 4: Aortic relative pressure traces from clinical and virtual analysis. Aortic relative 
pressure traces from the clinical (top row) and virtual cohort (remaining rows), presented as a 
function of isolated variations of arterial resistance, stroke volume, cardiac period, aortic area, 
and aortic stiffness, respectively. Relative pressure is shown for DCMred (left), DCMpres 
(middle), and controls (right). For the clinical data, each individual subject is given in black. 
For the virtual data, isolated variations around baseline (black) are given as positive variations 
(red) and negative variations (blue), respectively, superimposed on the data range (grey).   
 
Tables 
TABLE 1: Data and subject characteristics. Data and subject characteristics for the DCMred, 
DCMpres, and control groups, respectively. Intragroup p-values are reported with significant 
differences indicated by * (p<0.05), ** (p<0.01), or *** (p<0.001), as well as with the color 
coding. Volumes are normalized by body surface area (BSA).  
Variable DCMred (n = 8) 
DCMpres 
(n = 5) 
Controls 











Subject demographics  
Age [yrs] 50.9 ± 5.5 42.8 ± 15.5 42.4 ± 12.4 0.080 0.967 0.524 
BMI [kg/m2] 30.2 ± 6.8 26.6 ± 7.6 23.8 ± 3.7 0.011* 0.458 0.429 
BSA [m2] 2.05 ± 0.22 1.83 ± 0.35 1.85 ± 0.23 0.053 0.965 0.284 
Male / Female 
[n] 4 / 4 3 / 2 9 / 7 0.772 0.882 0.724 
HR 
[beats/min] 66 ± 10.5 75.2 ± 15.8 68.3 ± 8.0 0.401 0.382 0.331 
Cine SSFP MRI  
LVEDV/BSA 
[mL/m2] 109.6 ± 38.9 86.7 ± 21.5 78.5 ± 9.4 0.032* 0.687 0.435 
LVESV/BSA 
[mL/m2] 69.2 ± 33.1 37.2 ± 11.9 28.8 ± 6.6 0.0003*** 0.186 0.045* 
SV/BSA 
[mL/m2] 46.1 ± 10.9 47.0 ± 6.2 49.6 ± 5.5 0.562 0.500 0.943 
EF [%] 41.6 ± 5.7 56.6 ± 6.1 63.9 ± 5.9 0.0001*** 0.049* 0.002** 
CO [l/min] 6.1 ± 1.1 6.3 ± 1.1 6.2 ± 1.0 0.674 0.965 0.833 
CI [l/(min/m2)] 2.9 ± 0.4 3.5 ± 0.4 3.4 ± 0.5 0.032* 0.622 0.045* 
RVEDV/BSA 
[mL] 
86.0 ± 28.5 76.9 ± 13.1 84.7 ± 8.6 0.973 0.298 0.833 
RVESV/BSA 
[mL] 
44.3 ± 9.4 29.6 ± 7.7 36.0 ± 5.3 0.811 0.070 0.524 
RVSV/BSA 
[mL] 
44.3 ± 9.4 47.1 ± 6.1 49.5 ± 5.5 0.207 0.559 0.524 
RVEF [%] 53.3 ± 8.2 61.8 ± 4.7 58.3 ± 4.1 0.258 0.204 0.118 
 
RVCO [l/min] 5.9 ± 1.1 6.3 ± 1.1 6.2 ± 1.0 0.457 1.000 0.499 
RVCI 
[l/(min/m2)] 2.9 ± 0.4 3.5 ± 0.4 3.4 ± 0.5 0.019* 0.687 0.030* 
Aortic 
curvature [-] 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.1 0.927 0.967 0.524 
Aortic length 
[cm] 27.8 ± 4.8 26.9 ± 3.1 25.5 ± 2.1 0.426 0.710 0.833 
Aortic 
diameter [cm] 1.6 ± 0.2 1.3 ± 0.2 1.5 ± 0.2 0.150 0.083 0.030* 
Central blood pressure  
SBP [mmHg] 125.3 ± 8.8 116 ± 10.2 116.9 ± 8.8 0.022* 0.985 0.165 
DBP [mmHg] 75.5 ± 5.6 69.6 ± 7.3 71.4 ± 5.8 0.122 0.431 0.107 















TABLE 2: Aortic flow analysis. Aortic relative pressure metrics for the DCMred, DCMpres, and 
control groups, respectively. Intragroup p-values are reported with significant differences 
indicated by * (p<0.05), ** (p<0.01), or *** (p<0.001), as well as with the color coding.  
Variable DCMred (n = 8) 
DCMpres 
(n = 5) 
Controls 
























109 ± 22 108 ± 38 55 ± 22 0.0002*** 0.011* 0.908 
Pulse wave 
velocity [m/s] 11.0 ± 4.6 7.5 ± 2.5 7.5 ± 2.6 0.034* 0.967 0.127 
Aortic 
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Supplementary methods 
Structural magnetic resonance protocol and analysis 
For structural analysis, cine SSFP MRI (retrospective ECG gating, spatial resolution ~2x2x8 
mm3, temporal resolution ~20 ms) and 3D tagged MRI (prospective ECG triggering, spatial 
resolution ~3.4x3.4x7.7 mm3, temporal resolution ~30 ms) was acquired, all using a 1.5T 
Philips ACHIEVA system (Philips Healthcare Best, The Netherlands).  
Left and right ventricular volumes (end-diastolic volumes (LVEDV, RVEDV) end-systolic 
volumes (LVESV, RVESV)), as well as left and right ventricular output metrics such as 
ejection fraction, stroke volume and cardiac output (EF, SV, CO, RVEF, RVSV, RVCO) 
were calculated by manually identifying end-diastolic and end-systolic segmentations of the 
short-axis images (CVI software, Circle Cardiovascular Imaging Inc, Alberta, Canada).  
Mathematical details of the derivation of relative pressure from 4D flow MRI 
From the 4D flow MRI data, relative pressure was derived using a virtual work-energy 
approach – 𝜈WERP – originally presented and validated against invasive catheter 
measurements in Marlevi et al(1). The method originates from the Navier-Stokes equation, in 
which the conservation of mass and momentum are used to constrain the 3D movement of 
Newtonian fluid over time. From such, 𝜈WERP estimates the relative pressure ∆𝑝 across an 





𝜕𝑡 𝐾1 + 𝐴1 + 𝑉15. 
(A) 
Each entry in equation (A) now represents separated virtual energy components of an 
introduced virtual field, created in conjunction to the acquired 4D flow MRI. Specifically 𝑄 
is the virtual flow through the inlet,  𝐾1 the virtual kinetic energy held within the fluid, 𝐴1 the 
rate at which virtual kinetic energy changes within the field, and 𝑉1 the rate of virtual viscous 
energy dissipation by the field.  
With the above, 𝜈WERP acts directly on the non-invasively acquired 4D flow MRI data, 
and does not require any additional measurements to compute ∆𝑝. Specific details on data 
post-processing of the acquired velocity field, 𝒗, as well as the creation of the auxiliary 
virtual field, 𝒘, are all described using an identical setup in Marlevi et al(1).  
Virtual cohort creation and analysis 
A virtual cohort was utilized based on Willemet et al(2), where blood pressure, blood flow, 
and arterial area waveforms could be simulated using a validated one-dimensional (1D) 
computational model of arterial hemodynamics consisting of the 55 larger arteries of the 
human systemic circulation(3). The virtual cohort was adapted to match the clinical 
characteristics, creating three virtual subgroups: one virtual DCMred group, one virtual 
DCMpres group, and one virtual control group, respectively. Specific cardiovascular parameter 
values (all originating from the clinical acquisitions) are defined in Supplementary Table 1.  
For each subgroup, a baseline virtual subject was created to match the mean of the clinical 
characteristics. The independent influence of certain cardiovascular properties was then 
assessed by creating a set of virtual subjects for each defined property, varying that specific 
entity within the clinical subgroup range whilst keeping the rest of the properties at baseline 
level. By doing so, the isolated influence on aortic relative pressure from SV, heart rate, 
arterial peripheral resistance (calculated from mean blood pressure and cardiac output), aortic 
stiffness, and aortic area was evaluated. Similarly, virtual flow profiles were generated based 
on through-plane LVOT flows from the 4D flow MRI of each subgroup, respectively. For 
each virtual subject, aortic relative pressure was calculated from the LVOT to the end of the 
thoracic aorta, with relative pressure normalized by aortic length to match the derived clinical 
data. Note that the LVOT level was assigned at the aortic root, with no valvular influence 
included in the simulated output (assuming normal valvular function for the entire virtual 
cohort).  
General cardiovascular parameter values, which were kept constant over all virtual subjects, 
were taken from Willemet et al(2) and modified when appropriate. The parameters and their 
corresponding values were: blood density (1050 kg/m3), blood viscosity (0.0025 Pa×s), 
velocity profile coefficient (1.33, corresponding to a Poiseuille flow), and outflow pressure (0 
Pa).  
Aortic stiffness was calculated ensuring that PWV in the virtual subjects was equal to the 
mean PWV values extracted from each clinical subgroup. With the exact length of the 
clinical subject aortas unknown, virtual aortic lengths were taken from Willemet et al(2). 
Aortic diastolic areas were also extracted from the same reference, and scaled according to 
the ratio of the clinical to virtual average aortic areas. 
For each virtual subgroup, mean values of left-ventricular ejection time (LVET) and time-to-
peak flow were calculated from the corresponding clinical subgroup flow data. A spline 
interpolation was performed to smooth each flow waveform. LVET was then extracted using 
an in-house algorithm. Time-to-peak flow was extracted as the time of maximum flow. For 
each subgroup, the average values of LVET and time-to-peak flow were used to generate the 
virtual flow profiles.  
1D simulations were run for a total of 20 s with a 0.1 ms time step to ensure numerical 
convergence. A visual check of all virtual pressure waveforms at the ascending and 
abdominal aorta was additionally employed to confirm convergence.   
Supplementary results 
Correlation analysis 
Pearson correlation coefficients for a few maximum relative pressure, minimum relative 
pressure, time-to-peak relative pressure, pulse wave velocity, and aortic stiffness are all 
provided in Supplementary Table 2. Condensed key results are provided in the main 
manuscript, however for completeness here follows a detailed description of the obtained 
correlation results: 
For the aortic maximum relative pressure, no significant correlation could be identified with 
any of the subject characteristics in the DCM cohort.  
For the aortic minimum relative pressure, similar behavior could be observed: for the DCM 
patients no correlations could be inferred with any of the evaluated clinical parameters. For 
the control group however, slight negative correlation could be inferred between minimum 
aortic relative pressure and body surface area (R=-0.73, p=0.002).  
For TTP no correlation could be inferred for any of the clinical groups at the set significance 
level.  
Lastly, for PWV and derived arterial stiffness, only body mass index was correlated to 
arterial, stiffness (R=0.755, p = 0.001), however only inferable for the control group.  
As noted in the main manuscript, absolute systolic, diastolic, and central blood pressure 
(SBP, DBP or CBP) did not correlate with any of the evaluated aortic relative pressure 
metrics.   
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SUPPLEMENTARY TABLE 1: Parameter variation for virtual cohort. Parameter variations 
for each virtual cohort with all data derived from the in vivo imaging. For each subgroup, the 
baseline virtual subject corresponded to the mean parameter value. Each additional virtual 
subject within that subgroup corresponded to the variation of a single, isolated parameter 
(varied from minimum to maximum, one at a time). 
 
CV parameters 
Virtual DCMred Virtual DCMpres Virtual controls 
min mean max min mean max min mean max 
Peripheral resistance,  
[mmHg s/mL] 
0.69 0.77 0.84 0.64 0.89 1.20 0.61 0.78 1.04 
Stroke volume, [mL] 55.0 95.5 132.0 53.0 86.0 100.0 66.3 91.7 122.9 
Cardiac period, [s] 0.75 0.91 1.13 0.59 0.80 1.00 0.70 0.88 1.03 
Aortic area, [cm2] 1.86 2.96 3.87 1.21 1.96 2.72 1.72 2.49 3.66 
Aortic PWV, [m/s] 6.10 11.00 19.40 5.20 7.70 10.00 4.50 7.50 13.90 
 
  
SUPPLEMENTARY TABLE 2: Complete Pearson correlation coefficient table. Pearson 
correlation coefficient, for the evaluation of aortic relative pressure measurements. 
Correlation is evaluated against maximum relative pressure, minimum relative pressure, time 
to peak relative pressure, pulse wave velocity, and aortic stiffness, respectively. Data is also 
separated for DCM with reduced LV function (n=8), DCM with preserved LV function 
(n=5), and control group (n=16), respectively. If a correlation is statistically significant with 
Bonferroni correction (|R| > 0.5 and p < 0.002, m=21) this is indicated by * (correlations 
removed by Bonferroni correction indicated by +). Significance is also indicated by the color 
coding.  
  
SUPPLEMENTARY TABLE 3: Maximum relative pressure variations from the virtual 
cohort analysis. Results from the virtual cohort analysis, showing variations in aortic 
maximum relative pressure per unit length as a function of isolated variations of peripheral 
resistance, stroke volume, cardiac period, aortic area, and aortic stiffness, respectively. Data 
provided for baseline, minimum and maximum range, with all values reported in mmHg/m. 




Virtual DCMred Virtual DCMpres Virtual controls 
min baseline max min baseline max min baseline max 
Peripheral 
resistance 
36.3 36.5 36.7 39.8 42.0 43.8 49.4 51.3 52.5 
Stroke 
Volume 
23.9 36.5 45.6 30.1 42.0 46.0 41.5 51.3 60.8 
Cardiac 
period 
35.9 36.5 37.2 42.7 42.0 42.9 50.2 51.3 51.3 
Aortic area 28.1 36.5 56.5 31.5 42.0 62.5 38.1 51.3 68.5 
Aortic 
stiffness 
26.5 36.5 41.9 28.3 42.0 49.7 30.4 51.3 72.1 
Total range 23.9 36.5 56.5 28.3 42.0 62.5 30.4 51.3 72.1 
 
  
SUPPLEMENTARY TABLE 4: Minimum relative pressure variations from the virtual 
cohort analysis. Results from the virtual cohort analysis, showing variations in aortic 
minimum relative pressure per unit length as a function of isolated variations of peripheral 
resistance, stroke volume, cardiac period, aortic area, and aortic stiffness, respectively. Data 
provided for baseline, minimum and maximum range, with all values reported in mmHg/m. 




Virtual DCMred Virtual DCMpres Virtual controls 
min baseline max min baseline max min baseline max 
Peripheral 
resistance 
-38.4 -38.5 -38.7 -45.2 -43.8 -41.9 -38.5 -37.5 -36.1 
Stroke 
Volume 
-42.8 -38.5 -32.2 -45.0 -43.8 -37.2 -38.9 -37.5 -34.1 
Cardiac 
period 
-43.0 -38.5 -37.1 -49.0 -43.8 -42.0 -39.8 -37.5 -36.4 
Aortic area -57.8 -38.5 -30.2 -62.2 -43.8 -33.2 -51.1 -37.5 -26.5 
Aortic 
stiffness 
-49.0 -38.5 -28.9 -50.7 -43.8 -31.4 -49.2 -37.5 -23.9 
Total range -57.8 -38.5 -28.9 -62.2 -43.8 -31.4 -51.1 -37.5 -23.9 
 
